Category,ID,Description,BgRatio,pvalue,padjust,qvalue,geneID,gene_name,rankScore,Count
BP,GO:0072593,reactive oxygen species metabolic process,276/18493,3.64E-23,9.85E-20,3.43E-20,3630/207/6774/7157/1401/3553/5743/3586/3383/4846/4353/3458/847/4843/4314/2147/596/948,"INS,AKT1,STAT3,TP53,CRP,IL1B,PTGS2,IL10,ICAM1,NOS3,MPO,IFNG,CAT,NOS2,MMP3,F2,BCL2,CD36",2.798609503,18
BP,GO:2000377,regulation of reactive oxygen species metabolic process,185/18493,7.41E-19,1.00E-15,3.49E-16,3630/207/6774/7157/1401/3553/5743/3586/3383/3458/4314/2147/596/948,"INS,AKT1,STAT3,TP53,CRP,IL1B,PTGS2,IL10,ICAM1,IFNG,MMP3,F2,BCL2,CD36",1.731640632,14
BP,GO:0032496,response to lipopolysaccharide,324/18493,1.43E-18,1.29E-15,4.48E-16,3569/207/6347/3576/3553/5743/3586/5594/3383/7412/836/4846/4353/5054/4843/948,"IL6,AKT1,CCL2,CXCL8,IL1B,PTGS2,IL10,MAPK1,ICAM1,VCAM1,CASP3,NOS3,MPO,SERPINE1,NOS2,CD36",2.085701821,16
BP,GO:0002237,response to molecule of bacterial origin,337/18493,2.68E-18,1.81E-15,6.30E-16,3569/207/6347/3576/3553/5743/3586/5594/3383/7412/836/4846/4353/5054/4843/948,"IL6,AKT1,CCL2,CXCL8,IL1B,PTGS2,IL10,MAPK1,ICAM1,VCAM1,CASP3,NOS3,MPO,SERPINE1,NOS2,CD36",2.064956386,16
BP,GO:1903409,reactive oxygen species biosynthetic process,115/18493,6.30E-18,3.41E-15,1.19E-15,3630/207/6774/3553/5743/3586/3383/4846/4353/3458/4843/948,"INS,AKT1,STAT3,IL1B,PTGS2,IL10,ICAM1,NOS3,MPO,IFNG,NOS2,CD36",1.50858762,12
BP,GO:0006979,response to oxidative stress,441/18493,1.91E-16,8.59E-14,2.99E-14,3569/3630/207/7157/4318/5743/3586/5594/836/4846/4353/3162/847/4314/596/948,"IL6,INS,AKT1,TP53,MMP9,PTGS2,IL10,MAPK1,CASP3,NOS3,MPO,HMOX1,CAT,MMP3,BCL2,CD36",1.761569779,16
BP,GO:0034599,cellular response to oxidative stress,289/18493,4.02E-16,1.55E-13,5.41E-14,3569/3630/207/7157/4318/3586/5594/4846/4353/3162/847/4314/596/948,"IL6,INS,AKT1,TP53,MMP9,IL10,MAPK1,NOS3,MPO,HMOX1,CAT,MMP3,BCL2,CD36",1.495938428,14
BP,GO:0000302,response to reactive oxygen species,224/18493,5.24E-16,1.77E-13,6.16E-14,3569/207/4318/3586/5594/836/4846/4353/3162/847/4314/596/948,"IL6,AKT1,MMP9,IL10,MAPK1,CASP3,NOS3,MPO,HMOX1,CAT,MMP3,BCL2,CD36",1.32581211,13
BP,GO:0071216,cellular response to biotic stimulus,229/18493,6.99E-16,2.10E-13,7.31E-14,3569/207/6347/7157/3576/3553/3586/5594/3383/4846/5054/4843/948,"IL6,AKT1,CCL2,TP53,CXCL8,IL1B,IL10,MAPK1,ICAM1,NOS3,SERPINE1,NOS2,CD36",1.453351132,13
BP,GO:0071222,cellular response to lipopolysaccharide,199/18493,5.24E-15,1.36E-12,4.72E-13,3569/207/6347/3576/3553/3586/5594/3383/4846/5054/4843/948,"IL6,AKT1,CCL2,CXCL8,IL1B,IL10,MAPK1,ICAM1,NOS3,SERPINE1,NOS2,CD36",1.244321674,12
BP,GO:0070482,response to oxygen levels,349/18493,5.52E-15,1.36E-12,4.72E-13,207/7422/7157/5743/5468/3383/7412/836/3162/847/4313/4843/4314/596,"AKT1,VEGFA,TP53,PTGS2,PPARG,ICAM1,VCAM1,CASP3,HMOX1,CAT,MMP2,NOS2,MMP3,BCL2",1.373643837,14
BP,GO:0071219,cellular response to molecule of bacterial origin,206/18493,7.95E-15,1.79E-12,6.23E-13,3569/207/6347/3576/3553/3586/5594/3383/4846/5054/4843/948,"IL6,AKT1,CCL2,CXCL8,IL1B,IL10,MAPK1,ICAM1,NOS3,SERPINE1,NOS2,CD36",1.231717944,12
BP,GO:0006809,nitric oxide biosynthetic process,73/18493,2.69E-14,5.60E-12,1.95E-12,207/3553/5743/3586/3383/4846/3458/4843/948,"AKT1,IL1B,PTGS2,IL10,ICAM1,NOS3,IFNG,NOS2,CD36",0.828851796,9
BP,GO:0001666,response to hypoxia,314/18493,4.16E-14,8.02E-12,2.79E-12,207/7422/7157/5743/3383/7412/836/3162/847/4313/4843/4314/596,"AKT1,VEGFA,TP53,PTGS2,ICAM1,VCAM1,CASP3,HMOX1,CAT,MMP2,NOS2,MMP3,BCL2",1.182842293,13
BP,GO:0046209,nitric oxide metabolic process,77/18493,4.45E-14,8.02E-12,2.79E-12,207/3553/5743/3586/3383/4846/3458/4843/948,"AKT1,IL1B,PTGS2,IL10,ICAM1,NOS3,IFNG,NOS2,CD36",0.817370098,9
BP,GO:2001057,reactive nitrogen species metabolic process,80/18493,6.37E-14,1.03E-11,3.58E-12,207/3553/5743/3586/3383/4846/3458/4843/948,"AKT1,IL1B,PTGS2,IL10,ICAM1,NOS3,IFNG,NOS2,CD36",0.809382979,9
BP,GO:0036293,response to decreased oxygen levels,325/18493,6.47E-14,1.03E-11,3.58E-12,207/7422/7157/5743/3383/7412/836/3162/847/4313/4843/4314/596,"AKT1,VEGFA,TP53,PTGS2,ICAM1,VCAM1,CASP3,HMOX1,CAT,MMP2,NOS2,MMP3,BCL2",1.171283879,13
BP,GO:1903426,regulation of reactive oxygen species biosynthetic process,94/18493,2.86E-13,4.30E-11,1.50E-11,3630/207/6774/3553/5743/3586/3383/3458/948,"INS,AKT1,STAT3,IL1B,PTGS2,IL10,ICAM1,IFNG,CD36",0.834242112,9
BP,GO:0050900,leukocyte migration,478/18493,4.11E-13,5.69E-11,1.98E-11,3569/207/6347/7422/3576/3553/4318/3586/3383/7412/5054/3162/4312/7941,"IL6,AKT1,CCL2,VEGFA,CXCL8,IL1B,MMP9,IL10,ICAM1,VCAM1,SERPINE1,HMOX1,MMP1,PLA2G7",1.282018754,14
BP,GO:2000379,positive regulation of reactive oxygen species metabolic process,98/18493,4.21E-13,5.69E-11,1.98E-11,207/7157/1401/3553/5743/3383/3458/2147/948,"AKT1,TP53,CRP,IL1B,PTGS2,ICAM1,IFNG,F2,CD36",0.763966848,9
BP,GO:0031667,response to nutrient levels,481/18493,4.47E-13,5.76E-11,2.00E-11,207/7157/3553/5743/5468/5594/3383/7412/4353/3162/847/5444/3156/596,"AKT1,TP53,IL1B,PTGS2,PPARG,MAPK1,ICAM1,VCAM1,MPO,HMOX1,CAT,PON1,HMGCR,BCL2",1.146490935,14
BP,GO:0042136,neurotransmitter biosynthetic process,102/18493,6.09E-13,7.49E-11,2.60E-11,207/3553/5743/3586/3383/4846/3458/4843/948,"AKT1,IL1B,PTGS2,IL10,ICAM1,NOS3,IFNG,NOS2,CD36",0.745916859,9
BP,GO:0007568,aging,311/18493,1.08E-12,1.27E-10,4.42E-11,207/6774/7157/5743/3586/3383/7412/4353/5054/847/3156/596,"AKT1,STAT3,TP53,PTGS2,IL10,ICAM1,VCAM1,MPO,SERPINE1,CAT,HMGCR,BCL2",0.976031848,12
BP,GO:0051090,regulation of DNA-binding transcription factor activity,412/18493,1.33E-12,1.49E-10,5.20E-11,3569/3630/207/7422/3553/5468/3586/5594/3383/3162/847/959/948,"IL6,INS,AKT1,VEGFA,IL1B,PPARG,IL10,MAPK1,ICAM1,HMOX1,CAT,CD40LG,CD36",1.1245423,13
BP,GO:0033002,muscle cell proliferation,236/18493,1.42E-12,1.53E-10,5.33E-11,3569/207/6774/4318/5743/5468/3586/3458/3162/4313/3156,"IL6,AKT1,STAT3,MMP9,PTGS2,PPARG,IL10,IFNG,HMOX1,MMP2,HMGCR",0.963964633,11
BP,GO:0048660,regulation of smooth muscle cell proliferation,168/18493,1.48E-12,1.54E-10,5.36E-11,3569/207/4318/5743/5468/3586/3458/3162/4313/3156,"IL6,AKT1,MMP9,PTGS2,PPARG,IL10,IFNG,HMOX1,MMP2,HMGCR",0.861609017,10
BP,GO:0048659,smooth muscle cell proliferation,170/18493,1.67E-12,1.63E-10,5.67E-11,3569/207/4318/5743/5468/3586/3458/3162/4313/3156,"IL6,AKT1,MMP9,PTGS2,PPARG,IL10,IFNG,HMOX1,MMP2,HMGCR",0.859488085,10
BP,GO:0046677,response to antibiotic,323/18493,1.69E-12,1.63E-10,5.67E-11,3569/6774/7157/3586/3383/7412/836/3162/847/3156/596/1080,"IL6,STAT3,TP53,IL10,ICAM1,VCAM1,CASP3,HMOX1,CAT,HMGCR,BCL2,CFTR",0.915284097,12
BP,GO:0050727,regulation of inflammatory response,425/18493,1.96E-12,1.83E-10,6.37E-11,3569/3630/3553/4318/5743/5468/3586/5054/4843/4314/2147/4023/7941,"IL6,INS,IL1B,MMP9,PTGS2,PPARG,IL10,SERPINE1,NOS2,MMP3,F2,LPL,PLA2G7",1.043916391,13
BP,GO:0051091,positive regulation of DNA-binding transcription factor activity,255/18493,3.29E-12,2.97E-10,1.03E-10,3569/3630/207/7422/3553/5468/3586/3383/847/959/948,"IL6,INS,AKT1,VEGFA,IL1B,PPARG,IL10,ICAM1,CAT,CD40LG,CD36",0.9267482,11
BP,GO:0042110,T cell activation,451/18493,4.15E-12,3.62E-10,1.26E-10,3569/3630/207/6774/6347/3553/3586/3383/7412/836/3458/959/596,"IL6,INS,AKT1,STAT3,CCL2,IL1B,IL10,ICAM1,VCAM1,CASP3,IFNG,CD40LG,BCL2",1.104496462,13
BP,GO:0006953,acute-phase response,47/18493,6.21E-12,5.25E-10,1.83E-10,3569/3630/6774/1401/3553/5743/2147,"IL6,INS,STAT3,CRP,IL1B,PTGS2,F2",0.636028589,7
BP,GO:0062013,positive regulation of small molecule metabolic process,142/18493,1.25E-11,1.03E-09,3.57E-10,3630/207/6774/3553/5743/5468/4846/3458/4843,"INS,AKT1,STAT3,IL1B,PTGS2,PPARG,NOS3,IFNG,NOS2",0.761187208,9
BP,GO:0002526,acute inflammatory response,211/18493,1.44E-11,1.14E-09,3.98E-10,3569/3630/6774/1401/3553/5743/5468/3383/7412/2147,"IL6,INS,STAT3,CRP,IL1B,PTGS2,PPARG,ICAM1,VCAM1,F2",0.852727513,10
BP,GO:0010876,lipid localization,393/18493,1.67E-11,1.29E-09,4.50E-10,3569/207/1401/3553/5468/4843/4023/5444/5243/1071/1080/948,"IL6,AKT1,CRP,IL1B,PPARG,NOS2,LPL,PON1,ABCB1,CETP,CFTR,CD36",0.722040289,12
BP,GO:0042133,neurotransmitter metabolic process,148/18493,1.82E-11,1.37E-09,4.76E-10,207/3553/5743/3586/3383/4846/3458/4843/948,"AKT1,IL1B,PTGS2,IL10,ICAM1,NOS3,IFNG,NOS2,CD36",0.652969198,9
BP,GO:0043062,extracellular structure organization,402/18493,2.18E-11,1.59E-09,5.54E-10,4318/3383/7412/4353/5054/4313/4312/4314/4023/7941/1071/948,"MMP9,ICAM1,VCAM1,MPO,SERPINE1,MMP2,MMP1,MMP3,LPL,PLA2G7,CETP,CD36",0.710606377,12
BP,GO:1905952,regulation of lipid localization,152/18493,2.32E-11,1.65E-09,5.73E-10,3569/207/1401/3553/5468/4023/5444/1071/948,"IL6,AKT1,CRP,IL1B,PPARG,LPL,PON1,CETP,CD36",0.596630702,9
BP,GO:2001234,negative regulation of apoptotic signaling pathway,222/18493,2.38E-11,1.65E-09,5.74E-10,3630/207/3553/4318/5743/3383/4846/5054/3162/596,"INS,AKT1,IL1B,MMP9,PTGS2,ICAM1,NOS3,SERPINE1,HMOX1,BCL2",0.771267976,10
BP,GO:0048661,positive regulation of smooth muscle cell proliferation,98/18493,2.50E-11,1.69E-09,5.88E-10,3569/207/4318/5743/3586/3162/4313/3156,"IL6,AKT1,MMP9,PTGS2,IL10,HMOX1,MMP2,HMGCR",0.61785166,8
BP,GO:0034614,cellular response to reactive oxygen species,162/18493,4.11E-11,2.71E-09,9.44E-10,3569/207/4318/3586/5594/4846/4353/4314/948,"IL6,AKT1,MMP9,IL10,MAPK1,NOS3,MPO,MMP3,CD36",0.651908138,9
BP,GO:0045428,regulation of nitric oxide biosynthetic process,62/18493,4.75E-11,3.06E-09,1.06E-09,207/3553/5743/3586/3383/3458/948,"AKT1,IL1B,PTGS2,IL10,ICAM1,IFNG,CD36",0.496267728,7
BP,GO:0002685,regulation of leukocyte migration,180/18493,1.06E-10,6.65E-09,2.31E-09,3569/207/6347/7422/3576/3383/5054/3162/7941,"IL6,AKT1,CCL2,VEGFA,CXCL8,ICAM1,SERPINE1,HMOX1,PLA2G7",0.663363972,9
BP,GO:0035690,cellular response to drug,355/18493,1.16E-10,7.12E-09,2.48E-09,3569/7157/3553/5743/3586/5594/3383/3162/4843/4314/1080,"IL6,TP53,IL1B,PTGS2,IL10,MAPK1,ICAM1,HMOX1,NOS2,MMP3,CFTR",0.749859314,11
BP,GO:0035296,regulation of tube diameter,129/18493,2.31E-10,1.36E-08,4.73E-09,3630/207/1401/5743/3383/4846/3162/3156,"INS,AKT1,CRP,PTGS2,ICAM1,NOS3,HMOX1,HMGCR",0.560409595,8
BP,GO:0097746,regulation of blood vessel diameter,129/18493,2.31E-10,1.36E-08,4.73E-09,3630/207/1401/5743/3383/4846/3162/3156,"INS,AKT1,CRP,PTGS2,ICAM1,NOS3,HMOX1,HMGCR",0.560409595,8
BP,GO:0051051,negative regulation of transport,495/18493,2.40E-10,1.38E-08,4.81E-09,3630/207/3553/4318/5743/3586/3383/4846/3162/3156/596/948,"INS,AKT1,IL1B,MMP9,PTGS2,IL10,ICAM1,NOS3,HMOX1,HMGCR,BCL2,CD36",0.746395261,12
BP,GO:0045765,regulation of angiogenesis,381/18493,2.46E-10,1.38E-08,4.82E-09,3569/6774/7422/3576/3553/5743/5468/3586/4846/5054/3162,"IL6,STAT3,VEGFA,CXCL8,IL1B,PTGS2,PPARG,IL10,NOS3,SERPINE1,HMOX1",0.817035437,11
BP,GO:0045766,positive regulation of angiogenesis,200/18493,2.71E-10,1.49E-08,5.20E-09,6774/7422/3576/3553/5743/3586/4846/5054/3162,"STAT3,VEGFA,CXCL8,IL1B,PTGS2,IL10,NOS3,SERPINE1,HMOX1",0.649539594,9
BP,GO:0045429,positive regulation of nitric oxide biosynthetic process,42/18493,2.92E-10,1.55E-08,5.38E-09,207/3553/5743/3383/3458/948,"AKT1,IL1B,PTGS2,ICAM1,IFNG,CD36",0.384291626,6
BP,GO:1904407,positive regulation of nitric oxide metabolic process,42/18493,2.92E-10,1.55E-08,5.38E-09,207/3553/5743/3383/3458/948,"AKT1,IL1B,PTGS2,ICAM1,IFNG,CD36",0.384291626,6
BP,GO:2001233,regulation of apoptotic signaling pathway,391/18493,3.23E-10,1.68E-08,5.85E-09,3630/207/7157/3553/4318/5743/3383/4846/5054/3162/596,"INS,AKT1,TP53,IL1B,MMP9,PTGS2,ICAM1,NOS3,SERPINE1,HMOX1,BCL2",0.758781646,11
BP,GO:0050880,regulation of blood vessel size,136/18493,3.53E-10,1.80E-08,6.27E-09,3630/207/1401/5743/3383/4846/3162/3156,"INS,AKT1,CRP,PTGS2,ICAM1,NOS3,HMOX1,HMGCR",0.551678389,8
BP,GO:1903037,regulation of leukocyte cell-cell adhesion,293/18493,3.62E-10,1.82E-08,6.31E-09,3569/207/6347/3553/3586/3383/7412/836/3458/959,"IL6,AKT1,CCL2,IL1B,IL10,ICAM1,VCAM1,CASP3,IFNG,CD40LG",0.710776861,10
BP,GO:0035150,regulation of tube size,137/18493,3.74E-10,1.84E-08,6.38E-09,3630/207/1401/5743/3383/4846/3162/3156,"INS,AKT1,CRP,PTGS2,ICAM1,NOS3,HMOX1,HMGCR",0.551105499,8
BP,GO:0045785,positive regulation of cell adhesion,397/18493,3.80E-10,1.84E-08,6.38E-09,3569/207/6347/7422/3553/3586/3383/7412/3458/959/948,"IL6,AKT1,CCL2,VEGFA,IL1B,IL10,ICAM1,VCAM1,IFNG,CD40LG,CD36",0.737083513,11
BP,GO:1901342,regulation of vasculature development,421/18493,7.06E-10,3.35E-08,1.17E-08,3569/6774/7422/3576/3553/5743/5468/3586/4846/5054/3162,"IL6,STAT3,VEGFA,CXCL8,IL1B,PTGS2,PPARG,IL10,NOS3,SERPINE1,HMOX1",0.777129288,11
BP,GO:0001819,positive regulation of cytokine production,422/18493,7.24E-10,3.38E-08,1.17E-08,3569/3630/3553/5743/3586/5054/3458/3162/959/4023/948,"IL6,INS,IL1B,PTGS2,IL10,SERPINE1,IFNG,HMOX1,CD40LG,LPL,CD36",0.674414672,11
BP,GO:0097191,extrinsic apoptotic signaling pathway,224/18493,7.39E-10,3.39E-08,1.18E-08,207/3553/3383/836/4846/5054/3458/3162/596,"AKT1,IL1B,ICAM1,CASP3,NOS3,SERPINE1,IFNG,HMOX1,BCL2",0.554982379,9
BP,GO:1904018,positive regulation of vasculature development,228/18493,8.64E-10,3.89E-08,1.35E-08,6774/7422/3576/3553/5743/3586/4846/5054/3162,"STAT3,VEGFA,CXCL8,IL1B,PTGS2,IL10,NOS3,SERPINE1,HMOX1",0.614998961,9
BP,GO:1904951,positive regulation of establishment of protein localization,437/18493,1.05E-09,4.59E-08,1.60E-08,3569/3630/7157/3553/5743/3586/5594/3458/4023/596/1080,"IL6,INS,TP53,IL1B,PTGS2,IL10,MAPK1,IFNG,LPL,BCL2,CFTR",0.662846041,11
BP,GO:0007159,leukocyte cell-cell adhesion,327/18493,1.05E-09,4.59E-08,1.60E-08,3569/207/6347/3553/3586/3383/7412/836/3458/959,"IL6,AKT1,CCL2,IL1B,IL10,ICAM1,VCAM1,CASP3,IFNG,CD40LG",0.673813369,10
BP,GO:0050708,regulation of protein secretion,438/18493,1.07E-09,4.60E-08,1.60E-08,3569/3630/1401/3553/3586/3458/4843/959/4023/3156/1080,"IL6,INS,CRP,IL1B,IL10,IFNG,NOS2,CD40LG,LPL,HMGCR,CFTR",0.628458579,11
BP,GO:0001101,response to acid chemical,332/18493,1.22E-09,5.14E-08,1.79E-08,207/7422/5743/5468/3383/836/847/4313/5444/948,"AKT1,VEGFA,PTGS2,PPARG,ICAM1,CASP3,CAT,MMP2,PON1,CD36",0.583416809,10
BP,GO:0003018,vascular process in circulatory system,161/18493,1.36E-09,5.64E-08,1.96E-08,3630/207/1401/5743/3383/4846/3162/3156,"INS,AKT1,CRP,PTGS2,ICAM1,NOS3,HMOX1,HMGCR",0.516361768,8
BP,GO:1903428,positive regulation of reactive oxygen species biosynthetic process,55/18493,1.58E-09,6.48E-08,2.25E-08,207/3553/5743/3383/3458/948,"AKT1,IL1B,PTGS2,ICAM1,IFNG,CD36",0.353696785,6
BP,GO:2001237,negative regulation of extrinsic apoptotic signaling pathway,104/18493,1.92E-09,7.77E-08,2.70E-08,207/3553/3383/4846/5054/3162/596,"AKT1,IL1B,ICAM1,NOS3,SERPINE1,HMOX1,BCL2",0.407557818,7
BP,GO:0002791,regulation of peptide secretion,465/18493,2.01E-09,7.89E-08,2.74E-08,3569/3630/1401/3553/3586/3458/4843/959/4023/3156/1080,"IL6,INS,CRP,IL1B,IL10,IFNG,NOS2,CD40LG,LPL,HMGCR,CFTR",0.608380898,11
BP,GO:0022409,positive regulation of cell-cell adhesion,251/18493,2.01E-09,7.89E-08,2.74E-08,3569/207/6347/3553/3586/3383/7412/3458/959,"IL6,AKT1,CCL2,IL1B,IL10,ICAM1,VCAM1,IFNG,CD40LG",0.590089374,9
BP,GO:0032963,collagen metabolic process,106/18493,2.20E-09,8.50E-08,2.96E-08,3569/4318/5468/4313/4312/4314/2147,"IL6,MMP9,PPARG,MMP2,MMP1,MMP3,F2",0.409022819,7
BP,GO:0062012,regulation of small molecule metabolic process,355/18493,2.32E-09,8.84E-08,3.08E-08,3630/207/6774/3553/5743/5468/4846/3458/4843/3156,"INS,AKT1,STAT3,IL1B,PTGS2,PPARG,NOS3,IFNG,NOS2,HMGCR",0.625329211,10
BP,GO:0034612,response to tumor necrosis factor,257/18493,2.48E-09,9.20E-08,3.20E-08,207/6347/3576/5743/5594/3383/7412/836/959,"AKT1,CCL2,CXCL8,PTGS2,MAPK1,ICAM1,VCAM1,CASP3,CD40LG",0.570234309,9
BP,GO:1904019,epithelial cell apoptotic process,108/18493,2.51E-09,9.20E-08,3.20E-08,3569/6347/3586/3383/5054/3162/959,"IL6,CCL2,IL10,ICAM1,SERPINE1,HMOX1,CD40LG",0.436477488,7
BP,GO:0010038,response to metal ion,358/18493,2.52E-09,9.20E-08,3.20E-08,207/4318/5743/5594/3383/7412/836/3162/847/596,"AKT1,MMP9,PTGS2,MAPK1,ICAM1,VCAM1,CASP3,HMOX1,CAT,BCL2",0.591564413,10
BP,GO:1901652,response to peptide,481/18493,2.86E-09,1.03E-07,3.58E-08,3630/207/6774/7157/3553/5743/5468/3586/3383/847/948,"INS,AKT1,STAT3,TP53,IL1B,PTGS2,PPARG,IL10,ICAM1,CAT,CD36",0.692927649,11
BP,GO:0007263,nitric oxide mediated signal transduction,28/18493,3.03E-09,1.08E-07,3.75E-08,3630/7422/4846/4843/948,"INS,VEGFA,NOS3,NOS2,CD36",0.274219991,5
BP,GO:0010743,regulation of macrophage derived foam cell differentiation,30/18493,4.38E-09,1.54E-07,5.34E-08,1401/5468/4023/1071/948,"CRP,PPARG,LPL,CETP,CD36",0.208439749,5
BP,GO:0071453,cellular response to oxygen levels,187/18493,4.43E-09,1.54E-07,5.34E-08,207/7422/7157/5743/5468/3383/3162/596,"AKT1,VEGFA,TP53,PTGS2,PPARG,ICAM1,HMOX1,BCL2",0.469730535,8
BP,GO:0019915,lipid storage,66/18493,4.87E-09,1.67E-07,5.80E-08,3569/1401/3553/5468/4023/948,"IL6,CRP,IL1B,PPARG,LPL,CD36",0.328677769,6
BP,GO:0022407,regulation of cell-cell adhesion,388/18493,5.44E-09,1.84E-07,6.40E-08,3569/207/6347/3553/3586/3383/7412/836/3458/959,"IL6,AKT1,CCL2,IL1B,IL10,ICAM1,VCAM1,CASP3,IFNG,CD40LG",0.618409771,10
BP,GO:1900180,regulation of protein localization to nucleus,121/18493,5.57E-09,1.86E-07,6.47E-08,3630/207/5743/5594/3458/2147/948,"INS,AKT1,PTGS2,MAPK1,IFNG,F2,CD36",0.385453998,7
BP,GO:0051222,positive regulation of protein transport,402/18493,7.63E-09,2.52E-07,8.76E-08,3569/3630/7157/3553/5743/3586/5594/3458/4023/1080,"IL6,INS,TP53,IL1B,PTGS2,IL10,MAPK1,IFNG,LPL,CFTR",0.576403231,10
BP,GO:0060326,cell chemotaxis,295/18493,8.25E-09,2.69E-07,9.35E-08,3569/6347/7422/3576/3553/3586/7412/5054/7941,"IL6,CCL2,VEGFA,CXCL8,IL1B,IL10,VCAM1,SERPINE1,PLA2G7",0.530646123,9
BP,GO:0032103,positive regulation of response to external stimulus,297/18493,8.75E-09,2.82E-07,9.80E-08,3569/7422/3576/3553/5743/5054/2147/4023/7941,"IL6,VEGFA,CXCL8,IL1B,PTGS2,SERPINE1,F2,LPL,PLA2G7",0.484224017,9
BP,GO:0050863,regulation of T cell activation,305/18493,1.10E-08,3.51E-07,1.22E-07,3569/207/6347/3553/3586/7412/836/3458/959,"IL6,AKT1,CCL2,IL1B,IL10,VCAM1,CASP3,IFNG,CD40LG",0.535144128,9
BP,GO:0010742,macrophage derived foam cell differentiation,36/18493,1.15E-08,3.57E-07,1.24E-07,1401/5468/4023/1071/948,"CRP,PPARG,LPL,CETP,CD36",0.197222121,5
BP,GO:0090077,foam cell differentiation,36/18493,1.15E-08,3.57E-07,1.24E-07,1401/5468/4023/1071/948,"CRP,PPARG,LPL,CETP,CD36",0.197222121,5
BP,GO:1903039,positive regulation of leukocyte cell-cell adhesion,214/18493,1.28E-08,3.92E-07,1.36E-07,3569/207/6347/3553/3383/7412/3458/959,"IL6,AKT1,CCL2,IL1B,ICAM1,VCAM1,IFNG,CD40LG",0.474071625,8
BP,GO:1900182,positive regulation of protein localization to nucleus,78/18493,1.35E-08,4.11E-07,1.43E-07,3630/207/5743/5594/3458/2147,"INS,AKT1,PTGS2,MAPK1,IFNG,F2",0.350905166,6
BP,GO:0048608,reproductive structure development,428/18493,1.39E-08,4.14E-07,1.44E-07,207/7422/5743/5468/3586/5594/3383/836/4846/596,"AKT1,VEGFA,PTGS2,PPARG,IL10,MAPK1,ICAM1,CASP3,NOS3,BCL2",0.551620847,10
BP,GO:0045834,positive regulation of lipid metabolic process,138/18493,1.39E-08,4.14E-07,1.44E-07,3630/207/3553/5743/5468/3458/2147,"INS,AKT1,IL1B,PTGS2,PPARG,IFNG,F2",0.413216822,7
BP,GO:0030595,leukocyte chemotaxis,217/18493,1.42E-08,4.18E-07,1.45E-07,3569/6347/7422/3576/3553/3586/5054/7941,"IL6,CCL2,VEGFA,CXCL8,IL1B,IL10,SERPINE1,PLA2G7",0.459262747,8
BP,GO:0061458,reproductive system development,431/18493,1.48E-08,4.31E-07,1.50E-07,207/7422/5743/5468/3586/5594/3383/836/4846/596,"AKT1,VEGFA,PTGS2,PPARG,IL10,MAPK1,ICAM1,CASP3,NOS3,BCL2",0.550167283,10
BP,GO:0051235,maintenance of location,318/18493,1.58E-08,4.50E-07,1.57E-07,3569/207/1401/3553/5468/3586/2147/4023/948,"IL6,AKT1,CRP,IL1B,PPARG,IL10,F2,LPL,CD36",0.470977961,9
BP,GO:1903829,positive regulation of cellular protein localization,318/18493,1.58E-08,4.50E-07,1.57E-07,3630/207/7157/3553/5743/5594/3458/2147/596,"INS,AKT1,TP53,IL1B,PTGS2,MAPK1,IFNG,F2,BCL2",0.491008906,9
BP,GO:0097756,negative regulation of blood vessel diameter,81/18493,1.70E-08,4.79E-07,1.67E-07,3630/207/1401/5743/3383/3156,"INS,AKT1,CRP,PTGS2,ICAM1,HMGCR",0.344310755,6
BP,GO:0071496,cellular response to external stimulus,328/18493,2.07E-08,5.76E-07,2.00E-07,207/7157/3553/5743/5468/5594/3383/3162/596,"AKT1,TP53,IL1B,PTGS2,PPARG,MAPK1,ICAM1,HMOX1,BCL2",0.485060895,9
BP,GO:0070542,response to fatty acid,84/18493,2.12E-08,5.85E-07,2.04E-07,207/5743/5468/847/5444/948,"AKT1,PTGS2,PPARG,CAT,PON1,CD36",0.278082188,6
BP,GO:1904035,regulation of epithelial cell apoptotic process,85/18493,2.28E-08,6.22E-07,2.16E-07,3569/6347/3383/5054/3162/959,"IL6,CCL2,ICAM1,SERPINE1,HMOX1,CD40LG",0.328622434,6
BP,GO:0097305,response to alcohol,231/18493,2.31E-08,6.26E-07,2.18E-07,207/6774/5468/3383/7412/847/3156/1080,"AKT1,STAT3,PPARG,ICAM1,VCAM1,CAT,HMGCR,CFTR",0.390101326,8
BP,GO:0097237,cellular response to toxic substance,235/18493,2.64E-08,7.08E-07,2.46E-07,3569/5743/3586/4846/4353/3162/847/948,"IL6,PTGS2,IL10,NOS3,MPO,HMOX1,CAT,CD36",0.403892689,8
BP,GO:2001236,regulation of extrinsic apoptotic signaling pathway,156/18493,3.26E-08,8.59E-07,2.99E-07,207/3553/3383/4846/5054/3162/596,"AKT1,IL1B,ICAM1,NOS3,SERPINE1,HMOX1,BCL2",0.347712858,7
BP,GO:0001505,regulation of neurotransmitter levels,346/18493,3.27E-08,8.59E-07,2.99E-07,207/3553/5743/3586/3383/4846/3458/4843/948,"AKT1,IL1B,PTGS2,IL10,ICAM1,NOS3,IFNG,NOS2,CD36",0.446836539,9
BP,GO:0051249,regulation of lymphocyte activation,472/18493,3.49E-08,9.08E-07,3.16E-07,3569/207/6347/3553/3586/7412/836/3458/959/596,"IL6,AKT1,CCL2,IL1B,IL10,VCAM1,CASP3,IFNG,CD40LG,BCL2",0.518847443,10
BP,GO:0010883,regulation of lipid storage,45/18493,3.67E-08,9.46E-07,3.29E-07,3569/1401/5468/4023/948,"IL6,CRP,PPARG,LPL,CD36",0.233937101,5
BP,GO:0071456,cellular response to hypoxia,160/18493,3.88E-08,9.90E-07,3.44E-07,207/7422/7157/5743/3383/3162/596,"AKT1,VEGFA,TP53,PTGS2,ICAM1,HMOX1,BCL2",0.359007813,7
BP,GO:0048872,homeostasis of number of cells,248/18493,4.01E-08,1.01E-06,3.53E-07,3569/207/6774/7422/836/4846/3162/596,"IL6,AKT1,STAT3,VEGFA,CASP3,NOS3,HMOX1,BCL2",0.427697103,8
BP,GO:0006869,lipid transport,359/18493,4.49E-08,1.12E-06,3.91E-07,207/3553/5468/4843/5444/5243/1071/1080/948,"AKT1,IL1B,PPARG,NOS2,PON1,ABCB1,CETP,CFTR,CD36",0.320500617,9
BP,GO:0035094,response to nicotine,47/18493,4.60E-08,1.14E-06,3.97E-07,5594/7412/836/3162/596,"MAPK1,VCAM1,CASP3,HMOX1,BCL2",0.223814919,5
BP,GO:0010634,positive regulation of epithelial cell migration,165/18493,4.79E-08,1.18E-06,4.10E-07,207/7422/4318/5743/4846/3458/3162,"AKT1,VEGFA,MMP9,PTGS2,NOS3,IFNG,HMOX1",0.381555256,7
BP,GO:0008015,blood circulation,492/18493,5.16E-08,1.26E-06,4.37E-07,3630/207/1401/5743/5468/3383/4846/3162/4843/3156,"INS,AKT1,CRP,PTGS2,PPARG,ICAM1,NOS3,HMOX1,NOS2,HMGCR",0.514407545,10
BP,GO:0051098,regulation of binding,369/18493,5.68E-08,1.37E-06,4.77E-07,207/4318/5468/3586/3458/3162/5444/596/948,"AKT1,MMP9,PPARG,IL10,IFNG,HMOX1,PON1,BCL2,CD36",0.382311956,9
BP,GO:0060627,regulation of vesicle-mediated transport,498/18493,5.78E-08,1.38E-06,4.81E-07,6347/7422/3553/5468/5594/5054/3458/3162/1080/948,"CCL2,VEGFA,IL1B,PPARG,MAPK1,SERPINE1,IFNG,HMOX1,CFTR,CD36",0.453911834,10
BP,GO:0036294,cellular response to decreased oxygen levels,170/18493,5.88E-08,1.40E-06,4.86E-07,207/7422/7157/5743/3383/3162/596,"AKT1,VEGFA,TP53,PTGS2,ICAM1,HMOX1,BCL2",0.350066938,7
BP,GO:0003013,circulatory system process,500/18493,6.00E-08,1.41E-06,4.91E-07,3630/207/1401/5743/5468/3383/4846/3162/4843/3156,"INS,AKT1,CRP,PTGS2,PPARG,ICAM1,NOS3,HMOX1,NOS2,HMGCR",0.510025282,10
BP,GO:0002696,positive regulation of leukocyte activation,372/18493,6.09E-08,1.42E-06,4.94E-07,3569/207/6347/3553/3586/7412/3458/959/596,"IL6,AKT1,CCL2,IL1B,IL10,VCAM1,IFNG,CD40LG,BCL2",0.451061351,9
BP,GO:0042063,gliogenesis,266/18493,6.90E-08,1.59E-06,5.55E-07,3569/207/6774/6347/3553/5468/5594/2147,"IL6,AKT1,STAT3,CCL2,IL1B,PPARG,MAPK1,F2",0.44421222,8
BP,GO:0001936,regulation of endothelial cell proliferation,175/18493,7.18E-08,1.65E-06,5.73E-07,207/6774/6347/7422/5468/3586/3162,"AKT1,STAT3,CCL2,VEGFA,PPARG,IL10,HMOX1",0.389819812,7
BP,GO:0033138,positive regulation of peptidyl-serine phosphorylation,103/18493,7.24E-08,1.65E-06,5.73E-07,3569/207/7422/5743/3458/596,"IL6,AKT1,VEGFA,PTGS2,IFNG,BCL2",0.306344237,6
BP,GO:0034504,protein localization to nucleus,269/18493,7.52E-08,1.70E-06,5.90E-07,3630/207/6774/5743/5594/3458/2147/948,"INS,AKT1,STAT3,PTGS2,MAPK1,IFNG,F2,CD36",0.390571837,8
BP,GO:0050867,positive regulation of cell activation,384/18493,7.99E-08,1.79E-06,6.21E-07,3569/207/6347/3553/3586/7412/3458/959/596,"IL6,AKT1,CCL2,IL1B,IL10,VCAM1,IFNG,CD40LG,BCL2",0.443395122,9
BP,GO:0097006,regulation of plasma lipoprotein particle levels,105/18493,8.13E-08,1.80E-06,6.27E-07,4353/3162/4023/7941/1071/948,"MPO,HMOX1,LPL,PLA2G7,CETP,CD36",0.183729067,6
BP,GO:0019216,regulation of lipid metabolic process,388/18493,8.72E-08,1.92E-06,6.67E-07,3630/207/3553/5743/5468/3458/2147/3156/948,"INS,AKT1,IL1B,PTGS2,PPARG,IFNG,F2,HMGCR,CD36",0.406132715,9
BP,GO:0002688,regulation of leukocyte chemotaxis,109/18493,1.02E-07,2.22E-06,7.71E-07,3569/6347/7422/3576/5054/7941,"IL6,CCL2,VEGFA,CXCL8,SERPINE1,PLA2G7",0.301127846,6
BP,GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,186/18493,1.09E-07,2.36E-06,8.20E-07,3569/6774/7422/7157/3383/3458/948,"IL6,STAT3,VEGFA,TP53,ICAM1,IFNG,CD36",0.345266039,7
BP,GO:0031663,lipopolysaccharide-mediated signaling pathway,56/18493,1.13E-07,2.42E-06,8.43E-07,207/6347/3553/5594/4846,"AKT1,CCL2,IL1B,MAPK1,NOS3",0.269484775,5
BP,GO:0010632,regulation of epithelial cell migration,284/18493,1.14E-07,2.43E-06,8.46E-07,207/7422/4318/5743/5468/4846/3458/3162,"AKT1,VEGFA,MMP9,PTGS2,PPARG,NOS3,IFNG,HMOX1",0.412685553,8
BP,GO:0046822,regulation of nucleocytoplasmic transport,112/18493,1.20E-07,2.53E-06,8.79E-07,7157/3553/5743/5594/3458/948,"TP53,IL1B,PTGS2,MAPK1,IFNG,CD36",0.270353697,6
BP,GO:0009895,negative regulation of catabolic process,287/18493,1.24E-07,2.57E-06,8.96E-07,3630/207/6774/3553/3586/3162/4843/596,"INS,AKT1,STAT3,IL1B,IL10,HMOX1,NOS2,BCL2",0.389282336,8
BP,GO:0097193,intrinsic apoptotic signaling pathway,287/18493,1.24E-07,2.57E-06,8.96E-07,3630/207/7157/4318/5743/836/3162/596,"INS,AKT1,TP53,MMP9,PTGS2,CASP3,HMOX1,BCL2",0.396548972,8
BP,GO:0001935,endothelial cell proliferation,190/18493,1.26E-07,2.60E-06,9.05E-07,207/6774/6347/7422/5468/3586/3162,"AKT1,STAT3,CCL2,VEGFA,PPARG,IL10,HMOX1",0.376412475,7
BP,GO:2000378,negative regulation of reactive oxygen species metabolic process,58/18493,1.35E-07,2.77E-06,9.63E-07,3630/6774/3586/4314/596,"INS,STAT3,IL10,MMP3,BCL2",0.227204565,5
BP,GO:0043434,response to peptide hormone,417/18493,1.61E-07,3.27E-06,1.14E-06,3630/207/6774/3553/5743/5468/3586/3383/847,"INS,AKT1,STAT3,IL1B,PTGS2,PPARG,IL10,ICAM1,CAT",0.477552588,9
BP,GO:0097529,myeloid leukocyte migration,199/18493,1.73E-07,3.49E-06,1.21E-06,3569/6347/7422/3576/3553/5054/7941,"IL6,CCL2,VEGFA,CXCL8,IL1B,SERPINE1,PLA2G7",0.343374239,7
BP,GO:0034284,response to monosaccharide,201/18493,1.85E-07,3.70E-06,1.29E-06,5743/3383/836/847/4023/3156/1080,"PTGS2,ICAM1,CASP3,CAT,LPL,HMGCR,CFTR",0.258586969,7
BP,GO:0002687,positive regulation of leukocyte migration,121/18493,1.89E-07,3.74E-06,1.30E-06,3569/7422/3576/3383/5054/7941,"IL6,VEGFA,CXCL8,ICAM1,SERPINE1,PLA2G7",0.283501433,6
BP,GO:0032768,regulation of monooxygenase activity,62/18493,1.90E-07,3.74E-06,1.30E-06,3630/207/3553/4846/3458,"INS,AKT1,IL1B,NOS3,IFNG",0.266154652,5
BP,GO:0050870,positive regulation of T cell activation,202/18493,1.91E-07,3.75E-06,1.30E-06,3569/207/6347/3553/7412/3458/959,"IL6,AKT1,CCL2,IL1B,VCAM1,IFNG,CD40LG",0.353122085,7
BP,GO:0046686,response to cadmium ion,63/18493,2.06E-07,4.00E-06,1.39E-06,207/4318/5594/3162/847,"AKT1,MMP9,MAPK1,HMOX1,CAT",0.24501349,5
BP,GO:0150077,regulation of neuroinflammatory response,25/18493,2.07E-07,4.00E-06,1.39E-06,3569/3553/4318/4314,"IL6,IL1B,MMP9,MMP3",0.202634011,4
BP,GO:0050670,regulation of lymphocyte proliferation,205/18493,2.11E-07,4.06E-06,1.41E-06,3569/3553/3586/7412/836/959/596,"IL6,IL1B,IL10,VCAM1,CASP3,CD40LG,BCL2",0.306950338,7
BP,GO:0032944,regulation of mononuclear cell proliferation,206/18493,2.18E-07,4.16E-06,1.45E-06,3569/3553/3586/7412/836/959/596,"IL6,IL1B,IL10,VCAM1,CASP3,CD40LG,BCL2",0.306307993,7
BP,GO:0072577,endothelial cell apoptotic process,64/18493,2.23E-07,4.21E-06,1.46E-06,6347/3586/3383/5054/959,"CCL2,IL10,ICAM1,SERPINE1,CD40LG",0.226065598,5
BP,GO:0009266,response to temperature stimulus,208/18493,2.33E-07,4.38E-06,1.52E-06,207/5743/5468/5594/4846/3162/4023,"AKT1,PTGS2,PPARG,MAPK1,NOS3,HMOX1,LPL",0.32578682,7
BP,GO:0002697,regulation of immune effector process,439/18493,2.48E-07,4.64E-06,1.61E-06,3569/3630/3553/3586/3458/3162/959/2147/948,"IL6,INS,IL1B,IL10,IFNG,HMOX1,CD40LG,F2,CD36",0.388245987,9
BP,GO:0009314,response to radiation,443/18493,2.68E-07,4.97E-06,1.73E-06,207/7157/5743/3383/7412/836/847/3156/596,"AKT1,TP53,PTGS2,ICAM1,VCAM1,CASP3,CAT,HMGCR,BCL2",0.377751797,9
BP,GO:0042742,defense response to bacterium,319/18493,2.77E-07,5.10E-06,1.78E-06,3569/1401/3586/4353/5054/4843/2147/948,"IL6,CRP,IL10,MPO,SERPINE1,NOS2,F2,CD36",0.329429025,8
BP,GO:0046824,positive regulation of nucleocytoplasmic transport,67/18493,2.81E-07,5.13E-06,1.78E-06,7157/3553/5743/5594/3458,"TP53,IL1B,PTGS2,MAPK1,IFNG",0.243199598,5
BP,GO:0007584,response to nutrient,216/18493,3.01E-07,5.43E-06,1.89E-06,3553/5743/5468/7412/3162/847/3156,"IL1B,PTGS2,PPARG,VCAM1,HMOX1,CAT,HMGCR",0.300045971,7
BP,GO:0070663,regulation of leukocyte proliferation,216/18493,3.01E-07,5.43E-06,1.89E-06,3569/3553/3586/7412/836/959/596,"IL6,IL1B,IL10,VCAM1,CASP3,CD40LG,BCL2",0.299716859,7
BP,GO:0006801,superoxide metabolic process,69/18493,3.26E-07,5.82E-06,2.02E-06,1401/4846/4353/4843/948,"CRP,NOS3,MPO,NOS2,CD36",0.187752735,5
BP,GO:0002700,regulation of production of molecular mediator of immune response,133/18493,3.32E-07,5.82E-06,2.02E-06,3569/3553/3586/3162/959/948,"IL6,IL1B,IL10,HMOX1,CD40LG,CD36",0.245705912,6
BP,GO:0050729,positive regulation of inflammatory response,133/18493,3.32E-07,5.82E-06,2.02E-06,3569/3553/5743/5054/4023/7941,"IL6,IL1B,PTGS2,SERPINE1,LPL,PLA2G7",0.253895223,6
BP,GO:0034368,protein-lipid complex remodeling,28/18493,3.33E-07,5.82E-06,2.02E-06,4353/4023/7941/1071,"MPO,LPL,PLA2G7,CETP",0.112547831,4
BP,GO:0034369,plasma lipoprotein particle remodeling,28/18493,3.33E-07,5.82E-06,2.02E-06,4353/4023/7941/1071,"MPO,LPL,PLA2G7,CETP",0.112547831,4
BP,GO:0032102,negative regulation of response to external stimulus,329/18493,3.51E-07,6.08E-06,2.12E-06,3630/6347/5468/3586/4846/5054/2147/3156,"INS,CCL2,PPARG,IL10,NOS3,SERPINE1,F2,HMGCR",0.347334207,8
BP,GO:0033135,regulation of peptidyl-serine phosphorylation,135/18493,3.62E-07,6.24E-06,2.17E-06,3569/207/7422/5743/3458/596,"IL6,AKT1,VEGFA,PTGS2,IFNG,BCL2",0.275686107,6
BP,GO:0009743,response to carbohydrate,223/18493,3.74E-07,6.40E-06,2.23E-06,5743/3383/836/847/4023/3156/1080,"PTGS2,ICAM1,CASP3,CAT,LPL,HMGCR,CFTR",0.24728139,7
BP,GO:0009411,response to UV,136/18493,3.78E-07,6.44E-06,2.24E-06,207/7157/5743/836/847/596,"AKT1,TP53,PTGS2,CASP3,CAT,BCL2",0.257316732,6
BP,GO:0051251,positive regulation of lymphocyte activation,333/18493,3.84E-07,6.49E-06,2.26E-06,3569/207/6347/3553/7412/3458/959/596,"IL6,AKT1,CCL2,IL1B,VCAM1,IFNG,CD40LG,BCL2",0.353062465,8
BP,GO:0032770,positive regulation of monooxygenase activity,29/18493,3.86E-07,6.49E-06,2.26E-06,3630/207/3553/3458,"INS,AKT1,IL1B,IFNG",0.209870439,4
BP,GO:0032637,interleukin-8 production,73/18493,4.33E-07,7.21E-06,2.51E-06,1401/3553/3586/5054/4843,"CRP,IL1B,IL10,SERPINE1,NOS2",0.223682294,5
BP,GO:0031669,cellular response to nutrient levels,228/18493,4.34E-07,7.21E-06,2.51E-06,7157/5743/5468/5594/3383/3162/596,"TP53,PTGS2,PPARG,MAPK1,ICAM1,HMOX1,BCL2",0.294622471,7
BP,GO:0034367,protein-containing complex remodeling,30/18493,4.45E-07,7.34E-06,2.55E-06,4353/4023/7941/1071,"MPO,LPL,PLA2G7,CETP",0.110381307,4
BP,GO:0048871,multicellular organismal homeostasis,471/18493,4.49E-07,7.36E-06,2.56E-06,3569/6774/7422/3553/5743/4846/596/1080/948,"IL6,STAT3,VEGFA,IL1B,PTGS2,NOS3,BCL2,CFTR,CD36",0.348175779,9
BP,GO:0042542,response to hydrogen peroxide,141/18493,4.68E-07,7.59E-06,2.64E-06,3569/3586/836/3162/847/596,"IL6,IL10,CASP3,HMOX1,CAT,BCL2",0.249706842,6
BP,GO:0045807,positive regulation of endocytosis,141/18493,4.68E-07,7.59E-06,2.64E-06,6347/7422/3553/5468/5054/948,"CCL2,VEGFA,IL1B,PPARG,SERPINE1,CD36",0.251776457,6
BP,GO:0032642,regulation of chemokine production,75/18493,4.95E-07,7.98E-06,2.78E-06,3569/3553/3586/3162/4023,"IL6,IL1B,IL10,HMOX1,LPL",0.227003872,5
BP,GO:0042593,glucose homeostasis,233/18493,5.03E-07,8.04E-06,2.80E-06,3630/207/6774/5468/3383/3156/1080,"INS,AKT1,STAT3,PPARG,ICAM1,HMGCR,CFTR",0.295016323,7
BP,GO:0055094,response to lipoprotein particle,31/18493,5.10E-07,8.11E-06,2.82E-06,207/5468/4023/948,"AKT1,PPARG,LPL,CD36",0.142886502,4
BP,GO:0010631,epithelial cell migration,346/18493,5.14E-07,8.13E-06,2.83E-06,207/7422/4318/5743/5468/4846/3458/3162,"AKT1,VEGFA,MMP9,PTGS2,PPARG,NOS3,IFNG,HMOX1",0.374157433,8
BP,GO:0033500,carbohydrate homeostasis,234/18493,5.17E-07,8.14E-06,2.83E-06,3630/207/6774/5468/3383/3156/1080,"INS,AKT1,STAT3,PPARG,ICAM1,HMGCR,CFTR",0.29473335,7
BP,GO:0071356,cellular response to tumor necrosis factor,235/18493,5.32E-07,8.32E-06,2.90E-06,207/6347/3576/5594/3383/7412/959,"AKT1,CCL2,CXCL8,MAPK1,ICAM1,VCAM1,CD40LG",0.320086521,7
BP,GO:0090132,epithelium migration,349/18493,5.48E-07,8.53E-06,2.97E-06,207/7422/4318/5743/5468/4846/3458/3162,"AKT1,VEGFA,MMP9,PTGS2,PPARG,NOS3,IFNG,HMOX1",0.372629568,8
BP,GO:0002718,regulation of cytokine production involved in immune response,77/18493,5.65E-07,8.74E-06,3.04E-06,3569/3553/3586/3162/948,"IL6,IL1B,IL10,HMOX1,CD36",0.207621133,5
BP,GO:0051092,positive regulation of NF-kappaB transcription factor activity,146/18493,5.75E-07,8.84E-06,3.07E-06,3630/3553/3383/847/959/948,"INS,IL1B,ICAM1,CAT,CD40LG,CD36",0.235312058,6
BP,GO:0046889,positive regulation of lipid biosynthetic process,78/18493,6.03E-07,9.22E-06,3.21E-06,3630/207/3553/5743/3458,"INS,AKT1,IL1B,PTGS2,IFNG",0.250459919,5
BP,GO:0090130,tissue migration,355/18493,6.24E-07,9.48E-06,3.30E-06,207/7422/4318/5743/5468/4846/3458/3162,"AKT1,VEGFA,MMP9,PTGS2,PPARG,NOS3,IFNG,HMOX1",0.369246472,8
BP,GO:0043536,positive regulation of blood vessel endothelial cell migration,79/18493,6.43E-07,9.67E-06,3.36E-06,207/7422/5743/4846/3162,"AKT1,VEGFA,PTGS2,NOS3,HMOX1",0.234186763,5
BP,GO:0002673,regulation of acute inflammatory response,149/18493,6.48E-07,9.67E-06,3.36E-06,3569/3630/3553/5743/5468/2147,"IL6,INS,IL1B,PTGS2,PPARG,F2",0.288543042,6
BP,GO:0051384,response to glucocorticoid,149/18493,6.48E-07,9.67E-06,3.36E-06,3569/5743/3586/3383/836/596,"IL6,PTGS2,IL10,ICAM1,CASP3,BCL2",0.254842148,6
BP,GO:0006913,nucleocytoplasmic transport,357/18493,6.51E-07,9.67E-06,3.36E-06,207/6774/7157/3553/5743/5594/3458/948,"AKT1,STAT3,TP53,IL1B,PTGS2,MAPK1,IFNG,CD36",0.348485326,8
BP,GO:0050878,regulation of body fluid levels,493/18493,6.57E-07,9.72E-06,3.38E-06,3569/7422/5594/4846/5054/959/2147/1080/948,"IL6,VEGFA,MAPK1,NOS3,SERPINE1,CD40LG,F2,CFTR,CD36",0.323202285,9
BP,GO:0071402,cellular response to lipoprotein particle stimulus,33/18493,6.61E-07,9.72E-06,3.38E-06,207/5468/4023/948,"AKT1,PPARG,LPL,CD36",0.140685331,4
BP,GO:0045861,negative regulation of proteolysis,359/18493,6.79E-07,9.92E-06,3.45E-06,3630/207/7422/4318/5743/3586/5054/2147,"INS,AKT1,VEGFA,MMP9,PTGS2,IL10,SERPINE1,F2",0.371837654,8
BP,GO:0030072,peptide hormone secretion,244/18493,6.85E-07,9.97E-06,3.47E-06,3569/3630/3553/3458/4843/3156/1080,"IL6,INS,IL1B,IFNG,NOS2,HMGCR,CFTR",0.275771569,7
BP,GO:0051169,nuclear transport,360/18493,6.93E-07,1.00E-05,3.49E-06,207/6774/7157/3553/5743/5594/3458/948,"AKT1,STAT3,TP53,IL1B,PTGS2,MAPK1,IFNG,CD36",0.347399218,8
BP,GO:0090066,regulation of anatomical structure size,497/18493,7.03E-07,1.01E-05,3.51E-06,3630/207/7422/1401/5743/3383/4846/3162/3156,"INS,AKT1,VEGFA,CRP,PTGS2,ICAM1,NOS3,HMOX1,HMGCR",0.405262117,9
BP,GO:0050730,regulation of peptidyl-tyrosine phosphorylation,245/18493,7.05E-07,1.01E-05,3.51E-06,3569/6774/7422/7157/3383/3458/948,"IL6,STAT3,VEGFA,TP53,ICAM1,IFNG,CD36",0.306548572,7
BP,GO:0042129,regulation of T cell proliferation,153/18493,7.57E-07,1.08E-05,3.75E-06,3569/3553/3586/7412/836/959,"IL6,IL1B,IL10,VCAM1,CASP3,CD40LG",0.268004084,6
BP,GO:0032602,chemokine production,82/18493,7.75E-07,1.10E-05,3.82E-06,3569/3553/3586/3162/4023,"IL6,IL1B,IL10,HMOX1,LPL",0.220836154,5
BP,GO:0043271,negative regulation of ion transport,154/18493,7.86E-07,1.11E-05,3.85E-06,207/4318/5743/3383/4846/596,"AKT1,MMP9,PTGS2,ICAM1,NOS3,BCL2",0.247710892,6
BP,GO:0002690,positive regulation of leukocyte chemotaxis,84/18493,8.74E-07,1.22E-05,4.24E-06,3569/7422/3576/5054/7941,"IL6,VEGFA,CXCL8,SERPINE1,PLA2G7",0.212887271,5
BP,GO:0008625,extrinsic apoptotic signaling pathway via death domain receptors,84/18493,8.74E-07,1.22E-05,4.24E-06,3383/4846/5054/3162/596,"ICAM1,NOS3,SERPINE1,HMOX1,BCL2",0.181217716,5
BP,GO:0006606,protein import into nucleus,157/18493,8.81E-07,1.22E-05,4.25E-06,207/6774/5743/5594/3458/948,"AKT1,STAT3,PTGS2,MAPK1,IFNG,CD36",0.245915312,6
BP,GO:0043535,regulation of blood vessel endothelial cell migration,158/18493,9.14E-07,1.26E-05,4.39E-06,207/7422/5743/5468/4846/3162,"AKT1,VEGFA,PTGS2,PPARG,NOS3,HMOX1",0.273626593,6
BP,GO:1903034,regulation of response to wounding,160/18493,9.84E-07,1.35E-05,4.70E-06,3586/4846/5054/2147/3156/948,"IL10,NOS3,SERPINE1,F2,HMGCR,CD36",0.185281196,6
BP,GO:0031668,cellular response to extracellular stimulus,258/18493,9.96E-07,1.36E-05,4.74E-06,7157/5743/5468/5594/3383/3162/596,"TP53,PTGS2,PPARG,MAPK1,ICAM1,HMOX1,BCL2",0.278798103,7
BP,GO:2001242,regulation of intrinsic apoptotic signaling pathway,161/18493,1.02E-06,1.37E-05,4.78E-06,3630/207/7157/4318/5743/596,"INS,AKT1,TP53,MMP9,PTGS2,BCL2",0.262754445,6
BP,GO:0031334,positive regulation of protein complex assembly,259/18493,1.02E-06,1.37E-05,4.78E-06,7422/7157/3383/3458/4312/4314/948,"VEGFA,TP53,ICAM1,IFNG,MMP1,MMP3,CD36",0.256902571,7
BP,GO:0032868,response to insulin,259/18493,1.02E-06,1.37E-05,4.78E-06,3630/207/3553/5468/3586/3383/847,"INS,AKT1,IL1B,PPARG,IL10,ICAM1,CAT",0.327533851,7
BP,GO:0001503,ossification,380/18493,1.04E-06,1.37E-05,4.78E-06,3569/207/4318/5743/5594/847/4313/596,"IL6,AKT1,MMP9,PTGS2,MAPK1,CAT,MMP2,BCL2",0.336444009,8
BP,GO:1900407,regulation of cellular response to oxidative stress,87/18493,1.04E-06,1.37E-05,4.78E-06,3630/207/3586/4314/948,"INS,AKT1,IL10,MMP3,CD36",0.197414695,5
BP,GO:1904705,regulation of vascular smooth muscle cell proliferation,87/18493,1.04E-06,1.37E-05,4.78E-06,4318/5468/3586/3162/4313,"MMP9,PPARG,IL10,HMOX1,MMP2",0.212544662,5
BP,GO:1990874,vascular smooth muscle cell proliferation,87/18493,1.04E-06,1.37E-05,4.78E-06,4318/5468/3586/3162/4313,"MMP9,PPARG,IL10,HMOX1,MMP2",0.212544662,5
BP,GO:0032409,regulation of transporter activity,260/18493,1.05E-06,1.38E-05,4.79E-06,3630/4318/5468/5444/5243/596/1080,"INS,MMP9,PPARG,PON1,ABCB1,BCL2,CFTR",0.21837257,7
BP,GO:0071276,cellular response to cadmium ion,37/18493,1.06E-06,1.38E-05,4.80E-06,207/4318/5594/3162,"AKT1,MMP9,MAPK1,HMOX1",0.181755456,4
BP,GO:1902042,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,37/18493,1.06E-06,1.38E-05,4.80E-06,3383/4846/5054/3162,"ICAM1,NOS3,SERPINE1,HMOX1",0.164770146,4
BP,GO:0046651,lymphocyte proliferation,264/18493,1.16E-06,1.50E-05,5.23E-06,3569/3553/3586/7412/836/959/596,"IL6,IL1B,IL10,VCAM1,CASP3,CD40LG,BCL2",0.274552226,7
BP,GO:0031960,response to corticosteroid,166/18493,1.22E-06,1.57E-05,5.45E-06,3569/5743/3586/3383/836/596,"IL6,PTGS2,IL10,ICAM1,CASP3,BCL2",0.244200769,6
BP,GO:0032943,mononuclear cell proliferation,266/18493,1.22E-06,1.57E-05,5.45E-06,3569/3553/3586/7412/836/959/596,"IL6,IL1B,IL10,VCAM1,CASP3,CD40LG,BCL2",0.273541909,7
BP,GO:0015908,fatty acid transport,93/18493,1.45E-06,1.84E-05,6.40E-06,207/3553/5468/4843/948,"AKT1,IL1B,PPARG,NOS2,CD36",0.183322855,5
BP,GO:0036473,cell death in response to oxidative stress,93/18493,1.45E-06,1.84E-05,6.40E-06,3630/207/3586/4314/596,"INS,AKT1,IL10,MMP3,BCL2",0.1953696,5
BP,GO:0030810,positive regulation of nucleotide biosynthetic process,40/18493,1.46E-06,1.84E-05,6.40E-06,3630/6774/4846/4843,"INS,STAT3,NOS3,NOS2",0.177922587,4
BP,GO:1900373,positive regulation of purine nucleotide biosynthetic process,40/18493,1.46E-06,1.84E-05,6.40E-06,3630/6774/4846/4843,"INS,STAT3,NOS3,NOS2",0.177922587,4
BP,GO:0002285,lymphocyte activation involved in immune response,174/18493,1.60E-06,2.01E-05,6.98E-06,3569/6774/3586/3383/3458/959,"IL6,STAT3,IL10,ICAM1,IFNG,CD40LG",0.255277704,6
BP,GO:0002367,cytokine production involved in immune response,95/18493,1.61E-06,2.01E-05,6.98E-06,3569/3553/3586/3162/948,"IL6,IL1B,IL10,HMOX1,CD36",0.19281301,5
BP,GO:0030574,collagen catabolic process,41/18493,1.62E-06,2.01E-05,6.98E-06,4318/4313/4312/4314,"MMP9,MMP2,MMP1,MMP3",0.145790281,4
BP,GO:1902882,regulation of response to oxidative stress,96/18493,1.70E-06,2.09E-05,7.27E-06,3630/207/3586/4314/948,"INS,AKT1,IL10,MMP3,CD36",0.190027442,5
BP,GO:2001243,negative regulation of intrinsic apoptotic signaling pathway,96/18493,1.70E-06,2.09E-05,7.27E-06,3630/207/4318/5743/596,"INS,AKT1,MMP9,PTGS2,BCL2",0.207136197,5
BP,GO:0032459,regulation of protein oligomerization,42/18493,1.78E-06,2.18E-05,7.60E-06,3630/7157/4312/4314,"INS,TP53,MMP1,MMP3",0.164410293,4
BP,GO:0018105,peptidyl-serine phosphorylation,282/18493,1.80E-06,2.20E-05,7.64E-06,3569/207/7422/5743/5594/3458/596,"IL6,AKT1,VEGFA,PTGS2,MAPK1,IFNG,BCL2",0.288746336,7
BP,GO:0042098,T cell proliferation,178/18493,1.83E-06,2.20E-05,7.66E-06,3569/3553/3586/7412/836/959,"IL6,IL1B,IL10,VCAM1,CASP3,CD40LG",0.251257801,6
BP,GO:0051170,import into nucleus,178/18493,1.83E-06,2.20E-05,7.66E-06,207/6774/5743/5594/3458/948,"AKT1,STAT3,PTGS2,MAPK1,IFNG,CD36",0.233102636,6
BP,GO:0071346,cellular response to interferon-gamma,178/18493,1.83E-06,2.20E-05,7.66E-06,6347/5468/3383/7412/3458/4843,"CCL2,PPARG,ICAM1,VCAM1,IFNG,NOS2",0.241168444,6
BP,GO:0070661,leukocyte proliferation,283/18493,1.85E-06,2.21E-05,7.69E-06,3569/3553/3586/7412/836/959/596,"IL6,IL1B,IL10,VCAM1,CASP3,CD40LG,BCL2",0.265040335,7
BP,GO:0008585,female gonad development,98/18493,1.88E-06,2.23E-05,7.77E-06,7422/3383/836/4846/596,"VEGFA,ICAM1,CASP3,NOS3,BCL2",0.181864458,5
BP,GO:0030301,cholesterol transport,98/18493,1.88E-06,2.23E-05,7.77E-06,5468/5444/1071/1080/948,"PPARG,PON1,CETP,CFTR,CD36",0.107040479,5
BP,GO:0051341,regulation of oxidoreductase activity,99/18493,1.98E-06,2.34E-05,8.13E-06,3630/207/3553/4846/3458,"INS,AKT1,IL1B,NOS3,IFNG",0.227130308,5
BP,GO:0052548,regulation of endopeptidase activity,417/18493,2.08E-06,2.44E-05,8.49E-06,207/6774/7422/4318/5743/5468/836/5054,"AKT1,STAT3,VEGFA,MMP9,PTGS2,PPARG,CASP3,SERPINE1",0.350137783,8
BP,GO:0043534,blood vessel endothelial cell migration,182/18493,2.08E-06,2.44E-05,8.49E-06,207/7422/5743/5468/4846/3162,"AKT1,VEGFA,PTGS2,PPARG,NOS3,HMOX1",0.257614503,6
BP,GO:0046890,regulation of lipid biosynthetic process,183/18493,2.15E-06,2.50E-05,8.71E-06,3630/207/3553/5743/3458/3156,"INS,AKT1,IL1B,PTGS2,IFNG,HMGCR",0.247164469,6
BP,GO:0061614,pri-miRNA transcription by RNA polymerase II,44/18493,2.16E-06,2.50E-05,8.71E-06,6774/7157/5468/3586,"STAT3,TP53,PPARG,IL10",0.176798766,4
BP,GO:0098869,cellular oxidant detoxification,101/18493,2.18E-06,2.53E-05,8.79E-06,5743/4846/4353/847/948,"PTGS2,NOS3,MPO,CAT,CD36",0.168341031,5
BP,GO:0050673,epithelial cell proliferation,420/18493,2.20E-06,2.53E-05,8.80E-06,207/6774/6347/7422/5468/3586/5594/3162,"AKT1,STAT3,CCL2,VEGFA,PPARG,IL10,MAPK1,HMOX1",0.351287867,8
BP,GO:0071827,plasma lipoprotein particle organization,45/18493,2.36E-06,2.71E-05,9.43E-06,4353/4023/7941/1071,"MPO,LPL,PLA2G7,CETP",0.098183196,4
BP,GO:0046545,development of primary female sexual characteristics,103/18493,2.41E-06,2.75E-05,9.56E-06,7422/3383/836/4846/596,"VEGFA,ICAM1,CASP3,NOS3,BCL2",0.178340332,5
BP,GO:0010745,negative regulation of macrophage derived foam cell differentiation,13/18493,2.44E-06,2.77E-05,9.62E-06,1401/5468/1071,"CRP,PPARG,CETP",0.102373831,3
BP,GO:0044130,negative regulation of growth of symbiont in host,13/18493,2.44E-06,2.77E-05,9.62E-06,3586/4353/948,"IL10,MPO,CD36",0.090371263,3
BP,GO:1901214,regulation of neuron death,296/18493,2.49E-06,2.80E-05,9.75E-06,207/6774/6347/3586/836/3162/596,"AKT1,STAT3,CCL2,IL10,CASP3,HMOX1,BCL2",0.273580767,7
BP,GO:0045981,positive regulation of nucleotide metabolic process,46/18493,2.59E-06,2.89E-05,1.01E-05,3630/6774/4846/4843,"INS,STAT3,NOS3,NOS2",0.17054139,4
BP,GO:1900544,positive regulation of purine nucleotide metabolic process,46/18493,2.59E-06,2.89E-05,1.01E-05,3630/6774/4846/4843,"INS,STAT3,NOS3,NOS2",0.17054139,4
BP,GO:1990748,cellular detoxification,105/18493,2.65E-06,2.95E-05,1.03E-05,5743/4846/4353/847/948,"PTGS2,NOS3,MPO,CAT,CD36",0.165888859,5
BP,GO:0007565,female pregnancy,191/18493,2.76E-06,3.06E-05,1.06E-05,207/3553/4318/5743/4313/596,"AKT1,IL1B,MMP9,PTGS2,MMP2,BCL2",0.22588593,6
BP,GO:0018209,peptidyl-serine modification,301/18493,2.78E-06,3.07E-05,1.07E-05,3569/207/7422/5743/5594/3458/596,"IL6,AKT1,VEGFA,PTGS2,MAPK1,IFNG,BCL2",0.279765001,7
BP,GO:0150076,neuroinflammatory response,47/18493,2.82E-06,3.10E-05,1.08E-05,3569/3553/4318/4314,"IL6,IL1B,MMP9,MMP3",0.169228196,4
BP,GO:0071887,leukocyte apoptotic process,107/18493,2.91E-06,3.18E-05,1.11E-05,3569/207/7157/3586/836,"IL6,AKT1,TP53,IL10,CASP3",0.225808971,5
BP,GO:0015918,sterol transport,108/18493,3.04E-06,3.31E-05,1.15E-05,5468/5444/1071/1080/948,"PPARG,PON1,CETP,CFTR,CD36",0.103111704,5
BP,GO:0050999,regulation of nitric-oxide synthase activity,48/18493,3.07E-06,3.31E-05,1.15E-05,3630/207/3553/4846,"INS,AKT1,IL1B,NOS3",0.18287528,4
BP,GO:0046879,hormone secretion,306/18493,3.10E-06,3.31E-05,1.15E-05,3569/3630/3553/3458/4843/3156/1080,"IL6,INS,IL1B,IFNG,NOS2,HMGCR,CFTR",0.247048934,7
BP,GO:0034349,glial cell apoptotic process,14/18493,3.11E-06,3.31E-05,1.15E-05,6347/7157/836,"CCL2,TP53,CASP3",0.127518585,3
BP,GO:0034374,low-density lipoprotein particle remodeling,14/18493,3.11E-06,3.31E-05,1.15E-05,4353/7941/1071,"MPO,PLA2G7,CETP",0.070302547,3
BP,GO:0044126,regulation of growth of symbiont in host,14/18493,3.11E-06,3.31E-05,1.15E-05,3586/4353/948,"IL10,MPO,CD36",0.088831436,3
BP,GO:0044146,negative regulation of growth of symbiont involved in interaction with host,14/18493,3.11E-06,3.31E-05,1.15E-05,3586/4353/948,"IL10,MPO,CD36",0.088831436,3
BP,GO:0009746,response to hexose,196/18493,3.20E-06,3.39E-05,1.18E-05,5743/3383/836/4023/3156/1080,"PTGS2,ICAM1,CASP3,LPL,HMGCR,CFTR",0.177085148,6
BP,GO:0052547,regulation of peptidase activity,442/18493,3.21E-06,3.39E-05,1.18E-05,207/6774/7422/4318/5743/5468/836/5054,"AKT1,STAT3,VEGFA,MMP9,PTGS2,PPARG,CASP3,SERPINE1",0.339297613,8
BP,GO:0009416,response to light stimulus,308/18493,3.23E-06,3.40E-05,1.18E-05,207/7157/5743/836/847/3156/596,"AKT1,TP53,PTGS2,CASP3,CAT,HMGCR,BCL2",0.239238926,7
BP,GO:0071825,protein-lipid complex subunit organization,49/18493,3.34E-06,3.50E-05,1.22E-05,4353/4023/7941/1071,"MPO,LPL,PLA2G7,CETP",0.095784628,4
BP,GO:0034341,response to interferon-gamma,198/18493,3.39E-06,3.55E-05,1.23E-05,6347/5468/3383/7412/3458/4843,"CCL2,PPARG,ICAM1,VCAM1,IFNG,NOS2",0.230459837,6
BP,GO:0032655,regulation of interleukin-12 production,50/18493,3.63E-06,3.77E-05,1.31E-05,3586/3458/959/948,"IL10,IFNG,CD40LG,CD36",0.112891772,4
BP,GO:0001938,positive regulation of endothelial cell proliferation,112/18493,3.64E-06,3.77E-05,1.31E-05,207/6774/7422/3586/3162,"AKT1,STAT3,VEGFA,IL10,HMOX1",0.213724988,5
BP,GO:1901215,negative regulation of neuron death,201/18493,3.70E-06,3.82E-05,1.33E-05,207/6774/6347/3586/3162/596,"AKT1,STAT3,CCL2,IL10,HMOX1,BCL2",0.226857121,6
BP,GO:0043254,regulation of protein complex assembly,451/18493,3.72E-06,3.83E-05,1.33E-05,3630/7422/7157/3383/3458/4312/4314/948,"INS,VEGFA,TP53,ICAM1,IFNG,MMP1,MMP3,CD36",0.285404028,8
BP,GO:0009914,hormone transport,316/18493,3.83E-06,3.92E-05,1.36E-05,3569/3630/3553/3458/4843/3156/1080,"IL6,INS,IL1B,IFNG,NOS2,HMGCR,CFTR",0.24296645,7
BP,GO:0010885,regulation of cholesterol storage,15/18493,3.88E-06,3.93E-05,1.37E-05,5468/4023/948,"PPARG,LPL,CD36",0.076136864,3
BP,GO:0030730,sequestering of triglyceride,15/18493,3.88E-06,3.93E-05,1.37E-05,3553/5468/4023,"IL1B,PPARG,LPL",0.108454432,3
BP,GO:0044144,modulation of growth of symbiont involved in interaction with host,15/18493,3.88E-06,3.93E-05,1.37E-05,3586/4353/948,"IL10,MPO,CD36",0.087352416,3
BP,GO:0090276,regulation of peptide hormone secretion,203/18493,3.92E-06,3.96E-05,1.38E-05,3630/3553/3458/4843/3156/1080,"INS,IL1B,IFNG,NOS2,HMGCR,CFTR",0.190735654,6
BP,GO:0008202,steroid metabolic process,318/18493,3.99E-06,4.01E-05,1.40E-05,3553/3458/847/5444/3156/1071/1080,"IL1B,IFNG,CAT,PON1,HMGCR,CETP,CFTR",0.181988045,7
BP,GO:0001667,ameboidal-type cell migration,456/18493,4.04E-06,4.05E-05,1.41E-05,207/7422/4318/5743/5468/4846/3458/3162,"AKT1,VEGFA,MMP9,PTGS2,PPARG,NOS3,IFNG,HMOX1",0.322904262,8
BP,GO:0007566,embryo implantation,52/18493,4.25E-06,4.21E-05,1.47E-05,3553/4318/5743/4313,"IL1B,MMP9,PTGS2,MMP2",0.158700364,4
BP,GO:0032615,interleukin-12 production,52/18493,4.25E-06,4.21E-05,1.47E-05,3586/3458/959/948,"IL10,IFNG,CD40LG,CD36",0.111668148,4
BP,GO:0051353,positive regulation of oxidoreductase activity,52/18493,4.25E-06,4.21E-05,1.47E-05,3630/207/3553/3458,"INS,AKT1,IL1B,IFNG",0.177006909,4
BP,GO:0015711,organic anion transport,460/18493,4.31E-06,4.25E-05,1.48E-05,207/3553/5468/4843/5243/1071/1080/948,"AKT1,IL1B,PPARG,NOS2,ABCB1,CETP,CFTR,CD36",0.213313398,8
BP,GO:0071241,cellular response to inorganic substance,207/18493,4.39E-06,4.31E-05,1.50E-05,207/4318/5743/5594/3162/4314,"AKT1,MMP9,PTGS2,MAPK1,HMOX1,MMP3",0.232724527,6
BP,GO:0030336,negative regulation of cell migration,324/18493,4.51E-06,4.42E-05,1.54E-05,207/6774/6347/5468/5054/3162/596,"AKT1,STAT3,CCL2,PPARG,SERPINE1,HMOX1,BCL2",0.259741245,7
BP,GO:0032722,positive regulation of chemokine production,53/18493,4.59E-06,4.48E-05,1.56E-05,3569/3553/3162/4023,"IL6,IL1B,HMOX1,LPL",0.154136463,4
BP,GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,209/18493,4.64E-06,4.51E-05,1.57E-05,207/7422/4318/5743/5468/836,"AKT1,VEGFA,MMP9,PTGS2,PPARG,CASP3",0.248881923,6
BP,GO:0046660,female sex differentiation,118/18493,4.70E-06,4.56E-05,1.59E-05,7422/3383/836/4846/596,"VEGFA,ICAM1,CASP3,NOS3,BCL2",0.169742595,5
BP,GO:0050663,cytokine secretion,210/18493,4.76E-06,4.59E-05,1.60E-05,3630/1401/3586/4843/4023/948,"INS,CRP,IL10,NOS2,LPL,CD36",0.197486693,6
BP,GO:0050920,regulation of chemotaxis,210/18493,4.76E-06,4.59E-05,1.60E-05,3569/6347/7422/3576/5054/7941,"IL6,CCL2,VEGFA,CXCL8,SERPINE1,PLA2G7",0.231058743,6
BP,GO:0017038,protein import,214/18493,5.31E-06,5.09E-05,1.77E-05,207/6774/5743/5594/3458/948,"AKT1,STAT3,PTGS2,MAPK1,IFNG,CD36",0.214874999,6
BP,GO:0007596,blood coagulation,334/18493,5.51E-06,5.26E-05,1.83E-05,3569/5594/4846/5054/959/2147/948,"IL6,MAPK1,NOS3,SERPINE1,CD40LG,F2,CD36",0.221315751,7
BP,GO:0010595,positive regulation of endothelial cell migration,122/18493,5.54E-06,5.26E-05,1.83E-05,207/7422/5743/4846/3162,"AKT1,VEGFA,PTGS2,NOS3,HMOX1",0.199857635,5
BP,GO:0032368,regulation of lipid transport,122/18493,5.54E-06,5.26E-05,1.83E-05,207/3553/5468/5444/1071,"AKT1,IL1B,PPARG,PON1,CETP",0.163673107,5
BP,GO:0070997,neuron death,335/18493,5.62E-06,5.31E-05,1.85E-05,207/6774/6347/3586/836/3162/596,"AKT1,STAT3,CCL2,IL10,CASP3,HMOX1,BCL2",0.256880457,7
BP,GO:0098754,detoxification,123/18493,5.76E-06,5.41E-05,1.88E-05,5743/4846/4353/847/948,"PTGS2,NOS3,MPO,CAT,CD36",0.156236102,5
BP,GO:0010878,cholesterol storage,17/18493,5.78E-06,5.41E-05,1.88E-05,5468/4023/948,"PPARG,LPL,CD36",0.073737545,3
BP,GO:0044117,growth of symbiont in host,17/18493,5.78E-06,5.41E-05,1.88E-05,3586/4353/948,"IL10,MPO,CD36",0.084599659,3
BP,GO:0007599,hemostasis,339/18493,6.07E-06,5.64E-05,1.96E-05,3569/5594/4846/5054/959/2147/948,"IL6,MAPK1,NOS3,SERPINE1,CD40LG,F2,CD36",0.219709954,7
BP,GO:2000146,negative regulation of cell motility,339/18493,6.07E-06,5.64E-05,1.96E-05,207/6774/6347/5468/5054/3162/596,"AKT1,STAT3,CCL2,PPARG,SERPINE1,HMOX1,BCL2",0.253423287,7
BP,GO:0042743,hydrogen peroxide metabolic process,57/18493,6.15E-06,5.68E-05,1.98E-05,6774/4353/847/4314,"STAT3,MPO,CAT,MMP3",0.142033065,4
BP,GO:0050766,positive regulation of phagocytosis,57/18493,6.15E-06,5.68E-05,1.98E-05,6347/3553/5468/948,"CCL2,IL1B,PPARG,CD36",0.131903734,4
BP,GO:0050817,coagulation,340/18493,6.19E-06,5.70E-05,1.98E-05,3569/5594/4846/5054/959/2147/948,"IL6,MAPK1,NOS3,SERPINE1,CD40LG,F2,CD36",0.219507377,7
BP,GO:0044706,multi-multicellular organism process,221/18493,6.39E-06,5.86E-05,2.04E-05,207/3553/4318/5743/4313/596,"AKT1,IL1B,MMP9,PTGS2,MMP2,BCL2",0.211755237,6
BP,GO:0010594,regulation of endothelial cell migration,222/18493,6.55E-06,5.95E-05,2.07E-05,207/7422/5743/5468/4846/3162,"AKT1,VEGFA,PTGS2,PPARG,NOS3,HMOX1",0.235993439,6
BP,GO:0001836,release of cytochrome c from mitochondria,58/18493,6.60E-06,5.95E-05,2.07E-05,207/7157/4318/596,"AKT1,TP53,MMP9,BCL2",0.139333214,4
BP,GO:1902041,regulation of extrinsic apoptotic signaling pathway via death domain receptors,58/18493,6.60E-06,5.95E-05,2.07E-05,3383/4846/5054/3162,"ICAM1,NOS3,SERPINE1,HMOX1",0.14324515,4
BP,GO:1905953,negative regulation of lipid localization,58/18493,6.60E-06,5.95E-05,2.07E-05,3569/207/1401/5468,"IL6,AKT1,CRP,PPARG",0.175308124,4
BP,GO:2000351,regulation of endothelial cell apoptotic process,58/18493,6.60E-06,5.95E-05,2.07E-05,6347/3383/5054/959,"CCL2,ICAM1,SERPINE1,CD40LG",0.139322674,4
BP,GO:0030098,lymphocyte differentiation,344/18493,6.68E-06,6.01E-05,2.09E-05,3569/6774/3586/7412/3458/959/596,"IL6,STAT3,IL10,VCAM1,IFNG,CD40LG,BCL2",0.241310375,7
BP,GO:0032355,response to estradiol,127/18493,6.74E-06,6.02E-05,2.09E-05,6774/5743/3586/836/847,"STAT3,PTGS2,IL10,CASP3,CAT",0.192093877,5
BP,GO:0045471,response to ethanol,127/18493,6.74E-06,6.02E-05,2.09E-05,6774/3383/7412/847/3156,"STAT3,ICAM1,VCAM1,CAT,HMGCR",0.169075178,5
BP,GO:0044110,growth involved in symbiotic interaction,18/18493,6.92E-06,6.14E-05,2.14E-05,3586/4353/948,"IL10,MPO,CD36",0.083506326,3
BP,GO:0044116,growth of symbiont involved in interaction with host,18/18493,6.92E-06,6.14E-05,2.14E-05,3586/4353/948,"IL10,MPO,CD36",0.083506326,3
BP,GO:0045598,regulation of fat cell differentiation,128/18493,7.00E-06,6.19E-05,2.15E-05,3569/3630/207/5743/5468,"IL6,INS,AKT1,PTGS2,PPARG",0.222287152,5
BP,GO:0006066,alcohol metabolic process,348/18493,7.21E-06,6.33E-05,2.20E-05,3553/3458/847/5444/3156/1071/1080,"IL1B,IFNG,CAT,PON1,HMGCR,CETP,CFTR",0.173797194,7
BP,GO:0030198,extracellular matrix organization,348/18493,7.21E-06,6.33E-05,2.20E-05,4318/3383/7412/5054/4313/4312/4314,"MMP9,ICAM1,VCAM1,SERPINE1,MMP2,MMP1,MMP3",0.239097299,7
BP,GO:0006959,humoral immune response,349/18493,7.34E-06,6.43E-05,2.24E-05,3569/6347/1401/3576/3458/2147/596,"IL6,CCL2,CRP,CXCL8,IFNG,F2,BCL2",0.244155109,7
BP,GO:0071900,regulation of protein serine/threonine kinase activity,496/18493,7.49E-06,6.53E-05,2.27E-05,207/7422/3553/5594/836/3458/959/3156,"AKT1,VEGFA,IL1B,MAPK1,CASP3,IFNG,CD40LG,HMGCR",0.276912292,8
BP,GO:0050921,positive regulation of chemotaxis,130/18493,7.55E-06,6.55E-05,2.28E-05,3569/7422/3576/5054/7941,"IL6,VEGFA,CXCL8,SERPINE1,PLA2G7",0.181254715,5
BP,GO:0071347,cellular response to interleukin-1,130/18493,7.55E-06,6.55E-05,2.28E-05,3569/6347/3576/3553/3383,"IL6,CCL2,CXCL8,IL1B,ICAM1",0.209336525,5
BP,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,354/18493,8.06E-06,6.96E-05,2.42E-05,3569/6774/1401/3553/3586/3383/959,"IL6,STAT3,CRP,IL1B,IL10,ICAM1,CD40LG",0.272336535,7
BP,GO:0032635,interleukin-6 production,132/18493,8.14E-06,6.99E-05,2.43E-05,3569/3553/3586/4843/948,"IL6,IL1B,IL10,NOS2,CD36",0.164869399,5
BP,GO:0050671,positive regulation of lymphocyte proliferation,132/18493,8.14E-06,6.99E-05,2.43E-05,3569/3553/7412/959/596,"IL6,IL1B,VCAM1,CD40LG,BCL2",0.162506948,5
BP,GO:0002363,alpha-beta T cell lineage commitment,19/18493,8.21E-06,7.00E-05,2.44E-05,3569/6774/596,"IL6,STAT3,BCL2",0.104708909,3
BP,GO:0010888,negative regulation of lipid storage,19/18493,8.21E-06,7.00E-05,2.44E-05,3569/1401/5468,"IL6,CRP,PPARG",0.127556895,3
BP,GO:1901653,cellular response to peptide,356/18493,8.36E-06,7.11E-05,2.47E-05,3630/207/6774/7157/3553/5468/948,"INS,AKT1,STAT3,TP53,IL1B,PPARG,CD36",0.265038596,7
BP,GO:0033157,regulation of intracellular protein transport,232/18493,8.43E-06,7.11E-05,2.47E-05,7157/3553/5743/5594/3458/948,"TP53,IL1B,PTGS2,MAPK1,IFNG,CD36",0.200339667,6
BP,GO:2000116,regulation of cysteine-type endopeptidase activity,232/18493,8.43E-06,7.11E-05,2.47E-05,207/7422/4318/5743/5468/836,"AKT1,VEGFA,MMP9,PTGS2,PPARG,CASP3",0.23755244,6
BP,GO:0032946,positive regulation of mononuclear cell proliferation,133/18493,8.44E-06,7.11E-05,2.47E-05,3569/3553/7412/959/596,"IL6,IL1B,VCAM1,CD40LG,BCL2",0.162202676,5
BP,GO:0046631,alpha-beta T cell activation,134/18493,8.75E-06,7.33E-05,2.55E-05,3569/3630/6774/3458/596,"IL6,INS,STAT3,IFNG,BCL2",0.186933231,5
BP,GO:0061041,regulation of wound healing,134/18493,8.75E-06,7.33E-05,2.55E-05,4846/5054/2147/3156/948,"NOS3,SERPINE1,F2,HMGCR,CD36",0.119781112,5
BP,GO:0032872,regulation of stress-activated MAPK cascade,235/18493,9.07E-06,7.58E-05,2.64E-05,207/7422/3553/5594/959/3156,"AKT1,VEGFA,IL1B,MAPK1,CD40LG,HMGCR",0.202742456,6
BP,GO:0002532,production of molecular mediator involved in inflammatory response,63/18493,9.20E-06,7.65E-05,2.66E-05,3630/5054/4843/2147,"INS,SERPINE1,NOS2,F2",0.134392177,4
BP,GO:0014065,phosphatidylinositol 3-kinase signaling,136/18493,9.41E-06,7.81E-05,2.72E-05,3630/207/5594/847/2147,"INS,AKT1,MAPK1,CAT,F2",0.186580226,5
BP,GO:0070302,regulation of stress-activated protein kinase signaling cascade,237/18493,9.52E-06,7.88E-05,2.74E-05,207/7422/3553/5594/959/3156,"AKT1,VEGFA,IL1B,MAPK1,CD40LG,HMGCR",0.201906822,6
BP,GO:0002548,monocyte chemotaxis,64/18493,9.80E-06,8.03E-05,2.79E-05,3569/6347/5054/7941,"IL6,CCL2,SERPINE1,PLA2G7",0.137925899,4
BP,GO:0042306,regulation of protein import into nucleus,64/18493,9.80E-06,8.03E-05,2.79E-05,5743/5594/3458/948,"PTGS2,MAPK1,IFNG,CD36",0.118174205,4
BP,GO:0045600,positive regulation of fat cell differentiation,64/18493,9.80E-06,8.03E-05,2.79E-05,3630/207/5743/5468,"INS,AKT1,PTGS2,PPARG",0.167923819,4
BP,GO:0051924,regulation of calcium ion transport,239/18493,9.99E-06,8.16E-05,2.84E-05,6347/5743/3383/4846/2147/596,"CCL2,PTGS2,ICAM1,NOS3,F2,BCL2",0.186234917,6
BP,GO:0050678,regulation of epithelial cell proliferation,368/18493,1.04E-05,8.45E-05,2.94E-05,207/6774/6347/7422/5468/3586/3162,"AKT1,STAT3,CCL2,VEGFA,PPARG,IL10,HMOX1",0.274535186,7
BP,GO:0051926,negative regulation of calcium ion transport,65/18493,1.04E-05,8.47E-05,2.95E-05,5743/3383/4846/596,"PTGS2,ICAM1,NOS3,BCL2",0.121238395,4
BP,GO:0070665,positive regulation of leukocyte proliferation,139/18493,1.05E-05,8.47E-05,2.95E-05,3569/3553/7412/959/596,"IL6,IL1B,VCAM1,CD40LG,BCL2",0.15923001,5
BP,GO:0043900,regulation of multi-organism process,371/18493,1.09E-05,8.83E-05,3.07E-05,3576/3586/4353/3458/4843/596/948,"CXCL8,IL10,MPO,IFNG,NOS2,BCL2,CD36",0.192674692,7
BP,GO:0032677,regulation of interleukin-8 production,66/18493,1.11E-05,8.92E-05,3.10E-05,1401/3553/3586/5054,"CRP,IL1B,IL10,SERPINE1",0.148653758,4
BP,GO:0043369,"CD4-positive or CD8-positive, alpha-beta T cell lineage commitment",21/18493,1.12E-05,9.02E-05,3.14E-05,3569/6774/596,"IL6,STAT3,BCL2",0.101944414,3
BP,GO:0031330,negative regulation of cellular catabolic process,245/18493,1.15E-05,9.19E-05,3.20E-05,3630/207/6774/3586/3162/596,"INS,AKT1,STAT3,IL10,HMOX1,BCL2",0.21473595,6
BP,GO:0051271,negative regulation of cellular component movement,374/18493,1.15E-05,9.19E-05,3.20E-05,207/6774/6347/5468/5054/3162/596,"AKT1,STAT3,CCL2,PPARG,SERPINE1,HMOX1,BCL2",0.240793593,7
BP,GO:1903672,positive regulation of sprouting angiogenesis,67/18493,1.18E-05,9.33E-05,3.25E-05,7422/5743/3586/3162,"VEGFA,PTGS2,IL10,HMOX1",0.146718178,4
BP,GO:1904589,regulation of protein import,67/18493,1.18E-05,9.33E-05,3.25E-05,5743/5594/3458/948,"PTGS2,MAPK1,IFNG,CD36",0.116291148,4
BP,GO:0010959,regulation of metal ion transport,376/18493,1.19E-05,9.43E-05,3.28E-05,207/6347/5743/3383/4846/2147/596,"AKT1,CCL2,PTGS2,ICAM1,NOS3,F2,BCL2",0.226805153,7
BP,GO:0008203,cholesterol metabolic process,144/18493,1.24E-05,9.80E-05,3.41E-05,847/5444/3156/1071/1080,"CAT,PON1,HMGCR,CETP,CFTR",0.094239285,5
BP,GO:0009408,response to heat,145/18493,1.28E-05,0.000101009,3.51E-05,207/5743/5594/4846/3162,"AKT1,PTGS2,MAPK1,NOS3,HMOX1",0.183177063,5
BP,GO:0050995,negative regulation of lipid catabolic process,22/18493,1.30E-05,0.000101839,3.54E-05,3630/207/3553,"INS,AKT1,IL1B",0.12865031,3
BP,GO:0002262,myeloid cell homeostasis,146/18493,1.33E-05,0.000103527,3.60E-05,3569/6774/7422/836/3162,"IL6,STAT3,VEGFA,CASP3,HMOX1",0.195288803,5
BP,GO:0010212,response to ionizing radiation,146/18493,1.33E-05,0.000103527,3.60E-05,7157/3383/7412/836/596,"TP53,ICAM1,VCAM1,CASP3,BCL2",0.156140647,5
BP,GO:0007259,JAK-STAT cascade,147/18493,1.37E-05,0.000106701,3.71E-05,3569/6774/6347/3458/2147,"IL6,STAT3,CCL2,IFNG,F2",0.183650847,5
BP,GO:0048662,negative regulation of smooth muscle cell proliferation,70/18493,1.40E-05,0.00010857,3.78E-05,5468/3586/3458/3162,"PPARG,IL10,IFNG,HMOX1",0.137243901,4
BP,GO:0040013,negative regulation of locomotion,386/18493,1.41E-05,0.000109218,3.80E-05,207/6774/6347/5468/5054/3162/596,"AKT1,STAT3,CCL2,PPARG,SERPINE1,HMOX1,BCL2",0.23632312,7
BP,GO:0018108,peptidyl-tyrosine phosphorylation,387/18493,1.44E-05,0.000110743,3.85E-05,3569/6774/7422/7157/3383/3458/948,"IL6,STAT3,VEGFA,TP53,ICAM1,IFNG,CD36",0.242697641,7
BP,GO:0001890,placenta development,149/18493,1.47E-05,0.000112303,3.91E-05,207/5743/5468/3586/5594,"AKT1,PTGS2,PPARG,IL10,MAPK1",0.186903037,5
BP,GO:1902652,secondary alcohol metabolic process,149/18493,1.47E-05,0.000112303,3.91E-05,847/5444/3156/1071/1080,"CAT,PON1,HMGCR,CETP,CFTR",0.092844351,5
BP,GO:0038034,signal transduction in absence of ligand,71/18493,1.48E-05,0.000112936,3.93E-05,207/3553/836/596,"AKT1,IL1B,CASP3,BCL2",0.126959246,4
BP,GO:0097192,extrinsic apoptotic signaling pathway in absence of ligand,71/18493,1.48E-05,0.000112936,3.93E-05,207/3553/836/596,"AKT1,IL1B,CASP3,BCL2",0.126959246,4
BP,GO:0051043,regulation of membrane protein ectodomain proteolysis,23/18493,1.49E-05,0.000113013,3.93E-05,3553/3586/3458,"IL1B,IL10,IFNG",0.106436495,3
BP,GO:0071404,cellular response to low-density lipoprotein particle stimulus,23/18493,1.49E-05,0.000113013,3.93E-05,5468/4023/948,"PPARG,LPL,CD36",0.068205338,3
BP,GO:0018212,peptidyl-tyrosine modification,390/18493,1.51E-05,0.000113814,3.96E-05,3569/6774/7422/7157/3383/3458/948,"IL6,STAT3,VEGFA,TP53,ICAM1,IFNG,CD36",0.24196877,7
BP,GO:0048545,response to steroid hormone,390/18493,1.51E-05,0.000113814,3.96E-05,3569/5743/5468/3586/3383/836/596,"IL6,PTGS2,PPARG,IL10,ICAM1,CASP3,BCL2",0.236512424,7
BP,GO:0097696,STAT cascade,151/18493,1.56E-05,0.000117414,4.08E-05,3569/6774/6347/3458/2147,"IL6,STAT3,CCL2,IFNG,F2",0.181729517,5
BP,GO:0061045,negative regulation of wound healing,72/18493,1.57E-05,0.000117414,4.08E-05,4846/5054/2147/3156,"NOS3,SERPINE1,F2,HMGCR",0.10472145,4
BP,GO:0030100,regulation of endocytosis,260/18493,1.61E-05,0.000119278,4.15E-05,6347/7422/3553/5468/5054/948,"CCL2,VEGFA,IL1B,PPARG,SERPINE1,CD36",0.19293417,6
BP,GO:0043270,positive regulation of ion transport,260/18493,1.61E-05,0.000119278,4.15E-05,207/6347/3553/2147/5243/1080,"AKT1,CCL2,IL1B,F2,ABCB1,CFTR",0.167705085,6
BP,GO:0045926,negative regulation of growth,260/18493,1.61E-05,0.000119278,4.15E-05,7157/5468/3586/4353/596/948,"TP53,PPARG,IL10,MPO,BCL2,CD36",0.163746046,6
BP,GO:0030168,platelet activation,152/18493,1.61E-05,0.000119278,4.15E-05,3569/5594/4846/959/2147,"IL6,MAPK1,NOS3,CD40LG,F2",0.161493539,5
BP,GO:0070555,response to interleukin-1,152/18493,1.61E-05,0.000119278,4.15E-05,3569/6347/3576/3553/3383,"IL6,CCL2,CXCL8,IL1B,ICAM1",0.196304717,5
BP,GO:0046883,regulation of hormone secretion,261/18493,1.65E-05,0.000121395,4.22E-05,3630/3553/3458/4843/3156/1080,"INS,IL1B,IFNG,NOS2,HMGCR,CFTR",0.169642238,6
BP,GO:1900371,regulation of purine nucleotide biosynthetic process,73/18493,1.66E-05,0.000121674,4.23E-05,3630/6774/4846/4843,"INS,STAT3,NOS3,NOS2",0.147084301,4
BP,GO:0022617,extracellular matrix disassembly,74/18493,1.75E-05,0.000127738,4.44E-05,4318/4313/4312/4314,"MMP9,MMP2,MMP1,MMP3",0.120838281,4
BP,GO:0030808,regulation of nucleotide biosynthetic process,74/18493,1.75E-05,0.000127738,4.44E-05,3630/6774/4846/4843,"INS,STAT3,NOS3,NOS2",0.146290703,4
BP,GO:0043542,endothelial cell migration,266/18493,1.83E-05,0.000133684,4.65E-05,207/7422/5743/5468/4846/3162,"AKT1,VEGFA,PTGS2,PPARG,NOS3,HMOX1",0.216364304,6
BP,GO:1903201,regulation of oxidative stress-induced cell death,75/18493,1.84E-05,0.000134006,4.66E-05,3630/207/3586/4314,"INS,AKT1,IL10,MMP3",0.148251572,4
BP,GO:0051047,positive regulation of secretion,404/18493,1.90E-05,0.000137506,4.78E-05,3569/3630/3553/3586/3458/4023/1080,"IL6,INS,IL1B,IL10,IFNG,LPL,CFTR",0.228844542,7
BP,GO:0002440,production of molecular mediator of immune response,268/18493,1.91E-05,0.000138213,4.81E-05,3569/3553/3586/3162/959/948,"IL6,IL1B,IL10,HMOX1,CD40LG,CD36",0.181134933,6
BP,GO:0019430,removal of superoxide radicals,25/18493,1.93E-05,0.000138213,4.81E-05,4846/4353/948,"NOS3,MPO,CD36",0.074624811,3
BP,GO:0030194,positive regulation of blood coagulation,25/18493,1.93E-05,0.000138213,4.81E-05,5054/2147/948,"SERPINE1,F2,CD36",0.06330931,3
BP,GO:0032461,positive regulation of protein oligomerization,25/18493,1.93E-05,0.000138213,4.81E-05,7157/4312/4314,"TP53,MMP1,MMP3",0.090678185,3
BP,GO:1900048,positive regulation of hemostasis,25/18493,1.93E-05,0.000138213,4.81E-05,5054/2147/948,"SERPINE1,F2,CD36",0.06330931,3
BP,GO:0015718,monocarboxylic acid transport,158/18493,1.95E-05,0.000138495,4.82E-05,207/3553/5468/4843/948,"AKT1,IL1B,PPARG,NOS2,CD36",0.149371577,5
BP,GO:0090316,positive regulation of intracellular protein transport,158/18493,1.95E-05,0.000138495,4.82E-05,7157/3553/5743/5594/3458,"TP53,IL1B,PTGS2,MAPK1,IFNG",0.177394877,5
BP,GO:0030193,regulation of blood coagulation,77/18493,2.05E-05,0.000144856,5.04E-05,4846/5054/2147/948,"NOS3,SERPINE1,F2,CD36",0.09595225,4
BP,GO:1900046,regulation of hemostasis,77/18493,2.05E-05,0.000144856,5.04E-05,4846/5054/2147/948,"NOS3,SERPINE1,F2,CD36",0.09595225,4
BP,GO:0051348,negative regulation of transferase activity,274/18493,2.17E-05,0.000152779,5.32E-05,207/7157/3553/5468/836/3156,"AKT1,TP53,IL1B,PPARG,CASP3,HMGCR",0.198797934,6
BP,GO:0002360,T cell lineage commitment,26/18493,2.18E-05,0.000152779,5.32E-05,3569/6774/596,"IL6,STAT3,BCL2",0.096173063,3
BP,GO:0050820,positive regulation of coagulation,26/18493,2.18E-05,0.000152779,5.32E-05,5054/2147/948,"SERPINE1,F2,CD36",0.062595484,3
BP,GO:1903959,regulation of anion transmembrane transport,26/18493,2.18E-05,0.000152779,5.32E-05,207/5243/1080,"AKT1,ABCB1,CFTR",0.066017513,3
BP,GO:0016125,sterol metabolic process,162/18493,2.19E-05,0.000153399,5.34E-05,847/5444/3156/1071/1080,"CAT,PON1,HMGCR,CETP,CFTR",0.089660712,5
BP,GO:0048511,rhythmic process,276/18493,2.26E-05,0.000157055,5.46E-05,7157/5468/836/4846/5054/4843,"TP53,PPARG,CASP3,NOS3,SERPINE1,NOS2",0.195092941,6
BP,GO:0030307,positive regulation of cell growth,163/18493,2.26E-05,0.000157055,5.46E-05,3630/207/7422/2147/596,"INS,AKT1,VEGFA,F2,BCL2",0.156975742,5
BP,GO:1905954,positive regulation of lipid localization,79/18493,2.26E-05,0.000157055,5.46E-05,3553/4023/5444/948,"IL1B,LPL,PON1,CD36",0.086985968,4
BP,GO:0001558,regulation of cell growth,416/18493,2.29E-05,0.000158316,5.51E-05,3630/207/7422/7157/5468/2147/596,"INS,AKT1,VEGFA,TP53,PPARG,F2,BCL2",0.228785764,7
BP,GO:0048015,phosphatidylinositol-mediated signaling,164/18493,2.33E-05,0.000160654,5.59E-05,3630/207/5594/847/2147,"INS,AKT1,MAPK1,CAT,F2",0.172345633,5
BP,GO:0050764,regulation of phagocytosis,80/18493,2.38E-05,0.000163811,5.70E-05,6347/3553/5468/948,"CCL2,IL1B,PPARG,CD36",0.117616979,4
BP,GO:0071450,cellular response to oxygen radical,27/18493,2.45E-05,0.000167292,5.82E-05,4846/4353/948,"NOS3,MPO,CD36",0.073021369,3
BP,GO:0071451,cellular response to superoxide,27/18493,2.45E-05,0.000167292,5.82E-05,4846/4353/948,"NOS3,MPO,CD36",0.073021369,3
BP,GO:1902895,positive regulation of pri-miRNA transcription by RNA polymerase II,27/18493,2.45E-05,0.000167292,5.82E-05,6774/7157/3586,"STAT3,TP53,IL10",0.110554557,3
BP,GO:0032386,regulation of intracellular transport,422/18493,2.51E-05,0.000170913,5.95E-05,7157/3553/5743/5594/3458/3162/948,"TP53,IL1B,PTGS2,MAPK1,IFNG,HMOX1,CD36",0.212702551,7
BP,GO:0048017,inositol lipid-mediated signaling,167/18493,2.54E-05,0.000172641,6.01E-05,3630/207/5594/847/2147,"INS,AKT1,MAPK1,CAT,F2",0.17092602,5
BP,GO:0050818,regulation of coagulation,82/18493,2.62E-05,0.000177894,6.19E-05,4846/5054/2147/948,"NOS3,SERPINE1,F2,CD36",0.093722243,4
BP,GO:0051403,stress-activated MAPK cascade,284/18493,2.65E-05,0.000179297,6.24E-05,207/7422/3553/5594/959/3156,"AKT1,VEGFA,IL1B,MAPK1,CD40LG,HMGCR",0.184333714,6
BP,GO:0031349,positive regulation of defense response,427/18493,2.70E-05,0.000182458,6.35E-05,3569/3553/5743/5054/4023/7941/948,"IL6,IL1B,PTGS2,SERPINE1,LPL,PLA2G7,CD36",0.190012918,7
BP,GO:0002675,positive regulation of acute inflammatory response,28/18493,2.74E-05,0.000184301,6.41E-05,3569/3553/5743,"IL6,IL1B,PTGS2",0.114886465,3
BP,GO:0001659,temperature homeostasis,171/18493,2.85E-05,0.000191018,6.65E-05,6774/7422/3553/5743/948,"STAT3,VEGFA,IL1B,PTGS2,CD36",0.154544477,5
BP,GO:0043154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,84/18493,2.89E-05,0.000192755,6.71E-05,207/7422/4318/5743,"AKT1,VEGFA,MMP9,PTGS2",0.146290524,4
BP,GO:1903035,negative regulation of response to wounding,84/18493,2.89E-05,0.000192755,6.71E-05,4846/5054/2147/3156,"NOS3,SERPINE1,F2,HMGCR",0.098985273,4
BP,GO:0050796,regulation of insulin secretion,172/18493,2.93E-05,0.000194985,6.78E-05,3553/3458/4843/3156/1080,"IL1B,IFNG,NOS2,HMGCR,CFTR",0.117023087,5
BP,GO:0046427,positive regulation of JAK-STAT cascade,85/18493,3.02E-05,0.000200482,6.97E-05,3569/6774/3458/2147,"IL6,STAT3,IFNG,F2",0.134244069,4
BP,GO:0071674,mononuclear cell migration,85/18493,3.02E-05,0.000200482,6.97E-05,3569/6347/5054/7941,"IL6,CCL2,SERPINE1,PLA2G7",0.124541966,4
BP,GO:0002683,negative regulation of immune system process,437/18493,3.14E-05,0.000207399,7.22E-05,3630/207/6347/5468/3586/836/3162,"INS,AKT1,CCL2,PPARG,IL10,CASP3,HMOX1",0.249123134,7
BP,GO:0019932,second-messenger-mediated signaling,439/18493,3.23E-05,0.000213008,7.41E-05,3630/7422/3576/7412/4846/4843/948,"INS,VEGFA,CXCL8,VCAM1,NOS3,NOS2,CD36",0.212320894,7
BP,GO:0050829,defense response to Gram-negative bacterium,87/18493,3.31E-05,0.000218125,7.59E-05,3569/5054/4843/2147,"IL6,SERPINE1,NOS2,F2",0.11967897,4
BP,GO:0008217,regulation of blood pressure,177/18493,3.36E-05,0.000219885,7.65E-05,5743/5468/4846/3162/4843,"PTGS2,PPARG,NOS3,HMOX1,NOS2",0.153558373,5
BP,GO:1905475,regulation of protein localization to membrane,177/18493,3.36E-05,0.000219885,7.65E-05,3630/207/7157/3458/596,"INS,AKT1,TP53,IFNG,BCL2",0.159309041,5
BP,GO:0000303,response to superoxide,30/18493,3.38E-05,0.000220608,7.67E-05,4846/4353/948,"NOS3,MPO,CD36",0.070698276,3
BP,GO:0045907,positive regulation of vasoconstriction,30/18493,3.38E-05,0.000220608,7.67E-05,207/5743/3383,"AKT1,PTGS2,ICAM1",0.106006449,3
BP,GO:0001776,leukocyte homeostasis,88/18493,3.47E-05,0.000224346,7.80E-05,3569/207/836/596,"IL6,AKT1,CASP3,BCL2",0.1252439,4
BP,GO:0019217,regulation of fatty acid metabolic process,88/18493,3.47E-05,0.000224346,7.80E-05,3630/207/5743/5468,"INS,AKT1,PTGS2,PPARG",0.149626283,4
BP,GO:1904894,positive regulation of STAT cascade,88/18493,3.47E-05,0.000224346,7.80E-05,3569/6774/3458/2147,"IL6,STAT3,IFNG,F2",0.132470995,4
BP,GO:0051224,negative regulation of protein transport,181/18493,3.74E-05,0.000240985,8.38E-05,3630/3553/3586/3156/948,"INS,IL1B,IL10,HMGCR,CD36",0.13321518,5
BP,GO:0000305,response to oxygen radical,31/18493,3.74E-05,0.000240985,8.38E-05,4846/4353/948,"NOS3,MPO,CD36",0.069956393,3
BP,GO:0060333,interferon-gamma-mediated signaling pathway,90/18493,3.79E-05,0.00024334,8.47E-05,5468/3383/7412/3458,"PPARG,ICAM1,VCAM1,IFNG",0.12669101,4
BP,GO:0042113,B cell activation,303/18493,3.81E-05,0.000244252,8.50E-05,3569/3586/7412/836/959/596,"IL6,IL10,VCAM1,CASP3,CD40LG,BCL2",0.170739258,6
BP,GO:0023061,signal release,453/18493,3.94E-05,0.00025116,8.74E-05,3569/3630/3553/3458/4843/3156/1080,"IL6,INS,IL1B,IFNG,NOS2,HMGCR,CFTR",0.198504444,7
BP,GO:0042100,B cell proliferation,91/18493,3.96E-05,0.00025116,8.74E-05,3586/836/959/596,"IL10,CASP3,CD40LG,BCL2",0.09607684,4
BP,GO:0044070,regulation of anion transport,91/18493,3.96E-05,0.00025116,8.74E-05,207/3553/5243/1080,"AKT1,IL1B,ABCB1,CFTR",0.097057187,4
BP,GO:2000117,negative regulation of cysteine-type endopeptidase activity,91/18493,3.96E-05,0.00025116,8.74E-05,207/7422/4318/5743,"AKT1,VEGFA,MMP9,PTGS2",0.141764145,4
BP,GO:0043112,receptor metabolic process,184/18493,4.04E-05,0.000254206,8.84E-05,7422/3576/5468/3586/948,"VEGFA,CXCL8,PPARG,IL10,CD36",0.144272523,5
BP,GO:0050866,negative regulation of cell activation,184/18493,4.04E-05,0.000254206,8.84E-05,3586/836/4846/3162/2147,"IL10,CASP3,NOS3,HMOX1,F2",0.145317831,5
BP,GO:0071248,cellular response to metal ion,184/18493,4.04E-05,0.000254206,8.84E-05,207/4318/5743/5594/3162,"AKT1,MMP9,PTGS2,MAPK1,HMOX1",0.167817887,5
BP,GO:1904950,negative regulation of establishment of protein localization,184/18493,4.04E-05,0.000254206,8.84E-05,3630/3553/3586/3156/948,"INS,IL1B,IL10,HMGCR,CD36",0.132361083,5
BP,GO:0010574,regulation of vascular endothelial growth factor production,32/18493,4.12E-05,0.000257941,8.97E-05,3569/3553/5743,"IL6,IL1B,PTGS2",0.110395189,3
BP,GO:0032735,positive regulation of interleukin-12 production,32/18493,4.12E-05,0.000257941,8.97E-05,3458/959/948,"IFNG,CD40LG,CD36",0.058994262,3
BP,GO:0010660,regulation of muscle cell apoptotic process,92/18493,4.13E-05,0.000257941,8.97E-05,5468/3458/3162/3156,"PPARG,IFNG,HMOX1,HMGCR",0.105912752,4
BP,GO:0051346,negative regulation of hydrolase activity,458/18493,4.23E-05,0.000263473,9.17E-05,207/7422/7157/4318/5743/4846/5054,"AKT1,VEGFA,TP53,MMP9,PTGS2,NOS3,SERPINE1",0.236168085,7
BP,GO:1901655,cellular response to ketone,93/18493,4.31E-05,0.000267889,9.32E-05,207/5468/3383/1080,"AKT1,PPARG,ICAM1,CFTR",0.113389431,4
BP,GO:0042035,regulation of cytokine biosynthetic process,94/18493,4.49E-05,0.000278093,9.67E-05,3569/3553/3586/3162,"IL6,IL1B,IL10,HMOX1",0.137680542,4
BP,GO:1900542,regulation of purine nucleotide metabolic process,94/18493,4.49E-05,0.000278093,9.67E-05,3630/6774/4846/4843,"INS,STAT3,NOS3,NOS2",0.133596438,4
BP,GO:0071354,cellular response to interleukin-6,33/18493,4.53E-05,0.00027903,9.71E-05,3569/6774/3383,"IL6,STAT3,ICAM1",0.110699114,3
BP,GO:1903427,negative regulation of reactive oxygen species biosynthetic process,33/18493,4.53E-05,0.00027903,9.71E-05,3630/6774/3586,"INS,STAT3,IL10",0.111147343,3
BP,GO:0031098,stress-activated protein kinase signaling cascade,313/18493,4.57E-05,0.000280755,9.77E-05,207/7422/3553/5594/959/3156,"AKT1,VEGFA,IL1B,MAPK1,CD40LG,HMGCR",0.1747513,6
BP,GO:0002040,sprouting angiogenesis,189/18493,4.59E-05,0.000281669,9.80E-05,207/7422/5743/3586/3162,"AKT1,VEGFA,PTGS2,IL10,HMOX1",0.167547002,5
BP,GO:0042180,cellular ketone metabolic process,190/18493,4.71E-05,0.000288185,0.000100258,3630/207/5743/5468/3156,"INS,AKT1,PTGS2,PPARG,HMGCR",0.159241369,5
BP,GO:0009749,response to glucose,191/18493,4.83E-05,0.000294811,0.000102563,3383/836/4023/3156/1080,"ICAM1,CASP3,LPL,HMGCR,CFTR",0.107084671,5
BP,GO:0010657,muscle cell apoptotic process,96/18493,4.88E-05,0.000297263,0.000103416,5468/3458/3162/3156,"PPARG,IFNG,HMOX1,HMGCR",0.10409404,4
BP,GO:0034764,positive regulation of transmembrane transport,192/18493,4.95E-05,0.000300791,0.000104643,3630/207/2147/5243/1080,"INS,AKT1,F2,ABCB1,CFTR",0.123010788,5
BP,GO:0010573,vascular endothelial growth factor production,34/18493,4.96E-05,0.000300791,0.000104643,3569/3553/5743,"IL6,IL1B,PTGS2",0.108341878,3
BP,GO:0042102,positive regulation of T cell proliferation,97/18493,5.08E-05,0.000307502,0.000106978,3569/3553/7412/959,"IL6,IL1B,VCAM1,CD40LG",0.126888165,4
BP,GO:0010001,glial cell differentiation,194/18493,5.20E-05,0.000313957,0.000109224,207/6774/5468/5594/2147,"AKT1,STAT3,PPARG,MAPK1,F2",0.158384633,5
BP,GO:0006140,regulation of nucleotide metabolic process,98/18493,5.29E-05,0.000318677,0.000110866,3630/6774/4846/4843,"INS,STAT3,NOS3,NOS2",0.131373733,4
BP,GO:0043368,positive T cell selection,35/18493,5.42E-05,0.00032415,0.00011277,3569/6774/596,"IL6,STAT3,BCL2",0.087939698,3
BP,GO:1901099,negative regulation of signal transduction in absence of ligand,35/18493,5.42E-05,0.00032415,0.00011277,207/3553/596,"AKT1,IL1B,BCL2",0.081727198,3
BP,GO:2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,35/18493,5.42E-05,0.00032415,0.00011277,207/3553/596,"AKT1,IL1B,BCL2",0.081727198,3
BP,GO:0032147,activation of protein kinase activity,323/18493,5.44E-05,0.000324792,0.000112993,3630/207/7422/3553/5594/959,"INS,AKT1,VEGFA,IL1B,MAPK1,CD40LG",0.198862865,6
BP,GO:1903531,negative regulation of secretion by cell,196/18493,5.46E-05,0.000325285,0.000113165,3630/3553/3586/3162/3156,"INS,IL1B,IL10,HMOX1,HMGCR",0.148781192,5
BP,GO:0034405,response to fluid shear stress,36/18493,5.90E-05,0.000350005,0.000121765,207/5743/4846,"AKT1,PTGS2,NOS3",0.099061944,3
BP,GO:1904037,positive regulation of epithelial cell apoptotic process,36/18493,5.90E-05,0.000350005,0.000121765,3569/6347/959,"IL6,CCL2,CD40LG",0.095525992,3
BP,GO:0002042,cell migration involved in sprouting angiogenesis,101/18493,5.95E-05,0.000350754,0.000122025,207/7422/5743/3162,"AKT1,VEGFA,PTGS2,HMOX1",0.131676939,4
BP,GO:0002286,T cell activation involved in immune response,101/18493,5.95E-05,0.000350754,0.000122025,3569/6774/3383/3458,"IL6,STAT3,ICAM1,IFNG",0.136029046,4
BP,GO:0046632,alpha-beta T cell differentiation,101/18493,5.95E-05,0.000350754,0.000122025,3569/6774/3458/596,"IL6,STAT3,IFNG,BCL2",0.115500519,4
BP,GO:0016049,cell growth,485/18493,6.07E-05,0.00035708,0.000124226,3630/207/7422/7157/5468/2147/596,"INS,AKT1,VEGFA,TP53,PPARG,F2,BCL2",0.207520991,7
BP,GO:0070741,response to interleukin-6,37/18493,6.41E-05,0.000375128,0.000130505,3569/6774/3383,"IL6,STAT3,ICAM1",0.106696142,3
BP,GO:1902893,regulation of pri-miRNA transcription by RNA polymerase II,37/18493,6.41E-05,0.000375128,0.000130505,6774/7157/3586,"STAT3,TP53,IL10",0.100287967,3
BP,GO:0030073,insulin secretion,203/18493,6.45E-05,0.000375128,0.000130505,3553/3458/4843/3156/1080,"IL1B,IFNG,NOS2,HMGCR,CFTR",0.108059329,5
BP,GO:0043903,"regulation of symbiosis, encompassing mutualism through parasitism",203/18493,6.45E-05,0.000375128,0.000130505,3576/3586/4353/596/948,"CXCL8,IL10,MPO,BCL2,CD36",0.111361368,5
BP,GO:0050679,positive regulation of epithelial cell proliferation,203/18493,6.45E-05,0.000375128,0.000130505,207/6774/7422/3586/3162,"AKT1,STAT3,VEGFA,IL10,HMOX1",0.165520205,5
BP,GO:0009612,response to mechanical stimulus,204/18493,6.60E-05,0.00038314,0.000133292,207/3553/5743/5468/4353,"AKT1,IL1B,PTGS2,PPARG,MPO",0.161623228,5
BP,GO:0042089,cytokine biosynthetic process,105/18493,6.93E-05,0.000399199,0.000138879,3569/3553/3586/3162,"IL6,IL1B,IL10,HMOX1",0.131601569,4
BP,GO:0043467,regulation of generation of precursor metabolites and energy,105/18493,6.93E-05,0.000399199,0.000138879,3630/207/6774/4843,"INS,AKT1,STAT3,NOS2",0.13516496,4
BP,GO:0000060,"protein import into nucleus, translocation",38/18493,6.95E-05,0.000399199,0.000138879,207/5594/3458,"AKT1,MAPK1,IFNG",0.095272371,3
BP,GO:0010661,positive regulation of muscle cell apoptotic process,38/18493,6.95E-05,0.000399199,0.000138879,5468/3458/3156,"PPARG,IFNG,HMGCR",0.072571219,3
BP,GO:0090050,positive regulation of cell migration involved in sprouting angiogenesis,38/18493,6.95E-05,0.000399199,0.000138879,7422/5743/3162,"VEGFA,PTGS2,HMOX1",0.09287272,3
BP,GO:0014066,regulation of phosphatidylinositol 3-kinase signaling,106/18493,7.19E-05,0.000411011,0.000142988,3630/5594/847/2147,"INS,MAPK1,CAT,F2",0.117287956,4
BP,GO:0042107,cytokine metabolic process,106/18493,7.19E-05,0.000411011,0.000142988,3569/3553/3586/3162,"IL6,IL1B,IL10,HMOX1",0.131111232,4
BP,GO:0002446,neutrophil mediated immunity,499/18493,7.26E-05,0.000414453,0.000144185,3569/4318/5594/4353/847/2147/948,"IL6,MMP9,MAPK1,MPO,CAT,F2,CD36",0.185528914,7
BP,GO:0070371,ERK1 and ERK2 cascade,341/18493,7.34E-05,0.000418192,0.000145487,6347/3553/5594/3383/3156/948,"CCL2,IL1B,MAPK1,ICAM1,HMGCR,CD36",0.148084965,6
BP,GO:0002699,positive regulation of immune effector process,209/18493,7.40E-05,0.000420633,0.000146336,3569/3553/3458/3162/948,"IL6,IL1B,IFNG,HMOX1,CD36",0.135686555,5
BP,GO:0006909,phagocytosis,342/18493,7.46E-05,0.000423224,0.000147237,6347/1401/3553/5468/5594/948,"CCL2,CRP,IL1B,PPARG,MAPK1,CD36",0.168072028,6
BP,GO:0043029,T cell homeostasis,39/18493,7.52E-05,0.000425511,0.000148033,207/836/596,"AKT1,CASP3,BCL2",0.075866945,3
BP,GO:0002449,lymphocyte mediated immunity,344/18493,7.71E-05,0.000434328,0.0001511,3569/1401/3553/3586/3383/959,"IL6,CRP,IL1B,IL10,ICAM1,CD40LG",0.185254944,6
BP,GO:0009165,nucleotide biosynthetic process,344/18493,7.71E-05,0.000434328,0.0001511,3630/6774/5743/5594/4846/4843,"INS,STAT3,PTGS2,MAPK1,NOS3,NOS2",0.18786497,6
BP,GO:1901293,nucleoside phosphate biosynthetic process,347/18493,8.08E-05,0.000454675,0.000158179,3630/6774/5743/5594/4846/4843,"INS,STAT3,PTGS2,MAPK1,NOS3,NOS2",0.186753935,6
BP,GO:0032388,positive regulation of intracellular transport,214/18493,8.28E-05,0.000464475,0.000161588,7157/3553/5743/5594/3458,"TP53,IL1B,PTGS2,MAPK1,IFNG",0.15323405,5
BP,GO:0008406,gonad development,216/18493,8.65E-05,0.000484307,0.000168487,7422/3383/836/4846/596,"VEGFA,ICAM1,CASP3,NOS3,BCL2",0.129614701,5
BP,GO:1904706,negative regulation of vascular smooth muscle cell proliferation,41/18493,8.75E-05,0.000487881,0.000169731,5468/3586/3162,"PPARG,IL10,HMOX1",0.087405551,3
BP,GO:0045862,positive regulation of proteolysis,352/18493,8.75E-05,0.000487881,0.000169731,207/6774/3553/5468/836/3458,"AKT1,STAT3,IL1B,PPARG,CASP3,IFNG",0.188683734,6
BP,GO:0043393,regulation of protein binding,217/18493,8.84E-05,0.000490904,0.000170782,207/4318/3586/596/948,"AKT1,MMP9,IL10,BCL2,CD36",0.114482586,5
BP,GO:0045444,fat cell differentiation,217/18493,8.84E-05,0.000490904,0.000170782,3569/3630/207/5743/5468,"IL6,INS,AKT1,PTGS2,PPARG",0.174783767,5
BP,GO:0014013,regulation of gliogenesis,112/18493,8.90E-05,0.000493569,0.00017171,3569/3553/5468/2147,"IL6,IL1B,PPARG,F2",0.120608463,4
BP,GO:0007569,cell aging,113/18493,9.22E-05,0.000509864,0.000177378,7157/3383/5054/596,"TP53,ICAM1,SERPINE1,BCL2",0.098472935,4
BP,GO:0006509,membrane protein ectodomain proteolysis,42/18493,9.40E-05,0.000518085,0.000180238,3553/3586/3458,"IL1B,IL10,IFNG",0.088603789,3
BP,GO:0042307,positive regulation of protein import into nucleus,42/18493,9.40E-05,0.000518085,0.000180238,5743/5594/3458,"PTGS2,MAPK1,IFNG",0.087172108,3
BP,GO:0007160,cell-matrix adhesion,222/18493,9.84E-05,0.000538755,0.000187429,7422/7412/5054/596/948,"VEGFA,VCAM1,SERPINE1,BCL2,CD36",0.105149387,5
BP,GO:0045137,development of primary sexual characteristics,222/18493,9.84E-05,0.000538755,0.000187429,7422/3383/836/4846/596,"VEGFA,ICAM1,CASP3,NOS3,BCL2",0.127805482,5
BP,GO:0051048,negative regulation of secretion,222/18493,9.84E-05,0.000538755,0.000187429,3630/3553/3586/3162/3156,"INS,IL1B,IL10,HMOX1,HMGCR",0.139433588,5
BP,GO:0032965,regulation of collagen biosynthetic process,43/18493,0.000100946,0.000551636,0.000191911,3569/5468/2147,"IL6,PPARG,F2",0.087372634,3
BP,GO:0001952,regulation of cell-matrix adhesion,117/18493,0.000105488,0.000575292,0.000200141,7422/5054/596/948,"VEGFA,SERPINE1,BCL2,CD36",0.075838232,4
BP,GO:1904591,positive regulation of protein import,44/18493,0.000108175,0.000588758,0.000204825,5743/5594/3458,"PTGS2,MAPK1,IFNG",0.085698654,3
BP,GO:1905477,positive regulation of protein localization to membrane,119/18493,0.000112646,0.000611862,0.000212863,207/7157/3458/596,"AKT1,TP53,IFNG,BCL2",0.102098559,4
BP,GO:0006631,fatty acid metabolic process,369/18493,0.000113317,0.000614273,0.000213702,3630/207/5743/5468/4023/5444,"INS,AKT1,PTGS2,PPARG,LPL,PON1",0.166643187,6
BP,GO:0002686,negative regulation of leukocyte migration,45/18493,0.000115733,0.000623619,0.000216953,207/6347/3162,"AKT1,CCL2,HMOX1",0.092580202,3
BP,GO:0008631,intrinsic apoptotic signaling pathway in response to oxidative stress,45/18493,0.000115733,0.000623619,0.000216953,3630/207/596,"INS,AKT1,BCL2",0.081867232,3
BP,GO:1904036,negative regulation of epithelial cell apoptotic process,45/18493,0.000115733,0.000623619,0.000216953,3383/5054/3162,"ICAM1,SERPINE1,HMOX1",0.081124493,3
BP,GO:0034101,erythrocyte homeostasis,120/18493,0.000116354,0.000625722,0.000217685,6774/7422/836/3162,"STAT3,VEGFA,CASP3,HMOX1",0.119141936,4
BP,GO:0008637,apoptotic mitochondrial changes,121/18493,0.00012015,0.000643849,0.000223991,207/7157/4318/596,"AKT1,TP53,MMP9,BCL2",0.105231507,4
BP,GO:1903532,positive regulation of secretion by cell,373/18493,0.000120201,0.000643849,0.000223991,3569/3630/3586/3458/4023/1080,"IL6,INS,IL10,IFNG,LPL,CFTR",0.158287221,6
BP,GO:0006984,ER-nucleus signaling pathway,46/18493,0.000123627,0.000659028,0.000229272,6347/7157/3576,"CCL2,TP53,CXCL8",0.093597171,3
BP,GO:2001239,regulation of extrinsic apoptotic signaling pathway in absence of ligand,46/18493,0.000123627,0.000659028,0.000229272,207/3553/596,"AKT1,IL1B,BCL2",0.07450934,3
BP,GO:0042176,regulation of protein catabolic process,375/18493,0.000123766,0.000659028,0.000229272,3630/207/3553/3586/3458/4843,"INS,AKT1,IL1B,IL10,IFNG,NOS2",0.179177028,6
BP,GO:0051101,regulation of DNA binding,122/18493,0.000124036,0.000659168,0.00022932,4318/5468/3458/3162,"MMP9,PPARG,IFNG,HMOX1",0.111234228,4
BP,GO:0032675,regulation of interleukin-6 production,123/18493,0.000128011,0.000678961,0.000236206,3569/3553/3586/948,"IL6,IL1B,IL10,CD36",0.104173714,4
BP,GO:0002720,positive regulation of cytokine production involved in immune response,47/18493,0.000131863,0.00069395,0.000241421,3569/3553/948,"IL6,IL1B,CD36",0.075178486,3
BP,GO:0090199,regulation of release of cytochrome c from mitochondria,47/18493,0.000131863,0.00069395,0.000241421,207/7157/4318,"AKT1,TP53,MMP9",0.094757854,3
BP,GO:0101023,vascular endothelial cell proliferation,47/18493,0.000131863,0.00069395,0.000241421,6774/6347/5468,"STAT3,CCL2,PPARG",0.093166121,3
BP,GO:1905562,regulation of vascular endothelial cell proliferation,47/18493,0.000131863,0.00069395,0.000241421,6774/6347/5468,"STAT3,CCL2,PPARG",0.093166121,3
BP,GO:0010565,regulation of cellular ketone metabolic process,125/18493,0.000136238,0.000714196,0.000248464,3630/207/5743/5468,"INS,AKT1,PTGS2,PPARG",0.129005482,4
BP,GO:0030183,B cell differentiation,125/18493,0.000136238,0.000714196,0.000248464,3586/7412/959/596,"IL10,VCAM1,CD40LG,BCL2",0.084031163,4
BP,GO:0010712,regulation of collagen metabolic process,48/18493,0.000140449,0.000727807,0.0002532,3569/5468/2147,"IL6,PPARG,F2",0.084145067,3
BP,GO:0045058,T cell selection,48/18493,0.000140449,0.000727807,0.0002532,3569/6774/596,"IL6,STAT3,BCL2",0.079086616,3
BP,GO:0051972,regulation of telomerase activity,48/18493,0.000140449,0.000727807,0.0002532,7157/5468/5594,"TP53,PPARG,MAPK1",0.087706297,3
BP,GO:0060711,labyrinthine layer development,48/18493,0.000140449,0.000727807,0.0002532,207/3586/5594,"AKT1,IL10,MAPK1",0.090640496,3
BP,GO:1903793,positive regulation of anion transport,48/18493,0.000140449,0.000727807,0.0002532,3553/5243/1080,"IL1B,ABCB1,CFTR",0.050750593,3
BP,GO:1904707,positive regulation of vascular smooth muscle cell proliferation,48/18493,0.000140449,0.000727807,0.0002532,4318/3586/4313,"MMP9,IL10,MMP2",0.082853615,3
BP,GO:0050709,negative regulation of protein secretion,128/18493,0.000149289,0.000772135,0.000268621,3630/3553/3586/3156,"INS,IL1B,IL10,HMGCR",0.107361127,4
BP,GO:0046425,regulation of JAK-STAT cascade,129/18493,0.000153833,0.000794121,0.00027627,3569/6774/3458/2147,"IL6,STAT3,IFNG,F2",0.11254202,4
BP,GO:0022898,regulation of transmembrane transporter activity,245/18493,0.000156155,0.000804571,0.000279905,3630/4318/5243/596/1080,"INS,MMP9,ABCB1,BCL2,CFTR",0.094994758,5
BP,GO:0050714,positive regulation of protein secretion,246/18493,0.000159151,0.000818446,0.000284732,3569/3630/3586/4023/1080,"IL6,INS,IL10,LPL,CFTR",0.127721725,5
BP,GO:0050777,negative regulation of immune response,131/18493,0.000163222,0.000837789,0.000291462,3630/5468/3586/3162,"INS,PPARG,IL10,HMOX1",0.117453066,4
BP,GO:0010951,negative regulation of endopeptidase activity,250/18493,0.000171575,0.000878998,0.000305798,207/7422/4318/5743/5054,"AKT1,VEGFA,MMP9,PTGS2,SERPINE1",0.145494011,5
BP,GO:1904892,regulation of STAT cascade,133/18493,0.000173018,0.000884713,0.000307786,3569/6774/3458/2147,"IL6,STAT3,IFNG,F2",0.110838857,4
BP,GO:0071901,negative regulation of protein serine/threonine kinase activity,134/18493,0.000178072,0.000903775,0.000314418,207/3553/836/3156,"AKT1,IL1B,CASP3,HMGCR",0.100949263,4
BP,GO:0030195,negative regulation of blood coagulation,52/18493,0.000178416,0.000903775,0.000314418,4846/5054/2147,"NOS3,SERPINE1,F2",0.069004107,3
BP,GO:0032964,collagen biosynthetic process,52/18493,0.000178416,0.000903775,0.000314418,3569/5468/2147,"IL6,PPARG,F2",0.081623281,3
BP,GO:0050994,regulation of lipid catabolic process,52/18493,0.000178416,0.000903775,0.000314418,3630/207/3553,"INS,AKT1,IL1B",0.098095052,3
BP,GO:1900047,negative regulation of hemostasis,52/18493,0.000178416,0.000903775,0.000314418,4846/5054/2147,"NOS3,SERPINE1,F2",0.069004107,3
BP,GO:0002792,negative regulation of peptide secretion,135/18493,0.000183232,0.000926436,0.000322301,3630/3553/3586/3156,"INS,IL1B,IL10,HMGCR",0.104631754,4
BP,GO:0030099,myeloid cell differentiation,405/18493,0.000188102,0.000947682,0.000329693,6774/7422/4318/5468/836/3458,"STAT3,VEGFA,MMP9,PPARG,CASP3,IFNG",0.168800957,6
BP,GO:0015850,organic hydroxy compound transport,255/18493,0.000188135,0.000947682,0.000329693,5468/5444/1071/1080/948,"PPARG,PON1,CETP,CFTR,CD36",0.069578221,5
BP,GO:0001818,negative regulation of cytokine production,256/18493,0.000191589,0.000954143,0.000331941,3569/3586/3458/3162/2147,"IL6,IL10,IFNG,HMOX1,F2",0.130287525,5
BP,GO:0001660,fever generation,10/18493,0.000192945,0.000954143,0.000331941,3553/5743,"IL1B,PTGS2",0.05722703,2
BP,GO:0002679,respiratory burst involved in defense response,10/18493,0.000192945,0.000954143,0.000331941,3630/4353,"INS,MPO",0.06101542,2
BP,GO:0010749,regulation of nitric oxide mediated signal transduction,10/18493,0.000192945,0.000954143,0.000331941,3630/7422,"INS,VEGFA",0.0654059,2
BP,GO:0031284,positive regulation of guanylate cyclase activity,10/18493,0.000192945,0.000954143,0.000331941,4846/4843,"NOS3,NOS2",0.046457644,2
BP,GO:0045073,regulation of chemokine biosynthetic process,10/18493,0.000192945,0.000954143,0.000331941,3569/3162,"IL6,HMOX1",0.060345998,2
BP,GO:0046886,positive regulation of hormone biosynthetic process,10/18493,0.000192945,0.000954143,0.000331941,3553/3458,"IL1B,IFNG",0.05402405,2
BP,GO:0051918,negative regulation of fibrinolysis,10/18493,0.000192945,0.000954143,0.000331941,5054/2147,"SERPINE1,F2",0.042525145,2
BP,GO:0090336,positive regulation of brown fat cell differentiation,10/18493,0.000192945,0.000954143,0.000331941,3630/5743,"INS,PTGS2",0.063631507,2
BP,GO:2001225,regulation of chloride transport,10/18493,0.000192945,0.000954143,0.000331941,5243/1080,"ABCB1,CFTR",0.019673324,2
BP,GO:0045165,cell fate commitment,257/18493,0.000195091,0.000962993,0.000335019,3569/6774/5468/836/596,"IL6,STAT3,PPARG,CASP3,BCL2",0.129989654,5
BP,GO:0045123,cellular extravasation,54/18493,0.000199663,0.000983768,0.000342247,6347/3383/7412,"CCL2,ICAM1,VCAM1",0.083047176,3
BP,GO:0050728,negative regulation of inflammatory response,139/18493,0.000204958,0.001008022,0.000350685,3630/5468/3586/2147,"INS,PPARG,IL10,F2",0.107452283,4
BP,GO:0006816,calcium ion transport,413/18493,0.000209089,0.001026473,0.000357104,6347/5743/3383/4846/2147/596,"CCL2,PTGS2,ICAM1,NOS3,F2,BCL2",0.136150197,6
BP,GO:0010466,negative regulation of peptidase activity,261/18493,0.00020959,0.001027068,0.000357311,207/7422/4318/5743/5054,"AKT1,VEGFA,MMP9,PTGS2,SERPINE1",0.142275088,5
BP,GO:0090303,positive regulation of wound healing,55/18493,0.000210875,0.001027776,0.000357557,5054/2147/948,"SERPINE1,F2,CD36",0.049015925,3
BP,GO:1900408,negative regulation of cellular response to oxidative stress,55/18493,0.000210875,0.001027776,0.000357557,3630/207/3586,"INS,AKT1,IL10",0.094566555,3
BP,GO:1903202,negative regulation of oxidative stress-induced cell death,55/18493,0.000210875,0.001027776,0.000357557,3630/207/3586,"INS,AKT1,IL10",0.094566555,3
BP,GO:0071236,cellular response to antibiotic,141/18493,0.000216491,0.001053253,0.00036642,3569/7157/3586/1080,"IL6,TP53,IL10,CFTR",0.099954285,4
BP,GO:0001541,ovarian follicle development,56/18493,0.000222487,0.001076612,0.000374547,7422/3383/596,"VEGFA,ICAM1,BCL2",0.064608484,3
BP,GO:0019229,regulation of vasoconstriction,56/18493,0.000222487,0.001076612,0.000374547,207/5743/3383,"AKT1,PTGS2,ICAM1",0.086047101,3
BP,GO:0050819,negative regulation of coagulation,56/18493,0.000222487,0.001076612,0.000374547,4846/5054/2147,"NOS3,SERPINE1,F2",0.067281261,3
BP,GO:0002793,positive regulation of peptide secretion,265/18493,0.000224899,0.001086343,0.000377932,3569/3630/3586/4023/1080,"IL6,INS,IL10,LPL,CFTR",0.122633676,5
BP,GO:1903670,regulation of sprouting angiogenesis,143/18493,0.000228485,0.001101698,0.000383274,7422/5743/3586/3162,"VEGFA,PTGS2,IL10,HMOX1",0.107686408,4
BP,GO:0045927,positive regulation of growth,267/18493,0.000232866,0.001109839,0.000386106,3630/207/7422/2147/596,"INS,AKT1,VEGFA,F2,BCL2",0.121931831,5
BP,GO:0097755,positive regulation of blood vessel diameter,57/18493,0.000234505,0.001109839,0.000386106,3630/4846/3162,"INS,NOS3,HMOX1",0.084306345,3
BP,GO:1902883,negative regulation of response to oxidative stress,57/18493,0.000234505,0.001109839,0.000386106,3630/207/3586,"INS,AKT1,IL10",0.093510741,3
BP,GO:0055088,lipid homeostasis,144/18493,0.000234658,0.001109839,0.000386106,3630/5468/4023/1071,"INS,PPARG,LPL,CETP",0.089559852,4
BP,GO:0031652,positive regulation of heat generation,11/18493,0.000235507,0.001109839,0.000386106,3553/5743,"IL1B,PTGS2",0.055983231,2
BP,GO:0033197,response to vitamin E,11/18493,0.000235507,0.001109839,0.000386106,5468/847,"PPARG,CAT",0.050648389,2
BP,GO:0034372,very-low-density lipoprotein particle remodeling,11/18493,0.000235507,0.001109839,0.000386106,4023/1071,"LPL,CETP",0.027718896,2
BP,GO:0042033,chemokine biosynthetic process,11/18493,0.000235507,0.001109839,0.000386106,3569/3162,"IL6,HMOX1",0.05903441,2
BP,GO:0042368,vitamin D biosynthetic process,11/18493,0.000235507,0.001109839,0.000386106,3553/3458,"IL1B,IFNG",0.052849867,2
BP,GO:0050755,chemokine metabolic process,11/18493,0.000235507,0.001109839,0.000386106,3569/3162,"IL6,HMOX1",0.05903441,2
BP,GO:0051974,negative regulation of telomerase activity,11/18493,0.000235507,0.001109839,0.000386106,7157/5468,"TP53,PPARG",0.055941348,2
BP,GO:0060100,"positive regulation of phagocytosis, engulfment",11/18493,0.000235507,0.001109839,0.000386106,5468/948,"PPARG,CD36",0.033902207,2
BP,GO:1905155,positive regulation of membrane invagination,11/18493,0.000235507,0.001109839,0.000386106,5468/948,"PPARG,CD36",0.033902207,2
BP,GO:0007548,sex differentiation,268/18493,0.00023693,0.001114601,0.000387763,7422/3383/836/4846/596,"VEGFA,ICAM1,CASP3,NOS3,BCL2",0.115460229,5
BP,GO:0043388,positive regulation of DNA binding,58/18493,0.000246936,0.001159657,0.000403437,4318/5468/3458,"MMP9,PPARG,IFNG",0.078692309,3
BP,GO:0021700,developmental maturation,271/18493,0.000249445,0.001169411,0.000406831,7422/5468/4313/596/1080,"VEGFA,PPARG,MMP2,BCL2,CFTR",0.096121893,5
BP,GO:0002294,"CD4-positive, alpha-beta T cell differentiation involved in immune response",59/18493,0.000259786,0.001211589,0.000421504,3569/6774/3458,"IL6,STAT3,IFNG",0.088823209,3
BP,GO:0030888,regulation of B cell proliferation,59/18493,0.000259786,0.001211589,0.000421504,3586/836/596,"IL10,CASP3,BCL2",0.060663462,3
BP,GO:0033619,membrane protein proteolysis,59/18493,0.000259786,0.001211589,0.000421504,3553/3586/3458,"IL1B,IL10,IFNG",0.078654079,3
BP,GO:0002287,alpha-beta T cell activation involved in immune response,60/18493,0.000273061,0.00126707,0.000440806,3569/6774/3458,"IL6,STAT3,IFNG",0.088231016,3
BP,GO:0002293,alpha-beta T cell differentiation involved in immune response,60/18493,0.000273061,0.00126707,0.000440806,3569/6774/3458,"IL6,STAT3,IFNG",0.088231016,3
BP,GO:0048732,gland development,434/18493,0.000273088,0.00126707,0.000440806,207/7422/3586/5594/3162/596,"AKT1,VEGFA,IL10,MAPK1,HMOX1,BCL2",0.144566381,6
BP,GO:0008360,regulation of cell shape,151/18493,0.000281289,0.00128525,0.000447131,6347/7422/3383/2147,"CCL2,VEGFA,ICAM1,F2",0.099962898,4
BP,GO:0014074,response to purine-containing compound,151/18493,0.000281289,0.00128525,0.000447131,3553/5743/5468/1080,"IL1B,PTGS2,PPARG,CFTR",0.089580138,4
BP,GO:0002674,negative regulation of acute inflammatory response,12/18493,0.000282232,0.00128525,0.000447131,3630/5468,"INS,PPARG",0.060507175,2
BP,GO:0006527,arginine catabolic process,12/18493,0.000282232,0.00128525,0.000447131,4846/4843,"NOS3,NOS2",0.044467694,2
BP,GO:0010889,regulation of sequestering of triglyceride,12/18493,0.000282232,0.00128525,0.000447131,5468/4023,"PPARG,LPL",0.043239531,2
BP,GO:0030656,regulation of vitamin metabolic process,12/18493,0.000282232,0.00128525,0.000447131,3553/3458,"IL1B,IFNG",0.051710004,2
BP,GO:0031282,regulation of guanylate cyclase activity,12/18493,0.000282232,0.00128525,0.000447131,4846/4843,"NOS3,NOS2",0.044467694,2
BP,GO:0033160,"positive regulation of protein import into nucleus, translocation",12/18493,0.000282232,0.00128525,0.000447131,5594/3458,"MAPK1,IFNG",0.049852989,2
BP,GO:0034370,triglyceride-rich lipoprotein particle remodeling,12/18493,0.000282232,0.00128525,0.000447131,4023/1071,"LPL,CETP",0.027121057,2
BP,GO:0051712,positive regulation of killing of cells of other organism,12/18493,0.000282232,0.00128525,0.000447131,3458/4843,"IFNG,NOS2",0.043418315,2
BP,GO:0072540,T-helper 17 cell lineage commitment,12/18493,0.000282232,0.00128525,0.000447131,3569/6774,"IL6,STAT3",0.064258275,2
BP,GO:0031640,killing of cells of other organism,61/18493,0.000286767,0.001297164,0.000451275,3458/4843/2147,"IFNG,NOS2,F2",0.06024322,3
BP,GO:0032371,regulation of sterol transport,61/18493,0.000286767,0.001297164,0.000451275,5468/5444/1071,"PPARG,PON1,CETP",0.05138893,3
BP,GO:0032374,regulation of cholesterol transport,61/18493,0.000286767,0.001297164,0.000451275,5468/5444/1071,"PPARG,PON1,CETP",0.05138893,3
BP,GO:0044364,disruption of cells of other organism,61/18493,0.000286767,0.001297164,0.000451275,3458/4843/2147,"IFNG,NOS2,F2",0.06024322,3
BP,GO:0016999,antibiotic metabolic process,152/18493,0.000288455,0.001302622,0.000453174,6774/4353/847/4314,"STAT3,MPO,CAT,MMP3",0.096523743,4
BP,GO:0050890,cognition,285/18493,0.000314648,0.001418538,0.000493501,3630/5743/5594/836/3156,"INS,PTGS2,MAPK1,CASP3,HMGCR",0.121907044,5
BP,GO:0002637,regulation of immunoglobulin production,63/18493,0.000315495,0.001419991,0.000494006,3569/3586/959,"IL6,IL10,CD40LG",0.076279686,3
BP,GO:0002260,lymphocyte homeostasis,64/18493,0.00033053,0.001482724,0.00051583,207/836/596,"AKT1,CASP3,BCL2",0.063665785,3
BP,GO:1903036,positive regulation of response to wounding,64/18493,0.00033053,0.001482724,0.00051583,5054/2147/948,"SERPINE1,F2,CD36",0.046405085,3
BP,GO:0031650,regulation of heat generation,13/18493,0.000333103,0.001486871,0.000517273,3553/5743,"IL1B,PTGS2",0.053576723,2
BP,GO:0032310,prostaglandin secretion,13/18493,0.000333103,0.001486871,0.000517273,3553/4843,"IL1B,NOS2",0.046518574,2
BP,GO:0060099,"regulation of phagocytosis, engulfment",13/18493,0.000333103,0.001486871,0.000517273,5468/948,"PPARG,CD36",0.032444879,2
BP,GO:0001906,cell killing,158/18493,0.000334238,0.00148703,0.000517328,3383/3458/4843/2147,"ICAM1,IFNG,NOS2,F2",0.084221932,4
BP,GO:0046165,alcohol biosynthetic process,158/18493,0.000334238,0.00148703,0.000517328,3553/3458/3156/1080,"IL1B,IFNG,HMGCR,CFTR",0.069988542,4
BP,GO:0002292,T cell differentiation involved in immune response,66/18493,0.000361968,0.001602494,0.000557498,3569/6774/3458,"IL6,STAT3,IFNG",0.085124847,3
BP,GO:0014015,positive regulation of gliogenesis,66/18493,0.000361968,0.001602494,0.000557498,3569/3553/5468,"IL6,IL1B,PPARG",0.085605464,3
BP,GO:0015909,long-chain fatty acid transport,66/18493,0.000361968,0.001602494,0.000557498,207/5468/948,"AKT1,PPARG,CD36",0.06222347,3
BP,GO:0006733,oxidoreduction coenzyme metabolic process,162/18493,0.000367516,0.001624398,0.000565118,3630/6774/5743/3156,"INS,STAT3,PTGS2,HMGCR",0.098888902,4
BP,GO:0070838,divalent metal ion transport,459/18493,0.000368425,0.001625756,0.00056559,6347/5743/3383/4846/2147/596,"CCL2,PTGS2,ICAM1,NOS3,F2,BCL2",0.127052363,6
BP,GO:0035924,cellular response to vascular endothelial growth factor stimulus,67/18493,0.000378384,0.001666985,0.000579934,207/7422/7412,"AKT1,VEGFA,VCAM1",0.081745435,3
BP,GO:0072511,divalent inorganic cation transport,462/18493,0.000381427,0.001677024,0.000583426,6347/5743/3383/4846/2147/596,"CCL2,PTGS2,ICAM1,NOS3,F2,BCL2",0.126438093,6
BP,GO:0014854,response to inactivity,14/18493,0.000388103,0.001677024,0.000583426,3586/847,"IL10,CAT",0.047384716,2
BP,GO:0019372,lipoxygenase pathway,14/18493,0.000388103,0.001677024,0.000583426,5743/5444,"PTGS2,PON1",0.039866385,2
BP,GO:0032352,positive regulation of hormone metabolic process,14/18493,0.000388103,0.001677024,0.000583426,3553/3458,"IL1B,IFNG",0.049643193,2
BP,GO:0042362,fat-soluble vitamin biosynthetic process,14/18493,0.000388103,0.001677024,0.000583426,3553/3458,"IL1B,IFNG",0.049643193,2
BP,GO:0050930,induction of positive chemotaxis,14/18493,0.000388103,0.001677024,0.000583426,7422/3576,"VEGFA,CXCL8",0.054340268,2
BP,GO:0051709,regulation of killing of cells of other organism,14/18493,0.000388103,0.001677024,0.000583426,3458/4843,"IFNG,NOS2",0.041682916,2
BP,GO:0051917,regulation of fibrinolysis,14/18493,0.000388103,0.001677024,0.000583426,5054/2147,"SERPINE1,F2",0.039076744,2
BP,GO:0090399,replicative senescence,14/18493,0.000388103,0.001677024,0.000583426,7157/5054,"TP53,SERPINE1",0.04999704,2
BP,GO:0150078,positive regulation of neuroinflammatory response,14/18493,0.000388103,0.001677024,0.000583426,3569/3553,"IL6,IL1B",0.059606719,2
BP,GO:1905153,regulation of membrane invagination,14/18493,0.000388103,0.001677024,0.000583426,5468/948,"PPARG,CD36",0.031845186,2
BP,GO:2000402,negative regulation of lymphocyte migration,14/18493,0.000388103,0.001677024,0.000583426,207/6347,"AKT1,CCL2",0.05751515,2
BP,GO:0031670,cellular response to nutrient,68/18493,0.000395272,0.001702565,0.000592312,5743/5468/3162,"PTGS2,PPARG,HMOX1",0.073651704,3
BP,GO:0051187,cofactor catabolic process,68/18493,0.000395272,0.001702565,0.000592312,4353/3162/847,"MPO,HMOX1,CAT",0.068048131,3
BP,GO:0006914,autophagy,466/18493,0.000399321,0.001714544,0.000596479,207/7157/836/3458/3162/596,"AKT1,TP53,CASP3,IFNG,HMOX1,BCL2",0.134636424,6
BP,GO:0061919,process utilizing autophagic mechanism,466/18493,0.000399321,0.001714544,0.000596479,207/7157/836/3458/3162/596,"AKT1,TP53,CASP3,IFNG,HMOX1,BCL2",0.134636424,6
BP,GO:0048708,astrocyte differentiation,69/18493,0.000412638,0.001766115,0.00061442,6774/5594/2147,"STAT3,MAPK1,F2",0.069583944,3
BP,GO:1903524,positive regulation of blood circulation,69/18493,0.000412638,0.001766115,0.00061442,207/5743/3383,"AKT1,PTGS2,ICAM1",0.079814945,3
BP,GO:0010506,regulation of autophagy,303/18493,0.000416621,0.001780346,0.000619371,207/836/3458/3162/596,"AKT1,CASP3,IFNG,HMOX1,BCL2",0.106941284,5
BP,GO:0014068,positive regulation of phosphatidylinositol 3-kinase signaling,70/18493,0.000430487,0.001833806,0.00063797,3630/847/2147,"INS,CAT,F2",0.070114107,3
BP,GO:0042531,positive regulation of tyrosine phosphorylation of STAT protein,70/18493,0.000430487,0.001833806,0.00063797,3569/6774/3458,"IL6,STAT3,IFNG",0.083341563,3
BP,GO:0048469,cell maturation,169/18493,0.000431367,0.001834667,0.000638269,7422/5468/596/1080,"VEGFA,PPARG,BCL2,CFTR",0.068109558,4
BP,GO:0071375,cellular response to peptide hormone stimulus,307/18493,0.000442328,0.001878331,0.00065346,3630/207/6774/3553/5468,"INS,AKT1,STAT3,IL1B,PPARG",0.141180198,5
BP,GO:0015732,prostaglandin transport,15/18493,0.000447214,0.00188723,0.000656555,3553/4843,"IL1B,NOS2",0.044815061,2
BP,GO:0030889,negative regulation of B cell proliferation,15/18493,0.000447214,0.00188723,0.000656555,3586/836,"IL10,CASP3",0.048552877,2
BP,GO:0034116,positive regulation of heterotypic cell-cell adhesion,15/18493,0.000447214,0.00188723,0.000656555,3553/3586,"IL1B,IL10",0.051051935,2
BP,GO:0051044,positive regulation of membrane protein ectodomain proteolysis,15/18493,0.000447214,0.00188723,0.000656555,3553/3458,"IL1B,IFNG",0.048725879,2
BP,GO:0032874,positive regulation of stress-activated MAPK cascade,171/18493,0.000450978,0.00190015,0.00066105,7422/3553/959/3156,"VEGFA,IL1B,CD40LG,HMGCR",0.079999366,4
BP,GO:0070304,positive regulation of stress-activated protein kinase signaling cascade,172/18493,0.000461019,0.001939435,0.000674717,7422/3553/959/3156,"VEGFA,IL1B,CD40LG,HMGCR",0.079738094,4
BP,GO:0030641,regulation of cellular pH,72/18493,0.000467658,0.001961262,0.000682311,5594/596/1080,"MAPK1,BCL2,CFTR",0.040293937,3
BP,GO:0070227,lymphocyte apoptotic process,72/18493,0.000467658,0.001961262,0.000682311,207/7157/3586,"AKT1,TP53,IL10",0.080279153,3
BP,GO:0001701,in utero embryonic development,311/18493,0.000469218,0.001964758,0.000683527,207/7422/3586/5594/4846,"AKT1,VEGFA,IL10,MAPK1,NOS3",0.128161352,5
BP,GO:0042310,vasoconstriction,73/18493,0.000486991,0.002029754,0.000706139,207/5743/3383,"AKT1,PTGS2,ICAM1",0.078063112,3
BP,GO:0043627,response to estrogen,73/18493,0.000486991,0.002029754,0.000706139,5468/5594/3162,"PPARG,MAPK1,HMOX1",0.070893298,3
BP,GO:0046902,regulation of mitochondrial membrane permeability,73/18493,0.000486991,0.002029754,0.000706139,6774/7157/596,"STAT3,TP53,BCL2",0.062384905,3
BP,GO:0010821,regulation of mitochondrion organization,176/18493,0.000502784,0.002092354,0.000727917,207/7157/4318/596,"AKT1,TP53,MMP9,BCL2",0.088353028,4
BP,GO:0015849,organic acid transport,316/18493,0.000504547,0.002093249,0.000728228,207/3553/5468/4843/948,"AKT1,IL1B,PPARG,NOS2,CD36",0.103715505,5
BP,GO:0046942,carboxylic acid transport,316/18493,0.000504547,0.002093249,0.000728228,207/3553/5468/4843/948,"AKT1,IL1B,PPARG,NOS2,CD36",0.103715505,5
BP,GO:0010827,regulation of glucose transmembrane transport,74/18493,0.00050683,0.002096291,0.000729286,3630/207/3553,"INS,AKT1,IL1B",0.086319828,3
BP,GO:0043367,"CD4-positive, alpha-beta T cell differentiation",74/18493,0.00050683,0.002096291,0.000729286,3569/6774/3458,"IL6,STAT3,IFNG",0.081572247,3
BP,GO:0002295,T-helper cell lineage commitment,16/18493,0.000510421,0.002098312,0.00072999,3569/6774,"IL6,STAT3",0.059526558,2
BP,GO:0033158,"regulation of protein import into nucleus, translocation",16/18493,0.000510421,0.002098312,0.00072999,5594/3458,"MAPK1,IFNG",0.046182018,2
BP,GO:0071380,cellular response to prostaglandin E stimulus,16/18493,0.000510421,0.002098312,0.00072999,207/5468,"AKT1,PPARG",0.053392461,2
BP,GO:0090335,regulation of brown fat cell differentiation,16/18493,0.000510421,0.002098312,0.00072999,3630/5743,"INS,PTGS2",0.056421074,2
BP,GO:0071214,cellular response to abiotic stimulus,319/18493,0.000526686,0.00215411,0.000749401,207/7157/3553/5743/836,"AKT1,TP53,IL1B,PTGS2,CASP3",0.128694481,5
BP,GO:0104004,cellular response to environmental stimulus,319/18493,0.000526686,0.00215411,0.000749401,207/7157/3553/5743/836,"AKT1,TP53,IL1B,PTGS2,CASP3",0.128694481,5
BP,GO:0043618,regulation of transcription from RNA polymerase II promoter in response to stress,75/18493,0.00052718,0.00215411,0.000749401,7422/7157/3162,"VEGFA,TP53,HMOX1",0.074190792,3
BP,GO:0051193,regulation of cofactor metabolic process,75/18493,0.00052718,0.00215411,0.000749401,3630/6774/4314,"INS,STAT3,MMP3",0.076859766,3
BP,GO:0016042,lipid catabolic process,321/18493,0.000541848,0.002210708,0.000769091,3630/207/3553/4023/7941,"INS,AKT1,IL1B,LPL,PLA2G7",0.110809816,5
BP,GO:0006970,response to osmotic stress,76/18493,0.000548046,0.002229271,0.000775549,5743/836/5243,"PTGS2,CASP3,ABCB1",0.057422273,3
BP,GO:0010507,negative regulation of autophagy,76/18493,0.000548046,0.002229271,0.000775549,207/3162/596,"AKT1,HMOX1,BCL2",0.058143562,3
BP,GO:0071902,positive regulation of protein serine/threonine kinase activity,323/18493,0.000557337,0.002262409,0.000787078,7422/3553/5594/3458/959,"VEGFA,IL1B,MAPK1,IFNG,CD40LG",0.112872806,5
BP,GO:0043123,positive regulation of I-kappaB kinase/NF-kappaB signaling,181/18493,0.000558702,0.002262409,0.000787078,207/3553/3162/948,"AKT1,IL1B,HMOX1,CD36",0.081832335,4
BP,GO:0051099,positive regulation of binding,181/18493,0.000558702,0.002262409,0.000787078,4318/5468/3458/5444,"MMP9,PPARG,IFNG,PON1",0.084341573,4
BP,GO:0070372,regulation of ERK1 and ERK2 cascade,324/18493,0.000565205,0.002285322,0.000795049,6347/3553/3383/3156/948,"CCL2,IL1B,ICAM1,HMGCR,CD36",0.091942501,5
BP,GO:0042119,neutrophil activation,498/18493,0.000567395,0.002290751,0.000796938,3576/4318/5594/4353/847/948,"CXCL8,MMP9,MAPK1,MPO,CAT,CD36",0.123784428,6
BP,GO:0010744,positive regulation of macrophage derived foam cell differentiation,17/18493,0.000577707,0.002311683,0.00080422,4023/948,"LPL,CD36",0.021434841,2
BP,GO:0031649,heat generation,17/18493,0.000577707,0.002311683,0.00080422,3553/5743,"IL1B,PTGS2",0.049945451,2
BP,GO:0032966,negative regulation of collagen biosynthetic process,17/18493,0.000577707,0.002311683,0.00080422,3569/5468,"IL6,PPARG",0.05526883,2
BP,GO:0043373,"CD4-positive, alpha-beta T cell lineage commitment",17/18493,0.000577707,0.002311683,0.00080422,3569/6774,"IL6,STAT3",0.058591735,2
BP,GO:0045725,positive regulation of glycogen biosynthetic process,17/18493,0.000577707,0.002311683,0.00080422,3630/207,"INS,AKT1",0.059487868,2
BP,GO:0070102,interleukin-6-mediated signaling pathway,17/18493,0.000577707,0.002311683,0.00080422,3569/6774,"IL6,STAT3",0.058591735,2
BP,GO:0010721,negative regulation of cell development,326/18493,0.000581193,0.002319614,0.000806979,3569/6774/3553/2147/596,"IL6,STAT3,IL1B,F2,BCL2",0.107256923,5
BP,GO:0042594,response to starvation,183/18493,0.000582262,0.002319614,0.000806979,7157/5468/5594/596,"TP53,PPARG,MAPK1,BCL2",0.081477106,4
BP,GO:0050864,regulation of B cell activation,183/18493,0.000582262,0.002319614,0.000806979,3569/3586/836/596,"IL6,IL10,CASP3,BCL2",0.085929357,4
BP,GO:0031100,animal organ regeneration,78/18493,0.000591351,0.002348906,0.00081717,5468/3586/3162,"PPARG,IL10,HMOX1",0.06939091,3
BP,GO:0071260,cellular response to mechanical stimulus,78/18493,0.000591351,0.002348906,0.00081717,207/3553/5743,"AKT1,IL1B,PTGS2",0.078174381,3
BP,GO:0050707,regulation of cytokine secretion,184/18493,0.000594303,0.002357169,0.000820045,3630/1401/3586/4023,"INS,CRP,IL10,LPL",0.095655045,4
BP,GO:0042509,regulation of tyrosine phosphorylation of STAT protein,80/18493,0.000636787,0.002514613,0.000874818,3569/6774/3458,"IL6,STAT3,IFNG",0.079165792,3
BP,GO:0060964,regulation of gene silencing by miRNA,80/18493,0.000636787,0.002514613,0.000874818,6774/7157/5468,"STAT3,TP53,PPARG",0.07627748,3
BP,GO:1902930,regulation of alcohol biosynthetic process,80/18493,0.000636787,0.002514613,0.000874818,3553/3458/3156,"IL1B,IFNG,HMGCR",0.056830692,3
BP,GO:0031099,regeneration,188/18493,0.000644244,0.002522549,0.000877579,5468/3586/3162/596,"PPARG,IL10,HMOX1,BCL2",0.076305781,4
BP,GO:0002544,chronic inflammatory response,18/18493,0.000649055,0.002522549,0.000877579,3586/7412,"IL10,VCAM1",0.046362218,2
BP,GO:0002726,positive regulation of T cell cytokine production,18/18493,0.000649055,0.002522549,0.000877579,3569/3553,"IL6,IL1B",0.055798961,2
BP,GO:0010310,regulation of hydrogen peroxide metabolic process,18/18493,0.000649055,0.002522549,0.000877579,6774/4314,"STAT3,MMP3",0.044277345,2
BP,GO:0010544,negative regulation of platelet activation,18/18493,0.000649055,0.002522549,0.000877579,4846/2147,"NOS3,F2",0.037513848,2
BP,GO:0010713,negative regulation of collagen metabolic process,18/18493,0.000649055,0.002522549,0.000877579,3569/5468,"IL6,PPARG",0.054473967,2
BP,GO:0033189,response to vitamin A,18/18493,0.000649055,0.002522549,0.000877579,5468/847,"PPARG,CAT",0.044536116,2
BP,GO:0051023,regulation of immunoglobulin secretion,18/18493,0.000649055,0.002522549,0.000877579,3569/959,"IL6,CD40LG",0.046001568,2
BP,GO:0060252,positive regulation of glial cell proliferation,18/18493,0.000649055,0.002522549,0.000877579,3569/3553,"IL6,IL1B",0.055798961,2
BP,GO:0070230,positive regulation of lymphocyte apoptotic process,18/18493,0.000649055,0.002522549,0.000877579,7157/3586,"TP53,IL10",0.049011917,2
BP,GO:0090026,positive regulation of monocyte chemotaxis,18/18493,0.000649055,0.002522549,0.000877579,5054/7941,"SERPINE1,PLA2G7",0.030986335,2
BP,GO:0043405,regulation of MAP kinase activity,335/18493,0.000657392,0.002548016,0.000886439,7422/3553/5594/959/3156,"VEGFA,IL1B,MAPK1,CD40LG,HMGCR",0.099642231,5
BP,GO:0006885,regulation of pH,81/18493,0.000660318,0.002548016,0.000886439,5594/596/1080,"MAPK1,BCL2,CFTR",0.038602291,3
BP,GO:0032755,positive regulation of interleukin-6 production,81/18493,0.000660318,0.002548016,0.000886439,3569/3553/948,"IL6,IL1B,CD36",0.061734109,3
BP,GO:0043620,regulation of DNA-templated transcription in response to stress,81/18493,0.000660318,0.002548016,0.000886439,7422/7157/3162,"VEGFA,TP53,HMOX1",0.072161697,3
BP,GO:0090559,regulation of membrane permeability,81/18493,0.000660318,0.002548016,0.000886439,6774/7157/596,"STAT3,TP53,BCL2",0.060096722,3
BP,GO:1901654,response to ketone,190/18493,0.000670301,0.002582855,0.000898559,207/5468/3383/1080,"AKT1,PPARG,ICAM1,CFTR",0.082149154,4
BP,GO:0031589,cell-substrate adhesion,338/18493,0.000684388,0.002629677,0.000914848,7422/7412/5054/596/948,"VEGFA,VCAM1,SERPINE1,BCL2,CD36",0.083000346,5
BP,GO:0097194,execution phase of apoptosis,82/18493,0.000684397,0.002629677,0.000914848,207/7157/836,"AKT1,TP53,CASP3",0.075628651,3
BP,GO:0007260,tyrosine phosphorylation of STAT protein,83/18493,0.000709029,0.002711782,0.000943412,3569/6774/3458,"IL6,STAT3,IFNG",0.078167402,3
BP,GO:0060147,regulation of posttranscriptional gene silencing,83/18493,0.000709029,0.002711782,0.000943412,6774/7157/5468,"STAT3,TP53,PPARG",0.075315516,3
BP,GO:0060966,regulation of gene silencing by RNA,83/18493,0.000709029,0.002711782,0.000943412,6774/7157/5468,"STAT3,TP53,PPARG",0.075315516,3
BP,GO:0006694,steroid biosynthetic process,193/18493,0.000710778,0.002711782,0.000943412,3553/3458/3156/1080,"IL1B,IFNG,HMGCR,CFTR",0.063530081,4
BP,GO:0007623,circadian rhythm,193/18493,0.000710778,0.002711782,0.000943412,7157/5468/5054/4843,"TP53,PPARG,SERPINE1,NOS2",0.087153477,4
BP,GO:0030949,positive regulation of vascular endothelial growth factor receptor signaling pathway,19/18493,0.000724449,0.002752295,0.000957506,7422/3553,"VEGFA,IL1B",0.050014012,2
BP,GO:0070875,positive regulation of glycogen metabolic process,19/18493,0.000724449,0.002752295,0.000957506,3630/207,"INS,AKT1",0.05777805,2
BP,GO:1902176,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,19/18493,0.000724449,0.002752295,0.000957506,3630/207,"INS,AKT1",0.05777805,2
BP,GO:0051781,positive regulation of cell division,84/18493,0.000734221,0.002781606,0.000967703,7422/3553/847,"VEGFA,IL1B,CAT",0.070349061,3
BP,GO:0097306,cellular response to alcohol,84/18493,0.000734221,0.002781606,0.000967703,207/5468/1080,"AKT1,PPARG,CFTR",0.058335929,3
BP,GO:0002703,regulation of leukocyte mediated immunity,196/18493,0.000752959,0.002848607,0.000991013,3569/3553/3586/3162,"IL6,IL1B,IL10,HMOX1",0.098556349,4
BP,GO:0045833,negative regulation of lipid metabolic process,85/18493,0.000759976,0.002867134,0.000997458,3630/207/3553,"INS,AKT1,IL1B",0.081937156,3
BP,GO:0090049,regulation of cell migration involved in sprouting angiogenesis,85/18493,0.000759976,0.002867134,0.000997458,7422/5743/3162,"VEGFA,PTGS2,HMOX1",0.069475399,3
BP,GO:0002573,myeloid leukocyte differentiation,197/18493,0.000767405,0.002891129,0.001005806,7422/4318/5468/3458,"VEGFA,MMP9,PPARG,IFNG",0.093129259,4
BP,GO:0031331,positive regulation of cellular catabolic process,347/18493,0.000770389,0.002898334,0.001008312,3630/207/3553/3458/3162,"INS,AKT1,IL1B,IFNG,HMOX1",0.1233803,5
BP,GO:0031348,negative regulation of defense response,199/18493,0.000796885,0.002993852,0.001041543,3630/5468/3586/2147,"INS,PPARG,IL10,F2",0.090499612,4
BP,GO:0006525,arginine metabolic process,20/18493,0.000803872,0.002995142,0.001041991,4846/4843,"NOS3,NOS2",0.038816128,2
BP,GO:0010893,positive regulation of steroid biosynthetic process,20/18493,0.000803872,0.002995142,0.001041991,3553/3458,"IL1B,IFNG",0.045137986,2
BP,GO:0032682,negative regulation of chemokine production,20/18493,0.000803872,0.002995142,0.001041991,3569/3586,"IL6,IL10",0.052737063,2
BP,GO:0034393,positive regulation of smooth muscle cell apoptotic process,20/18493,0.000803872,0.002995142,0.001041991,5468/3458,"PPARG,IFNG",0.043851024,2
BP,GO:0051195,negative regulation of cofactor metabolic process,20/18493,0.000803872,0.002995142,0.001041991,6774/4314,"STAT3,MMP3",0.043006405,2
BP,GO:0060716,labyrinthine layer blood vessel development,20/18493,0.000803872,0.002995142,0.001041991,207/5594,"AKT1,MAPK1",0.049977294,2
BP,GO:0035710,"CD4-positive, alpha-beta T cell activation",87/18493,0.000813199,0.003025727,0.001052631,3569/6774/3458,"IL6,STAT3,IFNG",0.076718559,3
BP,GO:0001892,embryonic placenta development,88/18493,0.000840677,0.003119383,0.001085214,207/3586/5594,"AKT1,IL10,MAPK1",0.072383698,3
BP,GO:0031341,regulation of cell killing,88/18493,0.000840677,0.003119383,0.001085214,3383/3458/4843,"ICAM1,IFNG,NOS2",0.059982379,3
BP,GO:0043523,regulation of neuron apoptotic process,202/18493,0.000842596,0.003122221,0.001086201,6347/836/3162/596,"CCL2,CASP3,HMOX1,BCL2",0.07470683,4
BP,GO:0033273,response to vitamin,89/18493,0.000868738,0.003214688,0.00111837,5743/5468/847,"PTGS2,PPARG,CAT",0.065883442,3
BP,GO:0032869,cellular response to insulin stimulus,204/18493,0.000874081,0.003230038,0.00112371,3630/207/3553/5468,"INS,AKT1,IL1B,PPARG",0.103058659,4
BP,GO:0030728,ovulation,21/18493,0.000887307,0.003234725,0.001125341,5743/4846,"PTGS2,NOS3",0.044517655,2
BP,GO:0031281,positive regulation of cyclase activity,21/18493,0.000887307,0.003234725,0.001125341,4846/4843,"NOS3,NOS2",0.038302083,2
BP,GO:0035743,"CD4-positive, alpha-beta T cell cytokine production",21/18493,0.000887307,0.003234725,0.001125341,3569/3553,"IL6,IL1B",0.053479565,2
BP,GO:0036499,PERK-mediated unfolded protein response,21/18493,0.000887307,0.003234725,0.001125341,6347/3576,"CCL2,CXCL8",0.04890603,2
BP,GO:0042359,vitamin D metabolic process,21/18493,0.000887307,0.003234725,0.001125341,3553/3458,"IL1B,IFNG",0.04454022,2
BP,GO:0046827,positive regulation of protein export from nucleus,21/18493,0.000887307,0.003234725,0.001125341,7157/3553,"TP53,IL1B",0.048415541,2
BP,GO:0048305,immunoglobulin secretion,21/18493,0.000887307,0.003234725,0.001125341,3569/959,"IL6,CD40LG",0.04408942,2
BP,GO:0051349,positive regulation of lyase activity,21/18493,0.000887307,0.003234725,0.001125341,4846/4843,"NOS3,NOS2",0.038302083,2
BP,GO:0055093,response to hyperoxia,21/18493,0.000887307,0.003234725,0.001125341,5468/847,"PPARG,CAT",0.042684883,2
BP,GO:0090312,positive regulation of protein deacetylation,21/18493,0.000887307,0.003234725,0.001125341,7422/3458,"VEGFA,IFNG",0.045076677,2
BP,GO:0030004,cellular monovalent inorganic cation homeostasis,90/18493,0.000897389,0.003267075,0.001136595,5594/596/1080,"MAPK1,BCL2,CFTR",0.036995619,3
BP,GO:0071229,cellular response to acid chemical,206/18493,0.000906388,0.003295404,0.001146451,207/7422/5468/4313,"AKT1,VEGFA,PPARG,MMP2",0.093587076,4
BP,GO:0002702,positive regulation of production of molecular mediator of immune response,91/18493,0.000926633,0.003359976,0.001168915,3569/3553/948,"IL6,IL1B,CD36",0.058874839,3
BP,GO:0050810,regulation of steroid biosynthetic process,91/18493,0.000926633,0.003359976,0.001168915,3553/3458/3156,"IL1B,IFNG,HMGCR",0.054079039,3
BP,GO:0010810,regulation of cell-substrate adhesion,209/18493,0.000956419,0.003463338,0.001204874,7422/5054/596/948,"VEGFA,SERPINE1,BCL2,CD36",0.057590722,4
BP,GO:0010884,positive regulation of lipid storage,22/18493,0.000974739,0.003506209,0.001219788,4023/948,"LPL,CD36",0.019963801,2
BP,GO:0051000,positive regulation of nitric-oxide synthase activity,22/18493,0.000974739,0.003506209,0.001219788,3630/207,"INS,AKT1",0.055405307,2
BP,GO:0071379,cellular response to prostaglandin stimulus,22/18493,0.000974739,0.003506209,0.001219788,207/5468,"AKT1,PPARG",0.048947272,2
BP,GO:0071677,positive regulation of mononuclear cell migration,22/18493,0.000974739,0.003506209,0.001219788,5054/7941,"SERPINE1,PLA2G7",0.029280902,2
BP,GO:2000637,positive regulation of gene silencing by miRNA,22/18493,0.000974739,0.003506209,0.001219788,6774/7157,"STAT3,TP53",0.049577828,2
BP,GO:1903076,regulation of protein localization to plasma membrane,93/18493,0.000986923,0.00354532,0.001233395,3630/207/3458,"INS,AKT1,IFNG",0.075455543,3
BP,GO:0050830,defense response to Gram-positive bacterium,94/18493,0.001017977,0.003652028,0.001270518,3569/1401/948,"IL6,CRP,CD36",0.058199964,3
BP,GO:0009110,vitamin biosynthetic process,23/18493,0.001066151,0.003799655,0.001321876,3553/3458,"IL1B,IFNG",0.043289834,2
BP,GO:0034695,response to prostaglandin E,23/18493,0.001066151,0.003799655,0.001321876,207/5468,"AKT1,PPARG",0.048251362,2
BP,GO:0060148,positive regulation of posttranscriptional gene silencing,23/18493,0.001066151,0.003799655,0.001321876,6774/7157,"STAT3,TP53",0.048872953,2
BP,GO:1903589,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,23/18493,0.001066151,0.003799655,0.001321876,7422/3162,"VEGFA,HMOX1",0.043655666,2
BP,GO:2000353,positive regulation of endothelial cell apoptotic process,23/18493,0.001066151,0.003799655,0.001321876,6347/959,"CCL2,CD40LG",0.038299009,2
BP,GO:0001657,ureteric bud development,96/18493,0.001081931,0.00385082,0.001339676,7422/847/596,"VEGFA,CAT,BCL2",0.050324076,3
BP,GO:0062014,negative regulation of small molecule metabolic process,97/18493,0.001114839,0.003952345,0.001374996,3630/207/6774,"INS,AKT1,STAT3",0.079248332,3
BP,GO:0072163,mesonephric epithelium development,97/18493,0.001114839,0.003952345,0.001374996,7422/847/596,"VEGFA,CAT,BCL2",0.050088517,3
BP,GO:0072164,mesonephric tubule development,97/18493,0.001114839,0.003952345,0.001374996,7422/847/596,"VEGFA,CAT,BCL2",0.050088517,3
BP,GO:0002719,negative regulation of cytokine production involved in immune response,24/18493,0.001161526,0.004075134,0.001417714,3586/3162,"IL10,HMOX1",0.04120965,2
BP,GO:0010288,response to lead ion,24/18493,0.001161526,0.004075134,0.001417714,5743/847,"PTGS2,CAT",0.041295161,2
BP,GO:0032800,receptor biosynthetic process,24/18493,0.001161526,0.004075134,0.001417714,5468/3586,"PPARG,IL10",0.043567957,2
BP,GO:0090025,regulation of monocyte chemotaxis,24/18493,0.001161526,0.004075134,0.001417714,5054/7941,"SERPINE1,PLA2G7",0.028502068,2
BP,GO:1900120,regulation of receptor binding,24/18493,0.001161526,0.004075134,0.001417714,4318/3586,"MMP9,IL10",0.044236066,2
BP,GO:1900739,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,24/18493,0.001161526,0.004075134,0.001417714,7157/596,"TP53,BCL2",0.030492995,2
BP,GO:1900740,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,24/18493,0.001161526,0.004075134,0.001417714,7157/596,"TP53,BCL2",0.030492995,2
BP,GO:2000191,regulation of fatty acid transport,24/18493,0.001161526,0.004075134,0.001417714,207/3553,"AKT1,IL1B",0.048864103,2
BP,GO:0001894,tissue homeostasis,221/18493,0.001176126,0.004121013,0.001433675,3569/7422/4846/596,"IL6,VEGFA,NOS3,BCL2",0.079319782,4
BP,GO:0006469,negative regulation of protein kinase activity,222/18493,0.001195901,0.004184881,0.001455894,207/3553/836/3156,"AKT1,IL1B,CASP3,HMGCR",0.078874536,4
BP,GO:0034440,lipid oxidation,100/18493,0.001217343,0.004254411,0.001480083,207/5468/7941,"AKT1,PPARG,PLA2G7",0.05603529,3
BP,GO:0001823,mesonephros development,101/18493,0.001252787,0.004350251,0.001513425,7422/847/596,"VEGFA,CAT,BCL2",0.049220213,3
BP,GO:0006641,triglyceride metabolic process,101/18493,0.001252787,0.004350251,0.001513425,847/4023/1071,"CAT,LPL,CETP",0.041026227,3
BP,GO:0030593,neutrophil chemotaxis,101/18493,0.001252787,0.004350251,0.001513425,6347/3576/3553,"CCL2,CXCL8,IL1B",0.069189584,3
BP,GO:1904659,glucose transmembrane transport,101/18493,0.001252787,0.004350251,0.001513425,3630/207/3553,"INS,AKT1,IL1B",0.076102052,3
BP,GO:0009299,mRNA transcription,25/18493,0.001260849,0.004350251,0.001513425,6774/7157,"STAT3,TP53",0.04768619,2
BP,GO:0034114,regulation of heterotypic cell-cell adhesion,25/18493,0.001260849,0.004350251,0.001513425,3553/3586,"IL1B,IL10",0.044255014,2
BP,GO:0046885,regulation of hormone biosynthetic process,25/18493,0.001260849,0.004350251,0.001513425,3553/3458,"IL1B,IFNG",0.042238643,2
BP,GO:0050927,positive regulation of positive chemotaxis,25/18493,0.001260849,0.004350251,0.001513425,7422/3576,"VEGFA,CXCL8",0.046235124,2
BP,GO:0060330,regulation of response to interferon-gamma,25/18493,0.001260849,0.004350251,0.001513425,5468/3458,"PPARG,IFNG",0.041034347,2
BP,GO:0060334,regulation of interferon-gamma-mediated signaling pathway,25/18493,0.001260849,0.004350251,0.001513425,5468/3458,"PPARG,IFNG",0.041034347,2
BP,GO:0043122,regulation of I-kappaB kinase/NF-kappaB signaling,226/18493,0.001277341,0.004401538,0.001531268,207/3553/3162/948,"AKT1,IL1B,HMOX1,CD36",0.072891528,4
BP,GO:0002456,T cell mediated immunity,102/18493,0.001288876,0.004424377,0.001539213,3569/3553/3383,"IL6,IL1B,ICAM1",0.07155225,3
BP,GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,102/18493,0.001288876,0.004424377,0.001539213,7157/3162/596,"TP53,HMOX1,BCL2",0.049253584,3
BP,GO:0019233,sensory perception of pain,102/18493,0.001288876,0.004424377,0.001539213,5743/3586/5594,"PTGS2,IL10,MAPK1",0.064469345,3
BP,GO:0051402,neuron apoptotic process,230/18493,0.001362596,0.004623933,0.001608638,6347/836/3162/596,"CCL2,CASP3,HMOX1,BCL2",0.069621652,4
BP,GO:0032411,positive regulation of transporter activity,104/18493,0.001363007,0.004623933,0.001608638,5444/5243/1080,"PON1,ABCB1,CFTR",0.027062404,3
BP,GO:0034605,cellular response to heat,104/18493,0.001363007,0.004623933,0.001608638,5743/5594/3162,"PTGS2,MAPK1,HMOX1",0.061800825,3
BP,GO:2000278,regulation of DNA biosynthetic process,104/18493,0.001363007,0.004623933,0.001608638,7157/5468/5594,"TP53,PPARG,MAPK1",0.065262671,3
BP,GO:0031954,positive regulation of protein autophosphorylation,26/18493,0.001364103,0.004623933,0.001608638,3630/7422,"INS,VEGFA",0.050563737,2
BP,GO:0042953,lipoprotein transport,26/18493,0.001364103,0.004623933,0.001608638,5468/948,"PPARG,CD36",0.026791279,2
BP,GO:0044872,lipoprotein localization,26/18493,0.001364103,0.004623933,0.001608638,5468/948,"PPARG,CD36",0.026791279,2
BP,GO:0050926,regulation of positive chemotaxis,26/18493,0.001364103,0.004623933,0.001608638,7422/3576,"VEGFA,CXCL8",0.045716339,2
BP,GO:0060259,regulation of feeding behavior,26/18493,0.001364103,0.004623933,0.001608638,3630/6774,"INS,STAT3",0.051813299,2
BP,GO:0072539,T-helper 17 cell differentiation,26/18493,0.001364103,0.004623933,0.001608638,3569/6774,"IL6,STAT3",0.051899583,2
BP,GO:0001909,leukocyte mediated cytotoxicity,105/18493,0.001401059,0.004737329,0.001648087,3383/4843/2147,"ICAM1,NOS2,F2",0.050110444,3
BP,GO:0072676,lymphocyte migration,105/18493,0.001401059,0.004737329,0.001648087,207/6347/3383,"AKT1,CCL2,ICAM1",0.068898406,3
BP,GO:0019359,nicotinamide nucleotide biosynthetic process,106/18493,0.001439773,0.004850044,0.0016873,3630/6774/5743,"INS,STAT3,PTGS2",0.07284671,3
BP,GO:0019363,pyridine nucleotide biosynthetic process,106/18493,0.001439773,0.004850044,0.0016873,3630/6774/5743,"INS,STAT3,PTGS2",0.07284671,3
BP,GO:0043279,response to alkaloid,106/18493,0.001439773,0.004850044,0.0016873,5468/3383/836,"PPARG,ICAM1,CASP3",0.0620438,3
BP,GO:0030217,T cell differentiation,234/18493,0.001451761,0.004884344,0.001699233,3569/6774/3458/596,"IL6,STAT3,IFNG,BCL2",0.07726319,4
BP,GO:0002724,regulation of T cell cytokine production,27/18493,0.001471272,0.004931587,0.001715668,3569/3553,"IL6,IL1B",0.049546188,2
BP,GO:0010575,positive regulation of vascular endothelial growth factor production,27/18493,0.001471272,0.004931587,0.001715668,3553/5743,"IL1B,PTGS2",0.043710805,2
BP,GO:1905563,negative regulation of vascular endothelial cell proliferation,27/18493,0.001471272,0.004931587,0.001715668,6347/5468,"CCL2,PPARG",0.044030009,2
BP,GO:0031623,receptor internalization,107/18493,0.001479154,0.004951872,0.001722725,7422/3576/948,"VEGFA,CXCL8,CD36",0.050491831,3
BP,GO:0008645,hexose transmembrane transport,108/18493,0.001519207,0.005079673,0.001767187,3630/207/3553,"INS,AKT1,IL1B",0.073932527,3
BP,GO:0018107,peptidyl-threonine phosphorylation,109/18493,0.001559936,0.005188157,0.001804927,207/5594/596,"AKT1,MAPK1,BCL2",0.052052453,3
BP,GO:0072525,pyridine-containing compound biosynthetic process,109/18493,0.001559936,0.005188157,0.001804927,3630/6774/5743,"INS,STAT3,PTGS2",0.071925448,3
BP,GO:0009896,positive regulation of catabolic process,407/18493,0.001566576,0.005188157,0.001804927,3630/207/3553/3458/3162,"INS,AKT1,IL1B,IFNG,HMOX1",0.111087022,5
BP,GO:0001844,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,28/18493,0.00158234,0.005188157,0.001804927,7157/596,"TP53,BCL2",0.029154908,2
BP,GO:0005979,regulation of glycogen biosynthetic process,28/18493,0.00158234,0.005188157,0.001804927,3630/207,"INS,AKT1",0.051564984,2
BP,GO:0009065,glutamine family amino acid catabolic process,28/18493,0.00158234,0.005188157,0.001804927,4846/4843,"NOS3,NOS2",0.035146201,2
BP,GO:0010962,regulation of glucan biosynthetic process,28/18493,0.00158234,0.005188157,0.001804927,3630/207,"INS,AKT1",0.051564984,2
BP,GO:0036296,response to increased oxygen levels,28/18493,0.00158234,0.005188157,0.001804927,5468/847,"PPARG,CAT",0.039167883,2
BP,GO:0042730,fibrinolysis,28/18493,0.00158234,0.005188157,0.001804927,5054/2147,"SERPINE1,F2",0.032171182,2
BP,GO:0045922,negative regulation of fatty acid metabolic process,28/18493,0.00158234,0.005188157,0.001804927,3630/207,"INS,AKT1",0.051564984,2
BP,GO:0048643,positive regulation of skeletal muscle tissue development,28/18493,0.00158234,0.005188157,0.001804927,3156/596,"HMGCR,BCL2",0.015884184,2
BP,GO:0061082,myeloid leukocyte cytokine production,28/18493,0.00158234,0.005188157,0.001804927,3162/948,"HMOX1,CD36",0.02396275,2
BP,GO:0072538,T-helper 17 type immune response,28/18493,0.00158234,0.005188157,0.001804927,3569/6774,"IL6,STAT3",0.050788203,2
BP,GO:0072606,interleukin-8 secretion,28/18493,0.00158234,0.005188157,0.001804927,1401/4843,"CRP,NOS2",0.03776501,2
BP,GO:1902932,positive regulation of alcohol biosynthetic process,28/18493,0.00158234,0.005188157,0.001804927,3553/3458,"IL1B,IFNG",0.04087035,2
BP,GO:2000108,positive regulation of leukocyte apoptotic process,28/18493,0.00158234,0.005188157,0.001804927,7157/3586,"TP53,IL10",0.043104186,2
BP,GO:0015749,monosaccharide transmembrane transport,110/18493,0.001601345,0.005244114,0.001824395,3630/207/3553,"INS,AKT1,IL1B",0.073486632,3
BP,GO:0002698,negative regulation of immune effector process,111/18493,0.001643438,0.005356024,0.001863327,3630/3586/3162,"INS,IL10,HMOX1",0.065916835,3
BP,GO:0030218,erythrocyte differentiation,111/18493,0.001643438,0.005356024,0.001863327,6774/7422/836,"STAT3,VEGFA,CASP3",0.065925099,3
BP,GO:0043200,response to amino acid,111/18493,0.001643438,0.005356024,0.001863327,3383/836/4313,"ICAM1,CASP3,MMP2",0.058035905,3
BP,GO:1904375,regulation of protein localization to cell periphery,111/18493,0.001643438,0.005356024,0.001863327,3630/207/3458,"INS,AKT1,IFNG",0.069937681,3
BP,GO:0046394,carboxylic acid biosynthetic process,412/18493,0.001652981,0.005374175,0.001869642,3630/6774/3553/5743/4023,"INS,STAT3,IL1B,PTGS2,LPL",0.106548039,5
BP,GO:0051052,regulation of DNA metabolic process,412/18493,0.001652981,0.005374175,0.001869642,207/7157/5468/3586/5594,"AKT1,TP53,PPARG,IL10,MAPK1",0.108531262,5
BP,GO:0016053,organic acid biosynthetic process,413/18493,0.001670676,0.005425184,0.001887388,3630/6774/3553/5743/4023,"INS,STAT3,IL1B,PTGS2,LPL",0.106355445,5
BP,GO:0010822,positive regulation of mitochondrion organization,112/18493,0.00168622,0.005446229,0.001894709,7157/4318/596,"TP53,MMP9,BCL2",0.050232413,3
BP,GO:0034219,carbohydrate transmembrane transport,112/18493,0.00168622,0.005446229,0.001894709,3630/207/3553,"INS,AKT1,IL1B",0.072957354,3
BP,GO:1990266,neutrophil migration,112/18493,0.00168622,0.005446229,0.001894709,6347/3576/3553,"CCL2,CXCL8,IL1B",0.066330524,3
BP,GO:0033673,negative regulation of kinase activity,244/18493,0.001692402,0.005446229,0.001894709,207/3553/836/3156,"AKT1,IL1B,CASP3,HMGCR",0.075080149,4
BP,GO:0042036,negative regulation of cytokine biosynthetic process,29/18493,0.001697291,0.005446229,0.001894709,3569/3586,"IL6,IL10",0.04731038,2
BP,GO:0045940,positive regulation of steroid metabolic process,29/18493,0.001697291,0.005446229,0.001894709,3553/3458,"IL1B,IFNG",0.040493253,2
BP,GO:0046320,regulation of fatty acid oxidation,29/18493,0.001697291,0.005446229,0.001894709,207/5468,"AKT1,PPARG",0.04513426,2
BP,GO:0050869,negative regulation of B cell activation,29/18493,0.001697291,0.005446229,0.001894709,3586/836,"IL10,CASP3",0.040349481,2
BP,GO:0090200,positive regulation of release of cytochrome c from mitochondria,29/18493,0.001697291,0.005446229,0.001894709,7157/4318,"TP53,MMP9",0.043494824,2
BP,GO:1902175,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,29/18493,0.001697291,0.005446229,0.001894709,3630/207,"INS,AKT1",0.051089212,2
BP,GO:0070374,positive regulation of ERK1 and ERK2 cascade,245/18493,0.0017179,0.005505829,0.001915444,6347/3383/3156/948,"CCL2,ICAM1,HMGCR,CD36",0.056825857,4
BP,GO:0050804,modulation of chemical synaptic transmission,418/18493,0.001761255,0.0056381,0.00196146,3630/6774/3553/5743/5594,"INS,STAT3,IL1B,PTGS2,MAPK1",0.112789742,5
BP,GO:0007611,learning or memory,247/18493,0.001769697,0.005658429,0.001968532,5743/5594/836/3156,"PTGS2,MAPK1,CASP3,HMGCR",0.069716211,4
BP,GO:2000134,negative regulation of G1/S transition of mitotic cell cycle,114/18493,0.001773864,0.005665057,0.001970838,6347/7157/596,"CCL2,TP53,BCL2",0.050991277,3
BP,GO:0099177,regulation of trans-synaptic signaling,419/18493,0.001779796,0.005677299,0.001975097,3630/6774/3553/5743/5594,"INS,STAT3,IL1B,PTGS2,MAPK1",0.11263883,5
BP,GO:0001782,B cell homeostasis,30/18493,0.001816108,0.005772705,0.002008288,836/596,"CASP3,BCL2",0.026232631,2
BP,GO:0010543,regulation of platelet activation,30/18493,0.001816108,0.005772705,0.002008288,4846/2147,"NOS3,F2",0.03232259,2
BP,GO:2001171,positive regulation of ATP biosynthetic process,30/18493,0.001816108,0.005772705,0.002008288,3630/6774,"INS,STAT3",0.0496749,2
BP,GO:0060968,regulation of gene silencing,115/18493,0.001818736,0.005774272,0.002008833,6774/7157/5468,"STAT3,TP53,PPARG",0.065683958,3
BP,GO:0048568,embryonic organ development,422/18493,0.001836285,0.005823154,0.002025839,207/7422/3576/3586/5594,"AKT1,VEGFA,CXCL8,IL10,MAPK1",0.108308872,5
BP,GO:0018210,peptidyl-threonine modification,116/18493,0.001864312,0.005905109,0.002054351,207/5594/596,"AKT1,MAPK1,BCL2",0.050771867,3
BP,GO:0090596,sensory organ morphogenesis,251/18493,0.001876537,0.005929945,0.002062991,6774/7422/5594/596,"STAT3,VEGFA,MAPK1,BCL2",0.071881935,4
BP,GO:1901617,organic hydroxy compound biosynthetic process,251/18493,0.001876537,0.005929945,0.002062991,3553/3458/3156/1080,"IL1B,IFNG,HMGCR,CFTR",0.055119718,4
BP,GO:0060249,anatomical structure homeostasis,425/18493,0.001894083,0.005978407,0.00207985,3569/7422/5594/4846/596,"IL6,VEGFA,MAPK1,NOS3,BCL2",0.093994776,5
BP,GO:0019079,viral genome replication,117/18493,0.001910597,0.006023501,0.002095538,6347/3576/596,"CCL2,CXCL8,BCL2",0.05021046,3
BP,GO:0043491,protein kinase B signaling,253/18493,0.001931603,0.006055878,0.002106802,3630/207/6347/3553,"INS,AKT1,CCL2,IL1B",0.09350812,4
BP,GO:0001893,maternal placenta development,31/18493,0.001938776,0.006055878,0.002106802,207/5743,"AKT1,PTGS2",0.044521473,2
BP,GO:0016242,negative regulation of macroautophagy,31/18493,0.001938776,0.006055878,0.002106802,207/3162,"AKT1,HMOX1",0.04202702,2
BP,GO:0034694,response to prostaglandin,31/18493,0.001938776,0.006055878,0.002106802,207/5468,"AKT1,PPARG",0.044215563,2
BP,GO:0045742,positive regulation of epidermal growth factor receptor signaling pathway,31/18493,0.001938776,0.006055878,0.002106802,207/4318,"AKT1,MMP9",0.044835578,2
BP,GO:0048873,homeostasis of number of cells within a tissue,31/18493,0.001938776,0.006055878,0.002106802,4846/596,"NOS3,BCL2",0.025651474,2
BP,GO:0051204,protein insertion into mitochondrial membrane,31/18493,0.001938776,0.006055878,0.002106802,7157/596,"TP53,BCL2",0.02829794,2
BP,GO:1900745,positive regulation of p38MAPK cascade,31/18493,0.001938776,0.006055878,0.002106802,7422/3553,"VEGFA,IL1B",0.04332383,2
BP,GO:0019218,regulation of steroid metabolic process,119/18493,0.002005308,0.00625647,0.002176587,3553/3458/3156,"IL1B,IFNG,HMGCR",0.048176471,3
BP,GO:0043500,muscle adaptation,120/18493,0.002053743,0.006392837,0.002224028,3553/4846/3162,"IL1B,NOS3,HMOX1",0.057956374,3
BP,GO:0071621,granulocyte chemotaxis,120/18493,0.002053743,0.006392837,0.002224028,6347/3576/3553,"CCL2,CXCL8,IL1B",0.064291368,3
BP,GO:0010039,response to iron ion,32/18493,0.00206528,0.00640663,0.002228827,3162/596,"HMOX1,BCL2",0.024431522,2
BP,GO:0042744,hydrogen peroxide catabolic process,32/18493,0.00206528,0.00640663,0.002228827,4353/847,"MPO,CAT",0.036000211,2
BP,GO:1901030,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,32/18493,0.00206528,0.00640663,0.002228827,7157/596,"TP53,BCL2",0.027985942,2
BP,GO:0006164,purine nucleotide biosynthetic process,258/18493,0.002074166,0.006412136,0.002230742,3630/6774/4846/4843,"INS,STAT3,NOS3,NOS2",0.082393797,4
BP,GO:0007249,I-kappaB kinase/NF-kappaB signaling,258/18493,0.002074166,0.006412136,0.002230742,207/3553/3162/948,"AKT1,IL1B,HMOX1,CD36",0.067837051,4
BP,GO:0043406,positive regulation of MAP kinase activity,258/18493,0.002074166,0.006412136,0.002230742,7422/3553/5594/959,"VEGFA,IL1B,MAPK1,CD40LG",0.075527098,4
BP,GO:1902807,negative regulation of cell cycle G1/S phase transition,121/18493,0.002102902,0.006493551,0.002259066,6347/7157/596,"CCL2,TP53,BCL2",0.049645957,3
BP,GO:1903038,negative regulation of leukocyte cell-cell adhesion,122/18493,0.00215279,0.006640018,0.002310021,207/3586/836,"AKT1,IL10,CASP3",0.062307578,3
BP,GO:1903522,regulation of blood circulation,262/18493,0.002193348,0.00666566,0.002318942,207/5743/3383/4846,"AKT1,PTGS2,ICAM1,NOS3",0.081784666,4
BP,GO:0030947,regulation of vascular endothelial growth factor receptor signaling pathway,33/18493,0.002195602,0.00666566,0.002318942,7422/3553,"VEGFA,IL1B",0.042509909,2
BP,GO:0033028,myeloid cell apoptotic process,33/18493,0.002195602,0.00666566,0.002318942,3569/596,"IL6,BCL2",0.032191767,2
BP,GO:0033198,response to ATP,33/18493,0.002195602,0.00666566,0.002318942,3553/5743,"IL1B,PTGS2",0.041231477,2
BP,GO:0036003,positive regulation of transcription from RNA polymerase II promoter in response to stress,33/18493,0.002195602,0.00666566,0.002318942,7422/7157,"VEGFA,TP53",0.042779224,2
BP,GO:0045730,respiratory burst,33/18493,0.002195602,0.00666566,0.002318942,3630/4353,"INS,MPO",0.043960973,2
BP,GO:0046326,positive regulation of glucose import,33/18493,0.002195602,0.00666566,0.002318942,3630/207,"INS,AKT1",0.049109031,2
BP,GO:0048147,negative regulation of fibroblast proliferation,33/18493,0.002195602,0.00666566,0.002318942,7157/5468,"TP53,PPARG",0.04120063,2
BP,GO:0060251,regulation of glial cell proliferation,33/18493,0.002195602,0.00666566,0.002318942,3569/3553,"IL6,IL1B",0.046735871,2
BP,GO:0060674,placenta blood vessel development,33/18493,0.002195602,0.00666566,0.002318942,207/5594,"AKT1,MAPK1",0.043096837,2
BP,GO:0070873,regulation of glycogen metabolic process,33/18493,0.002195602,0.00666566,0.002318942,3630/207,"INS,AKT1",0.049109031,2
BP,GO:0071312,cellular response to alkaloid,33/18493,0.002195602,0.00666566,0.002318942,3383/836,"ICAM1,CASP3",0.038430721,2
BP,GO:0097009,energy homeostasis,33/18493,0.002195602,0.00666566,0.002318942,6774/948,"STAT3,CD36",0.027712029,2
BP,GO:1901186,positive regulation of ERBB signaling pathway,33/18493,0.002195602,0.00666566,0.002318942,207/4318,"AKT1,MMP9",0.043993255,2
BP,GO:0050715,positive regulation of cytokine secretion,123/18493,0.002203409,0.006681863,0.002324578,3630/3586/4023,"INS,IL10,LPL",0.058005135,3
BP,GO:0034976,response to endoplasmic reticulum stress,264/18493,0.002254682,0.006814679,0.002370784,6347/7157/3576/596,"CCL2,TP53,CXCL8,BCL2",0.070194259,4
BP,GO:0006639,acylglycerol metabolic process,124/18493,0.002254764,0.006814679,0.002370784,847/4023/1071,"CAT,LPL,CETP",0.037639678,3
BP,GO:0034763,negative regulation of transmembrane transport,124/18493,0.002254764,0.006814679,0.002370784,207/3553/4318,"AKT1,IL1B,MMP9",0.064726932,3
BP,GO:0016054,organic acid catabolic process,265/18493,0.00228579,0.006893046,0.002398048,207/4846/4843/5444,"AKT1,NOS3,NOS2,PON1",0.067538325,4
BP,GO:0046395,carboxylic acid catabolic process,265/18493,0.00228579,0.006893046,0.002398048,207/4846/4843/5444,"AKT1,NOS3,NOS2,PON1",0.067538325,4
BP,GO:0006638,neutral lipid metabolic process,125/18493,0.002306859,0.006948836,0.002417457,847/4023/1071,"CAT,LPL,CETP",0.037492586,3
BP,GO:0002701,negative regulation of production of molecular mediator of immune response,34/18493,0.002329727,0.006955753,0.002419863,3586/3162,"IL10,HMOX1",0.037205658,2
BP,GO:0030224,monocyte differentiation,34/18493,0.002329727,0.006955753,0.002419863,7422/5468,"VEGFA,PPARG",0.041048155,2
BP,GO:0032148,activation of protein kinase B activity,34/18493,0.002329727,0.006955753,0.002419863,3630/207,"INS,AKT1",0.048691521,2
BP,GO:0043276,anoikis,34/18493,0.002329727,0.006955753,0.002419863,207/596,"AKT1,BCL2",0.029695937,2
BP,GO:0090322,regulation of superoxide metabolic process,34/18493,0.002329727,0.006955753,0.002419863,1401/948,"CRP,CD36",0.026022172,2
BP,GO:0097421,liver regeneration,34/18493,0.002329727,0.006955753,0.002419863,3586/3162,"IL10,HMOX1",0.037205658,2
BP,GO:1903131,mononuclear cell differentiation,34/18493,0.002329727,0.006955753,0.002419863,7422/5468,"VEGFA,PPARG",0.041048155,2
BP,GO:2000352,negative regulation of endothelial cell apoptotic process,34/18493,0.002329727,0.006955753,0.002419863,3383/5054,"ICAM1,SERPINE1",0.037000574,2
BP,GO:0015980,energy derivation by oxidation of organic compounds,267/18493,0.002348894,0.007005247,0.002437082,3630/207/847/4843,"INS,AKT1,CAT,NOS2",0.08047375,4
BP,GO:0042326,negative regulation of phosphorylation,448/18493,0.002382686,0.0070982,0.00246942,207/6774/3553/836/3156,"AKT1,STAT3,IL1B,CASP3,HMGCR",0.093634227,5
BP,GO:0060485,mesenchyme development,269/18493,0.002413193,0.007173549,0.002495633,3553/5594/4846/596,"IL1B,MAPK1,NOS3,BCL2",0.064848358,4
BP,GO:0071333,cellular response to glucose stimulus,127/18493,0.002413283,0.007173549,0.002495633,3383/3156/1080,"ICAM1,HMGCR,CFTR",0.033841955,3
BP,GO:0002576,platelet degranulation,128/18493,0.002467619,0.007287082,0.00253513,7422/5054/948,"VEGFA,SERPINE1,CD36",0.043667952,3
BP,GO:0035270,endocrine system development,128/18493,0.002467619,0.007287082,0.00253513,3569/207/5594,"IL6,AKT1,MAPK1",0.067588097,3
BP,GO:0042177,negative regulation of protein catabolic process,128/18493,0.002467619,0.007287082,0.00253513,3630/3586/4843,"INS,IL10,NOS2",0.059104953,3
BP,GO:0032885,regulation of polysaccharide biosynthetic process,35/18493,0.00246764,0.007287082,0.00253513,3630/207,"INS,AKT1",0.048235457,2
BP,GO:0045923,positive regulation of fatty acid metabolic process,35/18493,0.00246764,0.007287082,0.00253513,5743/5468,"PTGS2,PPARG",0.039407991,2
BP,GO:0071470,cellular response to osmotic stress,35/18493,0.00246764,0.007287082,0.00253513,5743/836,"PTGS2,CASP3",0.038537218,2
BP,GO:0072522,purine-containing compound biosynthetic process,271/18493,0.002478699,0.007311756,0.002543714,3630/6774/4846/4843,"INS,STAT3,NOS3,NOS2",0.08025152,4
BP,GO:0050769,positive regulation of neurogenesis,453/18493,0.002500049,0.007366701,0.002562829,3569/7422/3553/5468/596,"IL6,VEGFA,IL1B,PPARG,BCL2",0.092724247,5
BP,GO:0071331,cellular response to hexose stimulus,129/18493,0.002522709,0.007421164,0.002581777,3383/3156/1080,"ICAM1,HMGCR,CFTR",0.033609353,3
BP,GO:0034765,regulation of ion transmembrane transport,454/18493,0.002524019,0.007421164,0.002581777,207/4318/2147/5243/1080,"AKT1,MMP9,F2,ABCB1,CFTR",0.069376178,5
BP,GO:0071326,cellular response to monosaccharide stimulus,130/18493,0.002578557,0.007565071,0.002631841,3383/3156/1080,"ICAM1,HMGCR,CFTR",0.033477711,3
BP,GO:1901796,regulation of signal transduction by p53 class mediator,130/18493,0.002578557,0.007565071,0.002631841,207/7157/596,"AKT1,TP53,BCL2",0.049946096,3
BP,GO:0030212,hyaluronan metabolic process,36/18493,0.002609325,0.007597657,0.002643178,207/3553,"AKT1,IL1B",0.043332567,2
BP,GO:0032350,regulation of hormone metabolic process,36/18493,0.002609325,0.007597657,0.002643178,3553/3458,"IL1B,IFNG",0.037907159,2
BP,GO:0034390,smooth muscle cell apoptotic process,36/18493,0.002609325,0.007597657,0.002643178,5468/3458,"PPARG,IFNG",0.036826361,2
BP,GO:0034391,regulation of smooth muscle cell apoptotic process,36/18493,0.002609325,0.007597657,0.002643178,5468/3458,"PPARG,IFNG",0.036826361,2
BP,GO:0042092,type 2 immune response,36/18493,0.002609325,0.007597657,0.002643178,3569/3586,"IL6,IL10",0.044288911,2
BP,GO:0060416,response to growth hormone,36/18493,0.002609325,0.007597657,0.002643178,207/6774,"AKT1,STAT3",0.044923281,2
BP,GO:1903580,positive regulation of ATP metabolic process,36/18493,0.002609325,0.007597657,0.002643178,3630/6774,"INS,STAT3",0.047027631,2
BP,GO:0007006,mitochondrial membrane organization,131/18493,0.002635166,0.007656417,0.00266362,6774/7157/596,"STAT3,TP53,BCL2",0.049025843,3
BP,GO:1903555,regulation of tumor necrosis factor superfamily cytokine production,131/18493,0.002635166,0.007656417,0.00266362,3586/3458/948,"IL10,IFNG,CD36",0.041541151,3
BP,GO:0046486,glycerolipid metabolic process,459/18493,0.002646396,0.007676675,0.002670667,847/4023/5444/7941/1071,"CAT,LPL,PON1,PLA2G7,CETP",0.055292223,5
BP,GO:0007162,negative regulation of cell adhesion,276/18493,0.002647814,0.007676675,0.002670667,207/3586/836/5054,"AKT1,IL10,CASP3,SERPINE1",0.077911593,4
BP,GO:0051146,striated muscle cell differentiation,277/18493,0.002682566,0.007769103,0.002702822,207/7422/836/596,"AKT1,VEGFA,CASP3,BCL2",0.068309978,4
BP,GO:0008286,insulin receptor signaling pathway,132/18493,0.00269254,0.007789649,0.00270997,3630/207/3553,"INS,AKT1,IL1B",0.067948671,3
BP,GO:0050768,negative regulation of neurogenesis,279/18493,0.002753011,0.007893687,0.002746164,3569/6774/3553/2147,"IL6,STAT3,IL1B,F2",0.079346239,4
BP,GO:0002251,organ or tissue specific immune response,37/18493,0.002754765,0.007893687,0.002746164,3569/4843,"IL6,NOS2",0.039127924,2
BP,GO:0002369,T cell cytokine production,37/18493,0.002754765,0.007893687,0.002746164,3569/3553,"IL6,IL1B",0.04515872,2
BP,GO:0010874,regulation of cholesterol efflux,37/18493,0.002754765,0.007893687,0.002746164,5444/1071,"PON1,CETP",0.018189737,2
BP,GO:0032094,response to food,37/18493,0.002754765,0.007893687,0.002746164,207/4353,"AKT1,MPO",0.040389596,2
BP,GO:0055090,acylglycerol homeostasis,37/18493,0.002754765,0.007893687,0.002746164,4023/1071,"LPL,CETP",0.01972596,2
BP,GO:0061756,leukocyte adhesion to vascular endothelial cell,37/18493,0.002754765,0.007893687,0.002746164,3383/7412,"ICAM1,VCAM1",0.037178589,2
BP,GO:0070328,triglyceride homeostasis,37/18493,0.002754765,0.007893687,0.002746164,4023/1071,"LPL,CETP",0.01972596,2
BP,GO:2000279,negative regulation of DNA biosynthetic process,37/18493,0.002754765,0.007893687,0.002746164,7157/5468,"TP53,PPARG",0.039810271,2
BP,GO:0007292,female gamete generation,134/18493,0.002809598,0.008025304,0.002791953,5743/4846/596,"PTGS2,NOS3,BCL2",0.043699316,3
BP,GO:0010675,regulation of cellular carbohydrate metabolic process,134/18493,0.002809598,0.008025304,0.002791953,3630/207/6774,"INS,AKT1,STAT3",0.069104411,3
BP,GO:0097530,granulocyte migration,134/18493,0.002809598,0.008025304,0.002791953,6347/3576/3553,"CCL2,CXCL8,IL1B",0.061397551,3
BP,GO:0045930,negative regulation of mitotic cell cycle,281/18493,0.002824719,0.008059984,0.002804018,6347/7157/3586/596,"CCL2,TP53,IL10,BCL2",0.066528231,4
BP,GO:0071706,tumor necrosis factor superfamily cytokine production,135/18493,0.002869288,0.008169921,0.002842264,3586/3458/948,"IL10,IFNG,CD36",0.040987676,3
BP,GO:0072655,establishment of protein localization to mitochondrion,135/18493,0.002869288,0.008169921,0.002842264,207/7157/596,"AKT1,TP53,BCL2",0.049159536,3
BP,GO:0006091,generation of precursor metabolites and energy,471/18493,0.002957703,0.008412814,0.002926766,3630/207/6774/847/4843,"INS,AKT1,STAT3,CAT,NOS2",0.099105234,5
BP,GO:0046683,response to organophosphorus,137/18493,0.002991008,0.008489693,0.002953511,3553/5743/1080,"IL1B,PTGS2,CFTR",0.045225182,3
BP,GO:0055067,monovalent inorganic cation homeostasis,137/18493,0.002991008,0.008489693,0.002953511,5594/596/1080,"MAPK1,BCL2,CFTR",0.030823341,3
BP,GO:0071322,cellular response to carbohydrate stimulus,138/18493,0.003053045,0.008640318,0.003005913,3383/3156/1080,"ICAM1,HMGCR,CFTR",0.032566795,3
BP,GO:0010677,negative regulation of cellular carbohydrate metabolic process,39/18493,0.003056852,0.008640318,0.003005913,3630/6774,"INS,STAT3",0.045788321,2
BP,GO:0043277,apoptotic cell clearance,39/18493,0.003056852,0.008640318,0.003005913,6347/948,"CCL2,CD36",0.025298366,2
BP,GO:0046825,regulation of protein export from nucleus,39/18493,0.003056852,0.008640318,0.003005913,7157/3553,"TP53,IL1B",0.04011948,2
BP,GO:0070585,protein localization to mitochondrion,139/18493,0.00311587,0.008797943,0.003060749,207/7157/596,"AKT1,TP53,BCL2",0.04840221,3
BP,GO:0019058,viral life cycle,289/18493,0.00312441,0.008812857,0.003065938,6347/3576/3383/596,"CCL2,CXCL8,ICAM1,BCL2",0.064797808,4
BP,GO:0072073,kidney epithelium development,140/18493,0.003179488,0.008958869,0.003116735,7422/847/596,"VEGFA,CAT,BCL2",0.042680984,3
BP,GO:0010828,positive regulation of glucose transmembrane transport,40/18493,0.003213467,0.008989067,0.00312724,3630/207,"INS,AKT1",0.04617824,2
BP,GO:0030225,macrophage differentiation,40/18493,0.003213467,0.008989067,0.00312724,7422/4318,"VEGFA,MMP9",0.039501456,2
BP,GO:0032881,regulation of polysaccharide metabolic process,40/18493,0.003213467,0.008989067,0.00312724,3630/207,"INS,AKT1",0.04617824,2
BP,GO:0050873,brown fat cell differentiation,40/18493,0.003213467,0.008989067,0.00312724,3630/5743,"INS,PTGS2",0.043109791,2
BP,GO:0061028,establishment of endothelial barrier,40/18493,0.003213467,0.008989067,0.00312724,3553/3383,"IL1B,ICAM1",0.038014391,2
BP,GO:0090311,regulation of protein deacetylation,40/18493,0.003213467,0.008989067,0.00312724,7422/3458,"VEGFA,IFNG",0.037041655,2
BP,GO:1900015,regulation of cytokine production involved in inflammatory response,40/18493,0.003213467,0.008989067,0.00312724,4843/2147,"NOS2,F2",0.025865133,2
BP,GO:0008643,carbohydrate transport,141/18493,0.003243901,0.009055471,0.003150342,3630/207/3553,"INS,AKT1,IL1B",0.065841288,3
BP,GO:0030879,mammary gland development,141/18493,0.003243901,0.009055471,0.003150342,207/7422/5594,"AKT1,VEGFA,MAPK1",0.060636873,3
BP,GO:0072330,monocarboxylic acid biosynthetic process,293/18493,0.003282129,0.009152741,0.003184181,3630/6774/5743/4023,"INS,STAT3,PTGS2,LPL",0.0760024,4
BP,GO:0001678,cellular glucose homeostasis,142/18493,0.003309112,0.009209001,0.003203754,3383/3156/1080,"ICAM1,HMGCR,CFTR",0.03212989,3
BP,GO:0044344,cellular response to fibroblast growth factor stimulus,142/18493,0.003309112,0.009209001,0.003203754,6347/3576/5594,"CCL2,CXCL8,MAPK1",0.058339226,3
BP,GO:0043312,neutrophil degranulation,485/18493,0.003353613,0.00932325,0.0032435,4318/5594/4353/847/948,"MMP9,MAPK1,MPO,CAT,CD36",0.075499066,5
BP,GO:0006110,regulation of glycolytic process,41/18493,0.003373775,0.009354216,0.003254274,3630/6774,"INS,STAT3",0.045023263,2
BP,GO:1901028,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,41/18493,0.003373775,0.009354216,0.003254274,7157/596,"TP53,BCL2",0.025888592,2
BP,GO:0038127,ERBB signaling pathway,143/18493,0.003375126,0.009354216,0.003254274,207/4318/5594,"AKT1,MMP9,MAPK1",0.059313892,3
BP,GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,144/18493,0.003441944,0.009523388,0.003313127,3569/3553/3586,"IL6,IL1B,IL10",0.06176243,3
BP,GO:0002283,neutrophil activation involved in immune response,488/18493,0.003443206,0.009523388,0.003313127,4318/5594/4353/847/948,"MMP9,MAPK1,MPO,CAT,CD36",0.075156078,5
BP,GO:0051961,negative regulation of nervous system development,298/18493,0.003486836,0.009634209,0.003351681,3569/6774/3553/2147,"IL6,STAT3,IL1B,F2",0.076080792,4
BP,GO:0019362,pyridine nucleotide metabolic process,145/18493,0.003509571,0.009667402,0.003363229,3630/6774/5743,"INS,STAT3,PTGS2",0.06341721,3
BP,GO:0046496,nicotinamide nucleotide metabolic process,145/18493,0.003509571,0.009667402,0.003363229,3630/6774/5743,"INS,STAT3,PTGS2",0.06341721,3
BP,GO:0048592,eye morphogenesis,145/18493,0.003509571,0.009667402,0.003363229,6774/7422/596,"STAT3,VEGFA,BCL2",0.046863843,3
BP,GO:0002437,inflammatory response to antigenic stimulus,42/18493,0.003537762,0.00969569,0.00337307,3586/3383,"IL10,ICAM1",0.036238823,2
BP,GO:0006775,fat-soluble vitamin metabolic process,42/18493,0.003537762,0.00969569,0.00337307,3553/3458,"IL1B,IFNG",0.036012999,2
BP,GO:0030811,regulation of nucleotide catabolic process,42/18493,0.003537762,0.00969569,0.00337307,3630/6774,"INS,STAT3",0.044677736,2
BP,GO:0042149,cellular response to glucose starvation,42/18493,0.003537762,0.00969569,0.00337307,7157/596,"TP53,BCL2",0.025689912,2
BP,GO:0071675,regulation of mononuclear cell migration,42/18493,0.003537762,0.00969569,0.00337307,5054/7941,"SERPINE1,PLA2G7",0.024012585,2
BP,GO:0002706,regulation of lymphocyte mediated immunity,146/18493,0.003578009,0.009786161,0.003404545,3569/3553/3586,"IL6,IL1B,IL10",0.061401217,3
BP,GO:0009267,cellular response to starvation,146/18493,0.003578009,0.009786161,0.003404545,7157/5594/596,"TP53,MAPK1,BCL2",0.043757378,3
BP,GO:0043524,negative regulation of neuron apoptotic process,147/18493,0.003647261,0.009965496,0.003466934,6347/3162/596,"CCL2,HMOX1,BCL2",0.042180797,3
BP,GO:0002534,cytokine production involved in inflammatory response,43/18493,0.003705412,0.010073506,0.00350451,4843/2147,"NOS2,F2",0.02523988,2
BP,GO:0010907,positive regulation of glucose metabolic process,43/18493,0.003705412,0.010073506,0.00350451,3630/207,"INS,AKT1",0.045061947,2
BP,GO:0014009,glial cell proliferation,43/18493,0.003705412,0.010073506,0.00350451,3569/3553,"IL6,IL1B",0.04288436,2
BP,GO:0042771,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,43/18493,0.003705412,0.010073506,0.00350451,7157/596,"TP53,BCL2",0.025478083,2
BP,GO:0045912,negative regulation of carbohydrate metabolic process,43/18493,0.003705412,0.010073506,0.00350451,3630/6774,"INS,STAT3",0.044309341,2
BP,GO:0034767,positive regulation of ion transmembrane transport,148/18493,0.003717331,0.010085637,0.00350873,2147/5243/1080,"F2,ABCB1,CFTR",0.024678546,3
BP,GO:0071774,response to fibroblast growth factor,148/18493,0.003717331,0.010085637,0.00350873,6347/3576/5594,"CCL2,CXCL8,MAPK1",0.057207544,3
BP,GO:0000187,activation of MAPK activity,150/18493,0.003859935,0.010451575,0.003636038,3553/5594/959,"IL1B,MAPK1,CD40LG",0.048659218,3
BP,GO:0072524,pyridine-containing compound metabolic process,150/18493,0.003859935,0.010451575,0.003636038,3630/6774/5743,"INS,STAT3,PTGS2",0.06235101,3
BP,GO:0007157,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,44/18493,0.003876709,0.010465566,0.003640905,3383/7412,"ICAM1,VCAM1",0.035012948,2
BP,GO:0032309,icosanoid secretion,44/18493,0.003876709,0.010465566,0.003640905,3553/4843,"IL1B,NOS2",0.032576632,2
BP,GO:1901031,regulation of response to reactive oxygen species,44/18493,0.003876709,0.010465566,0.003640905,3586/948,"IL10,CD36",0.022584951,2
BP,GO:0030856,regulation of epithelial cell differentiation,151/18493,0.003932475,0.010605528,0.003689597,3553/5054/3458,"IL1B,SERPINE1,IFNG",0.051567552,3
BP,GO:0001754,eye photoreceptor cell differentiation,45/18493,0.004051638,0.010861923,0.003778795,6774/7422,"STAT3,VEGFA",0.039841581,2
BP,GO:0031018,endocrine pancreas development,45/18493,0.004051638,0.010861923,0.003778795,3569/207,"IL6,AKT1",0.044396,2
BP,GO:0034383,low-density lipoprotein particle clearance,45/18493,0.004051638,0.010861923,0.003778795,3162/948,"HMOX1,CD36",0.020597526,2
BP,GO:0035987,endodermal cell differentiation,45/18493,0.004051638,0.010861923,0.003778795,4318/4313,"MMP9,MMP2",0.034023227,2
BP,GO:0045776,negative regulation of blood pressure,45/18493,0.004051638,0.010861923,0.003778795,4846/4843,"NOS3,NOS2",0.030210422,2
BP,GO:0048538,thymus development,45/18493,0.004051638,0.010861923,0.003778795,5594/596,"MAPK1,BCL2",0.023555831,2
BP,GO:0051262,protein tetramerization,153/18493,0.004080046,0.010927252,0.003801523,7157/847/3156,"TP53,CAT,HMGCR",0.042663533,3
BP,GO:0002711,positive regulation of T cell mediated immunity,46/18493,0.004230184,0.011209346,0.003899662,3569/3553,"IL6,IL1B",0.041887866,2
BP,GO:0005978,glycogen biosynthetic process,46/18493,0.004230184,0.011209346,0.003899662,3630/207,"INS,AKT1",0.044014853,2
BP,GO:0009250,glucan biosynthetic process,46/18493,0.004230184,0.011209346,0.003899662,3630/207,"INS,AKT1",0.044014853,2
BP,GO:0031279,regulation of cyclase activity,46/18493,0.004230184,0.011209346,0.003899662,4846/4843,"NOS3,NOS2",0.030000104,2
BP,GO:0031952,regulation of protein autophosphorylation,46/18493,0.004230184,0.011209346,0.003899662,3630/7422,"INS,VEGFA",0.042235973,2
BP,GO:0032757,positive regulation of interleukin-8 production,46/18493,0.004230184,0.011209346,0.003899662,3553/5054,"IL1B,SERPINE1",0.034893407,2
BP,GO:0045824,negative regulation of innate immune response,46/18493,0.004230184,0.011209346,0.003899662,3630/5468,"INS,PPARG",0.04082113,2
BP,GO:0071715,icosanoid transport,46/18493,0.004230184,0.011209346,0.003899662,3553/4843,"IL1B,NOS2",0.032086107,2
BP,GO:1900744,regulation of p38MAPK cascade,46/18493,0.004230184,0.011209346,0.003899662,7422/3553,"VEGFA,IL1B",0.038100271,2
BP,GO:1901571,fatty acid derivative transport,46/18493,0.004230184,0.011209346,0.003899662,3553/4843,"IL1B,NOS2",0.032086107,2
BP,GO:0001959,regulation of cytokine-mediated signaling pathway,155/18493,0.004230958,0.011209346,0.003899662,3569/5468/3458,"IL6,PPARG,IFNG",0.056939281,3
BP,GO:0002819,regulation of adaptive immune response,157/18493,0.004385234,0.011598985,0.004035215,3569/3553/3586,"IL6,IL1B,IL10",0.059145864,3
BP,GO:0002204,somatic recombination of immunoglobulin genes involved in immune response,47/18493,0.004412331,0.011598985,0.004035215,3586/959,"IL10,CD40LG",0.028974531,2
BP,GO:0002208,somatic diversification of immunoglobulins involved in immune response,47/18493,0.004412331,0.011598985,0.004035215,3586/959,"IL10,CD40LG",0.028974531,2
BP,GO:0022602,ovulation cycle process,47/18493,0.004412331,0.011598985,0.004035215,836/4846,"CASP3,NOS3",0.033547641,2
BP,GO:0035722,interleukin-12-mediated signaling pathway,47/18493,0.004412331,0.011598985,0.004035215,3586/3458,"IL10,IFNG",0.033500694,2
BP,GO:0045190,isotype switching,47/18493,0.004412331,0.011598985,0.004035215,3586/959,"IL10,CD40LG",0.028974531,2
BP,GO:0051205,protein insertion into membrane,47/18493,0.004412331,0.011598985,0.004035215,7157/596,"TP53,BCL2",0.024696709,2
BP,GO:0051339,regulation of lyase activity,47/18493,0.004412331,0.011598985,0.004035215,4846/4843,"NOS3,NOS2",0.029771849,2
BP,GO:0016241,regulation of macroautophagy,158/18493,0.004463641,0.011722474,0.004078176,207/836/3162,"AKT1,CASP3,HMOX1",0.053472319,3
BP,GO:0050806,positive regulation of synaptic transmission,159/18493,0.004542896,0.011919044,0.004146561,3630/5743/5594,"INS,PTGS2,MAPK1",0.05787528,3
BP,GO:0009409,response to cold,48/18493,0.004598065,0.012017166,0.004180697,5468/4023,"PPARG,LPL",0.028719511,2
BP,GO:0043470,regulation of carbohydrate catabolic process,48/18493,0.004598065,0.012017166,0.004180697,3630/6774,"INS,STAT3",0.042609115,2
BP,GO:0070849,response to epidermal growth factor,48/18493,0.004598065,0.012017166,0.004180697,207/5594,"AKT1,MAPK1",0.038027801,2
BP,GO:1903587,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,48/18493,0.004598065,0.012017166,0.004180697,7422/3162,"VEGFA,HMOX1",0.034635809,2
BP,GO:0043433,negative regulation of DNA-binding transcription factor activity,160/18493,0.004623004,0.012070681,0.004199315,3586/3162/847,"IL10,HMOX1,CAT",0.048408362,3
BP,GO:0035821,modification of morphology or physiology of other organism,161/18493,0.004703966,0.012270231,0.004268737,3458/4843/2147,"IFNG,NOS2,F2",0.039879966,3
BP,GO:0006109,regulation of carbohydrate metabolic process,162/18493,0.004785786,0.012439805,0.004327731,3630/207/6774,"INS,AKT1,STAT3",0.062827185,3
BP,GO:0051302,regulation of cell division,162/18493,0.004785786,0.012439805,0.004327731,7422/3553/847,"VEGFA,IL1B,CAT",0.052442715,3
BP,GO:0060324,face development,49/18493,0.00478737,0.012439805,0.004327731,5594/4313,"MAPK1,MMP2",0.032218009,2
BP,GO:0071349,cellular response to interleukin-12,49/18493,0.00478737,0.012439805,0.004327731,3586/3458,"IL10,IFNG",0.032974647,2
BP,GO:0035051,cardiocyte differentiation,163/18493,0.004868466,0.012638389,0.004396817,7422/5594/7412,"VEGFA,MAPK1,VCAM1",0.052498586,3
BP,GO:0002695,negative regulation of leukocyte activation,164/18493,0.004952009,0.012842937,0.004467978,3586/836/3162,"IL10,CASP3,HMOX1",0.049147633,3
BP,GO:0001706,endoderm formation,50/18493,0.004980232,0.012854511,0.004472004,4318/4313,"MMP9,MMP2",0.032756098,2
BP,GO:0001954,positive regulation of cell-matrix adhesion,50/18493,0.004980232,0.012854511,0.004472004,7422/948,"VEGFA,CD36",0.02306809,2
BP,GO:0016447,somatic recombination of immunoglobulin gene segments,50/18493,0.004980232,0.012854511,0.004472004,3586/959,"IL10,CD40LG",0.028306362,2
BP,GO:0070231,T cell apoptotic process,50/18493,0.004980232,0.012854511,0.004472004,207/7157,"AKT1,TP53",0.038897111,2
BP,GO:0070671,response to interleukin-12,50/18493,0.004980232,0.012854511,0.004472004,3586/3458,"IL10,IFNG",0.032728149,2
BP,GO:0051100,negative regulation of binding,165/18493,0.005036416,0.012962423,0.004509546,207/3586/3162,"AKT1,IL10,HMOX1",0.052902384,3
BP,GO:0060759,regulation of response to cytokine stimulus,165/18493,0.005036416,0.012962423,0.004509546,3569/5468/3458,"IL6,PPARG,IFNG",0.055097008,3
BP,GO:2001252,positive regulation of chromosome organization,165/18493,0.005036416,0.012962423,0.004509546,7422/3553/5594,"VEGFA,IL1B,MAPK1",0.053885711,3
BP,GO:2000045,regulation of G1/S transition of mitotic cell cycle,166/18493,0.005121692,0.01316937,0.004581542,6347/7157/596,"CCL2,TP53,BCL2",0.04267668,3
BP,GO:0045840,positive regulation of mitotic nuclear division,51/18493,0.005176635,0.013272793,0.004617522,3630/3553,"INS,IL1B",0.040242527,2
BP,GO:0048260,positive regulation of receptor-mediated endocytosis,51/18493,0.005176635,0.013272793,0.004617522,7422/5054,"VEGFA,SERPINE1",0.033984958,2
BP,GO:0097345,mitochondrial outer membrane permeabilization,51/18493,0.005176635,0.013272793,0.004617522,7157/596,"TP53,BCL2",0.023949749,2
BP,GO:0048638,regulation of developmental growth,334/18493,0.005223698,0.013380778,0.004655089,207/6774/7422/596,"AKT1,STAT3,VEGFA,BCL2",0.063789617,4
BP,GO:0038066,p38MAPK cascade,52/18493,0.005376563,0.013710304,0.004769729,7422/3553,"VEGFA,IL1B",0.03639166,2
BP,GO:0048641,regulation of skeletal muscle tissue development,52/18493,0.005376563,0.013710304,0.004769729,3156/596,"HMGCR,BCL2",0.012950396,2
BP,GO:0097366,response to bronchodilator,52/18493,0.005376563,0.013710304,0.004769729,3383/4314,"ICAM1,MMP3",0.028968043,2
BP,GO:2001169,regulation of ATP biosynthetic process,52/18493,0.005376563,0.013710304,0.004769729,3630/6774,"INS,STAT3",0.041338849,2
BP,GO:0030324,lung development,169/18493,0.005382752,0.013710304,0.004769729,7422/5594/4846,"VEGFA,MAPK1,NOS3",0.051197714,3
BP,GO:0043901,negative regulation of multi-organism process,169/18493,0.005382752,0.013710304,0.004769729,3586/4353/948,"IL10,MPO,CD36",0.036935783,3
BP,GO:0022408,negative regulation of cell-cell adhesion,170/18493,0.005471524,0.013910218,0.004839278,207/3586/836,"AKT1,IL10,CASP3",0.05311908,3
BP,GO:2001235,positive regulation of apoptotic signaling pathway,170/18493,0.005471524,0.013910218,0.004839278,7157/4318/596,"TP53,MMP9,BCL2",0.041196452,3
BP,GO:0010950,positive regulation of endopeptidase activity,171/18493,0.005561176,0.014124866,0.004913953,6774/5468/836,"STAT3,PPARG,CASP3",0.052358567,3
BP,GO:0010332,response to gamma radiation,53/18493,0.005580003,0.014159389,0.004925963,7157/596,"TP53,BCL2",0.023591438,2
BP,GO:0030323,respiratory tube development,173/18493,0.005743132,0.014546042,0.005060477,7422/5594/4846,"VEGFA,MAPK1,NOS3",0.050491488,3
BP,GO:0048167,regulation of synaptic plasticity,173/18493,0.005743132,0.014546042,0.005060477,3630/5743/5594,"INS,PTGS2,MAPK1",0.05527287,3
BP,GO:0002381,immunoglobulin production involved in immunoglobulin mediated immune response,54/18493,0.005786939,0.014629599,0.005089546,3586/959,"IL10,CD40LG",0.027465426,2
BP,GO:0031295,T cell costimulation,54/18493,0.005786939,0.014629599,0.005089546,207/959,"AKT1,CD40LG",0.030595757,2
BP,GO:0006898,receptor-mediated endocytosis,346/18493,0.005911983,0.01493176,0.005194666,7422/3576/5054/948,"VEGFA,CXCL8,SERPINE1,CD36",0.055021119,4
BP,GO:0002043,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,55/18493,0.005997357,0.015049026,0.005235462,7422/3162,"VEGFA,HMOX1",0.032873419,2
BP,GO:0031294,lymphocyte costimulation,55/18493,0.005997357,0.015049026,0.005235462,207/959,"AKT1,CD40LG",0.030391048,2
BP,GO:0046324,regulation of glucose import,55/18493,0.005997357,0.015049026,0.005235462,3630/207,"INS,AKT1",0.041127916,2
BP,GO:0051196,regulation of coenzyme metabolic process,55/18493,0.005997357,0.015049026,0.005235462,3630/6774,"INS,STAT3",0.040441015,2
BP,GO:0061178,regulation of insulin secretion involved in cellular response to glucose stimulus,55/18493,0.005997357,0.015049026,0.005235462,3156/1080,"HMGCR,CFTR",0.012510952,2
BP,GO:0070498,interleukin-1-mediated signaling pathway,55/18493,0.005997357,0.015049026,0.005235462,3569/3553,"IL6,IL1B",0.039140439,2
BP,GO:0071398,cellular response to fatty acid,55/18493,0.005997357,0.015049026,0.005235462,207/5468,"AKT1,PPARG",0.036334052,2
BP,GO:0022406,membrane docking,177/18493,0.006117712,0.015336805,0.005335579,3383/7412/1080,"ICAM1,VCAM1,CFTR",0.037320322,3
BP,GO:0001960,negative regulation of cytokine-mediated signaling pathway,56/18493,0.006211241,0.015468169,0.00538128,3569/5468,"IL6,PPARG",0.037960876,2
BP,GO:0010656,negative regulation of muscle cell apoptotic process,56/18493,0.006211241,0.015468169,0.00538128,3162/3156,"HMOX1,HMGCR",0.021976881,2
BP,GO:0032890,regulation of organic acid transport,56/18493,0.006211241,0.015468169,0.00538128,207/3553,"AKT1,IL1B",0.037019539,2
BP,GO:0042130,negative regulation of T cell proliferation,56/18493,0.006211241,0.015468169,0.00538128,3586/836,"IL10,CASP3",0.032269565,2
BP,GO:0055081,anion homeostasis,56/18493,0.006211241,0.015468169,0.00538128,3630/1071,"INS,CETP",0.027799416,2
BP,GO:1903078,positive regulation of protein localization to plasma membrane,56/18493,0.006211241,0.015468169,0.00538128,207/3458,"AKT1,IFNG",0.034425919,2
BP,GO:1903749,positive regulation of establishment of protein localization to mitochondrion,56/18493,0.006211241,0.015468169,0.00538128,7157/596,"TP53,BCL2",0.023101552,2
BP,GO:0006732,coenzyme metabolic process,351/18493,0.006215859,0.015468169,0.00538128,3630/6774/5743/3156,"INS,STAT3,PTGS2,HMGCR",0.064189551,4
BP,GO:0002377,immunoglobulin production,180/18493,0.006408055,0.015851687,0.005514703,3569/3586/959,"IL6,IL10,CD40LG",0.048213286,3
BP,GO:0048639,positive regulation of developmental growth,180/18493,0.006408055,0.015851687,0.005514703,207/7422/596,"AKT1,VEGFA,BCL2",0.04254656,3
BP,GO:0017001,antibiotic catabolic process,57/18493,0.006428577,0.015851687,0.005514703,4353/847,"MPO,CAT",0.029542508,2
BP,GO:0033344,cholesterol efflux,57/18493,0.006428577,0.015851687,0.005514703,5444/1071,"PON1,CETP",0.015570381,2
BP,GO:0042093,T-helper cell differentiation,57/18493,0.006428577,0.015851687,0.005514703,3569/6774,"IL6,STAT3",0.040006764,2
BP,GO:0042108,positive regulation of cytokine biosynthetic process,57/18493,0.006428577,0.015851687,0.005514703,3553/3162,"IL1B,HMOX1",0.032078603,2
BP,GO:0046626,regulation of insulin receptor signaling pathway,57/18493,0.006428577,0.015851687,0.005514703,3630/3553,"INS,IL1B",0.038589269,2
BP,GO:0070228,regulation of lymphocyte apoptotic process,57/18493,0.006428577,0.015851687,0.005514703,7157/3586,"TP53,IL10",0.033953928,2
BP,GO:1902110,positive regulation of mitochondrial membrane permeability involved in apoptotic process,57/18493,0.006428577,0.015851687,0.005514703,7157/596,"TP53,BCL2",0.022965836,2
BP,GO:2001244,positive regulation of intrinsic apoptotic signaling pathway,57/18493,0.006428577,0.015851687,0.005514703,7157/596,"TP53,BCL2",0.022965836,2
BP,GO:0007369,gastrulation,181/18493,0.006506639,0.016029563,0.005576585,4318/3586/4313,"MMP9,IL10,MMP2",0.047396274,3
BP,GO:0043409,negative regulation of MAPK cascade,182/18493,0.00660613,0.016245073,0.00565156,207/3553/3156,"AKT1,IL1B,HMGCR",0.043697568,3
BP,GO:0061138,morphogenesis of a branching epithelium,182/18493,0.00660613,0.016245073,0.00565156,7422/3586/596,"VEGFA,IL10,BCL2",0.039242185,3
BP,GO:0001885,endothelial cell development,58/18493,0.00664935,0.016336504,0.005683368,3553/3383,"IL1B,ICAM1",0.033194621,2
BP,GO:0030308,negative regulation of cell growth,184/18493,0.006807835,0.016695552,0.005808278,7157/5468/596,"TP53,PPARG,BCL2",0.038940758,3
BP,GO:0046328,regulation of JNK cascade,184/18493,0.006807835,0.016695552,0.005808278,207/3553/959,"AKT1,IL1B,CD40LG",0.046807865,3
BP,GO:0002562,somatic diversification of immune receptors via germline recombination within a single locus,59/18493,0.006873545,0.016750396,0.005827358,3586/959,"IL10,CD40LG",0.026585334,2
BP,GO:0016444,somatic cell DNA recombination,59/18493,0.006873545,0.016750396,0.005827358,3586/959,"IL10,CD40LG",0.026585334,2
BP,GO:0032370,positive regulation of lipid transport,59/18493,0.006873545,0.016750396,0.005827358,3553/5444,"IL1B,PON1",0.026170628,2
BP,GO:0034113,heterotypic cell-cell adhesion,59/18493,0.006873545,0.016750396,0.005827358,3553/3586,"IL1B,IL10",0.033282351,2
BP,GO:0072678,T cell migration,59/18493,0.006873545,0.016750396,0.005827358,6347/3383,"CCL2,ICAM1",0.033483454,2
BP,GO:1902686,mitochondrial outer membrane permeabilization involved in programmed cell death,59/18493,0.006873545,0.016750396,0.005827358,7157/596,"TP53,BCL2",0.022660255,2
BP,GO:2000401,regulation of lymphocyte migration,59/18493,0.006873545,0.016750396,0.005827358,207/6347,"AKT1,CCL2",0.036803067,2
BP,GO:1902806,regulation of cell cycle G1/S phase transition,185/18493,0.006910054,0.01682421,0.005853038,6347/7157/596,"CCL2,TP53,BCL2",0.040262608,3
BP,GO:0001658,branching involved in ureteric bud morphogenesis,60/18493,0.007101148,0.017227448,0.005993322,7422/596,"VEGFA,BCL2",0.022666335,2
BP,GO:0016445,somatic diversification of immunoglobulins,60/18493,0.007101148,0.017227448,0.005993322,3586/959,"IL10,CD40LG",0.026402768,2
BP,GO:0060135,maternal process involved in female pregnancy,60/18493,0.007101148,0.017227448,0.005993322,207/5743,"AKT1,PTGS2",0.035406813,2
BP,GO:0060761,negative regulation of response to cytokine stimulus,60/18493,0.007101148,0.017227448,0.005993322,3569/5468,"IL6,PPARG",0.036980027,2
BP,GO:0045088,regulation of innate immune response,365/18493,0.007121869,0.017262236,0.006005424,3630/5468/3458/948,"INS,PPARG,IFNG,CD36",0.055497463,4
BP,GO:0010952,positive regulation of peptidase activity,189/18493,0.007328092,0.01769264,0.006155159,6774/5468/836,"STAT3,PPARG,CASP3",0.049590427,3
BP,GO:0071897,DNA biosynthetic process,189/18493,0.007328092,0.01769264,0.006155159,7157/5468/5594,"TP53,PPARG,MAPK1",0.048974004,3
BP,GO:0035794,positive regulation of mitochondrial membrane permeability,61/18493,0.007332144,0.01769264,0.006155159,7157/596,"TP53,BCL2",0.022356997,2
BP,GO:0048747,muscle fiber development,61/18493,0.007332144,0.01769264,0.006155159,7422/596,"VEGFA,BCL2",0.022517628,2
BP,GO:1900076,regulation of cellular response to insulin stimulus,61/18493,0.007332144,0.01769264,0.006155159,3630/3553,"INS,IL1B",0.037566243,2
BP,GO:1901991,negative regulation of mitotic cell cycle phase transition,191/18493,0.007542635,0.018184339,0.006326218,6347/7157/596,"CCL2,TP53,BCL2",0.039496357,3
BP,GO:0035773,insulin secretion involved in cellular response to glucose stimulus,62/18493,0.007566518,0.018193273,0.006329326,3156/1080,"HMGCR,CFTR",0.01194528,2
BP,GO:0045685,regulation of glial cell differentiation,62/18493,0.007566518,0.018193273,0.006329326,5468/2147,"PPARG,F2",0.026098136,2
BP,GO:0046530,photoreceptor cell differentiation,62/18493,0.007566518,0.018193273,0.006329326,6774/7422,"STAT3,VEGFA",0.035297663,2
BP,GO:0042692,muscle cell differentiation,373/18493,0.007677019,0.018442573,0.006416056,207/7422/836/596,"AKT1,VEGFA,CASP3,BCL2",0.056152853,4
BP,GO:0030278,regulation of ossification,193/18493,0.007760882,0.018627493,0.006480389,3569/5594/596,"IL6,MAPK1,BCL2",0.041187772,3
BP,GO:0010676,positive regulation of cellular carbohydrate metabolic process,63/18493,0.007804257,0.018648864,0.006487824,3630/207,"INS,AKT1",0.039025949,2
BP,GO:0046323,glucose import,63/18493,0.007804257,0.018648864,0.006487824,3630/207,"INS,AKT1",0.039025949,2
BP,GO:1902108,regulation of mitochondrial membrane permeability involved in apoptotic process,63/18493,0.007804257,0.018648864,0.006487824,7157/596,"TP53,BCL2",0.022065322,2
BP,GO:1904377,positive regulation of protein localization to cell periphery,63/18493,0.007804257,0.018648864,0.006487824,207/3458,"AKT1,IFNG",0.03288173,2
BP,GO:1905710,positive regulation of membrane permeability,63/18493,0.007804257,0.018648864,0.006487824,7157/596,"TP53,BCL2",0.022065322,2
BP,GO:0060541,respiratory system development,194/18493,0.007871398,0.018792703,0.006537864,7422/5594/4846,"VEGFA,MAPK1,NOS3",0.047434266,3
BP,GO:0031343,positive regulation of cell killing,64/18493,0.008045345,0.01914042,0.006658833,3458/4843,"IFNG,NOS2",0.025802302,2
BP,GO:0050795,regulation of behavior,64/18493,0.008045345,0.01914042,0.006658833,3630/6774,"INS,STAT3",0.038123427,2
BP,GO:0051785,positive regulation of nuclear division,64/18493,0.008045345,0.01914042,0.006658833,3630/3553,"INS,IL1B",0.036833898,2
BP,GO:0071242,cellular response to ammonium ion,64/18493,0.008045345,0.01914042,0.006658833,5594/836,"MAPK1,CASP3",0.030511272,2
BP,GO:0001763,morphogenesis of a branching structure,196/18493,0.008095228,0.019242173,0.006694232,7422/3586/596,"VEGFA,IL10,BCL2",0.037629483,3
BP,GO:0014823,response to activity,65/18493,0.008289768,0.019635571,0.006831093,3586/847,"IL10,CAT",0.029142423,2
BP,GO:0033627,cell adhesion mediated by integrin,65/18493,0.008289768,0.019635571,0.006831093,3383/5054,"ICAM1,SERPINE1",0.029271754,2
BP,GO:0046888,negative regulation of hormone secretion,65/18493,0.008289768,0.019635571,0.006831093,3553/3156,"IL1B,HMGCR",0.023274236,2
BP,GO:0060675,ureteric bud morphogenesis,65/18493,0.008289768,0.019635571,0.006831093,7422/596,"VEGFA,BCL2",0.021936108,2
BP,GO:0097164,ammonium ion metabolic process,199/18493,0.008437992,0.019969175,0.006947152,5444/7941/1071,"PON1,PLA2G7,CETP",0.020983945,3
BP,GO:0002709,regulation of T cell mediated immunity,66/18493,0.008537512,0.020134236,0.007004575,3569/3553,"IL6,IL1B",0.036425255,2
BP,GO:0032387,negative regulation of intracellular transport,66/18493,0.008537512,0.020134236,0.007004575,3162/948,"HMOX1,CD36",0.0177867,2
BP,GO:0050918,positive chemotaxis,66/18493,0.008537512,0.020134236,0.007004575,7422/3576,"VEGFA,CXCL8",0.033206963,2
BP,GO:0072171,mesonephric tubule morphogenesis,66/18493,0.008537512,0.020134236,0.007004575,7422/596,"VEGFA,BCL2",0.02179614,2
BP,GO:0045454,cell redox homeostasis,67/18493,0.008788562,0.02070824,0.007204267,4846/4843,"NOS3,NOS2",0.025900004,2
BP,GO:0046434,organophosphate catabolic process,203/18493,0.008908184,0.020971834,0.00729597,3630/6774/5444,"INS,STAT3,PON1",0.045762931,3
BP,GO:0045787,positive regulation of cell cycle,390/18493,0.008950255,0.021052556,0.007324053,3630/7157/3553/3586,"INS,TP53,IL1B,IL10",0.067576627,4
BP,GO:0017157,regulation of exocytosis,204/18493,0.009028096,0.02110531,0.007342406,3458/3162/1080,"IFNG,HMOX1,CFTR",0.032304052,3
BP,GO:0006625,protein targeting to peroxisome,68/18493,0.009042904,0.02110531,0.007342406,847/4843,"CAT,NOS2",0.024770995,2
BP,GO:0033692,cellular polysaccharide biosynthetic process,68/18493,0.009042904,0.02110531,0.007342406,3630/207,"INS,AKT1",0.03781322,2
BP,GO:0042698,ovulation cycle,68/18493,0.009042904,0.02110531,0.007342406,836/4846,"CASP3,NOS3",0.029041788,2
BP,GO:0050805,negative regulation of synaptic transmission,68/18493,0.009042904,0.02110531,0.007342406,3553/5743,"IL1B,PTGS2",0.031747622,2
BP,GO:0051453,regulation of intracellular pH,68/18493,0.009042904,0.02110531,0.007342406,596/1080,"BCL2,CFTR",0.009828104,2
BP,GO:0051881,regulation of mitochondrial membrane potential,68/18493,0.009042904,0.02110531,0.007342406,207/596,"AKT1,BCL2",0.02306149,2
BP,GO:0072662,protein localization to peroxisome,68/18493,0.009042904,0.02110531,0.007342406,847/4843,"CAT,NOS2",0.024770995,2
BP,GO:0072663,establishment of protein localization to peroxisome,68/18493,0.009042904,0.02110531,0.007342406,847/4843,"CAT,NOS2",0.024770995,2
BP,GO:0002200,somatic diversification of immune receptors,69/18493,0.009300524,0.021631914,0.007525608,3586/959,"IL10,CD40LG",0.024922681,2
BP,GO:0040014,regulation of multicellular organism growth,69/18493,0.009300524,0.021631914,0.007525608,6774/596,"STAT3,BCL2",0.022286674,2
BP,GO:0042440,pigment metabolic process,69/18493,0.009300524,0.021631914,0.007525608,3162/596,"HMOX1,BCL2",0.018545051,2
BP,GO:0043574,peroxisomal transport,69/18493,0.009300524,0.021631914,0.007525608,847/4843,"CAT,NOS2",0.024612766,2
BP,GO:0032945,negative regulation of mononuclear cell proliferation,70/18493,0.009561407,0.02218148,0.007716799,3586/836,"IL10,CASP3",0.029479351,2
BP,GO:0050672,negative regulation of lymphocyte proliferation,70/18493,0.009561407,0.02218148,0.007716799,3586/836,"IL10,CASP3",0.029479351,2
BP,GO:1903747,regulation of establishment of protein localization to mitochondrion,70/18493,0.009561407,0.02218148,0.007716799,7157/596,"TP53,BCL2",0.021104057,2
BP,GO:0048762,mesenchymal cell differentiation,210/18493,0.00976755,0.022640293,0.007876417,3553/5594/596,"IL1B,MAPK1,BCL2",0.035621274,3
BP,GO:0034381,plasma lipoprotein particle clearance,71/18493,0.00982554,0.022716312,0.007902863,3162/948,"HMOX1,CD36",0.017237151,2
BP,GO:0061180,mammary gland epithelium development,71/18493,0.00982554,0.022716312,0.007902863,207/5594,"AKT1,MAPK1",0.032551257,2
BP,GO:0061844,antimicrobial humoral immune response mediated by antimicrobial peptide,71/18493,0.00982554,0.022716312,0.007902863,3576/2147,"CXCL8,F2",0.025563166,2
BP,GO:1901988,negative regulation of cell cycle phase transition,211/18493,0.009894137,0.022855372,0.007951241,6347/7157/596,"CCL2,TP53,BCL2",0.037242942,3
BP,GO:0006417,regulation of translation,402/18493,0.009927948,0.022913907,0.007971605,3569/207/6774/5594,"IL6,AKT1,STAT3,MAPK1",0.0689267,4
BP,GO:0016064,immunoglobulin mediated immune response,212/18493,0.010021684,0.023090848,0.008033162,1401/3586/959,"CRP,IL10,CD40LG",0.040432023,3
BP,GO:0045732,positive regulation of protein catabolic process,212/18493,0.010021684,0.023090848,0.008033162,207/3553/3458,"AKT1,IL1B,IFNG",0.046925797,3
BP,GO:0002312,B cell activation involved in immune response,72/18493,0.010092908,0.023235162,0.008083368,3586/959,"IL10,CD40LG",0.024457869,2
BP,GO:0007254,JNK cascade,213/18493,0.010150192,0.023327332,0.008115433,207/3553/959,"AKT1,IL1B,CD40LG",0.042982325,3
BP,GO:0019724,B cell mediated immunity,213/18493,0.010150192,0.023327332,0.008115433,1401/3586/959,"CRP,IL10,CD40LG",0.040322696,3
BP,GO:0001649,osteoblast differentiation,214/18493,0.010279663,0.023604828,0.008211973,3569/207/847,"IL6,AKT1,CAT",0.049779193,3
BP,GO:0005977,glycogen metabolic process,73/18493,0.010363497,0.02377715,0.008271922,3630/207,"INS,AKT1",0.036644978,2
BP,GO:0001933,negative regulation of protein phosphorylation,408/18493,0.010441953,0.023936851,0.008327481,207/3553/836/3156,"AKT1,IL1B,CASP3,HMGCR",0.053756645,4
BP,GO:0000271,polysaccharide biosynthetic process,74/18493,0.010637293,0.024220437,0.008426139,3630/207,"INS,AKT1",0.036463943,2
BP,GO:0006073,cellular glucan metabolic process,74/18493,0.010637293,0.024220437,0.008426139,3630/207,"INS,AKT1",0.036463943,2
BP,GO:0006096,glycolytic process,74/18493,0.010637293,0.024220437,0.008426139,3630/6774,"INS,STAT3",0.035854937,2
BP,GO:0007492,endoderm development,74/18493,0.010637293,0.024220437,0.008426139,4318/4313,"MMP9,MMP2",0.02799019,2
BP,GO:0015914,phospholipid transport,74/18493,0.010637293,0.024220437,0.008426139,5243/1071,"ABCB1,CETP",0.011631216,2
BP,GO:0044042,glucan metabolic process,74/18493,0.010637293,0.024220437,0.008426139,3630/207,"INS,AKT1",0.036463943,2
BP,GO:0072078,nephron tubule morphogenesis,74/18493,0.010637293,0.024220437,0.008426139,7422/596,"VEGFA,BCL2",0.020764887,2
BP,GO:1903578,regulation of ATP metabolic process,74/18493,0.010637293,0.024220437,0.008426139,3630/6774,"INS,STAT3",0.035854937,2
BP,GO:0009108,coenzyme biosynthetic process,217/18493,0.010673865,0.024283266,0.008447997,3630/6774/5743,"INS,STAT3,PTGS2",0.050826335,3
BP,GO:0072331,signal transduction by p53 class mediator,218/18493,0.0108072,0.024565945,0.008546339,207/7157/596,"AKT1,TP53,BCL2",0.037901684,3
BP,GO:0001937,negative regulation of endothelial cell proliferation,75/18493,0.010914283,0.024726244,0.008602106,6347/5468,"CCL2,PPARG",0.030667037,2
BP,GO:0006695,cholesterol biosynthetic process,75/18493,0.010914283,0.024726244,0.008602106,3156/1080,"HMGCR,CFTR",0.01103057,2
BP,GO:0006757,ATP generation from ADP,75/18493,0.010914283,0.024726244,0.008602106,3630/6774,"INS,STAT3",0.035655756,2
BP,GO:0070664,negative regulation of leukocyte proliferation,75/18493,0.010914283,0.024726244,0.008602106,3586/836,"IL10,CASP3",0.028638684,2
BP,GO:0001910,regulation of leukocyte mediated cytotoxicity,76/18493,0.011194451,0.025234159,0.008778807,3383/4843,"ICAM1,NOS2",0.025103437,2
BP,GO:0043407,negative regulation of MAP kinase activity,76/18493,0.011194451,0.025234159,0.008778807,3553/3156,"IL1B,HMGCR",0.021788774,2
BP,GO:0072088,nephron epithelium morphogenesis,76/18493,0.011194451,0.025234159,0.008778807,7422/596,"VEGFA,BCL2",0.020536051,2
BP,GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator,76/18493,0.011194451,0.025234159,0.008778807,7157/596,"TP53,BCL2",0.020389556,2
BP,GO:1902653,secondary alcohol biosynthetic process,76/18493,0.011194451,0.025234159,0.008778807,3156/1080,"HMGCR,CFTR",0.01096995,2
BP,GO:1903557,positive regulation of tumor necrosis factor superfamily cytokine production,76/18493,0.011194451,0.025234159,0.008778807,3458/948,"IFNG,CD36",0.016861122,2
BP,GO:0031016,pancreas development,77/18493,0.011477785,0.025829791,0.008986023,3569/207,"IL6,AKT1",0.035892125,2
BP,GO:0060291,long-term synaptic potentiation,77/18493,0.011477785,0.025829791,0.008986023,3630/5594,"INS,MAPK1",0.033023186,2
BP,GO:0009064,glutamine family amino acid metabolic process,78/18493,0.01176427,0.026343006,0.009164567,4846/4843,"NOS3,NOS2",0.024292312,2
BP,GO:0034644,cellular response to UV,78/18493,0.01176427,0.026343006,0.009164567,7157/5743,"TP53,PTGS2",0.030118988,2
BP,GO:0042866,pyruvate biosynthetic process,78/18493,0.01176427,0.026343006,0.009164567,3630/6774,"INS,STAT3",0.035045372,2
BP,GO:0051289,protein homotetramerization,78/18493,0.01176427,0.026343006,0.009164567,7157/847,"TP53,CAT",0.028072887,2
BP,GO:0061333,renal tubule morphogenesis,78/18493,0.01176427,0.026343006,0.009164567,7422/596,"VEGFA,BCL2",0.02029604,2
BP,GO:0072028,nephron morphogenesis,78/18493,0.01176427,0.026343006,0.009164567,7422/596,"VEGFA,BCL2",0.02029604,2
BP,GO:0046777,protein autophosphorylation,227/18493,0.012050996,0.026902459,0.009359198,3630/207/7422,"INS,AKT1,VEGFA",0.050940336,3
BP,GO:0007045,cell-substrate adherens junction assembly,79/18493,0.012053893,0.026902459,0.009359198,7422/596,"VEGFA,BCL2",0.020178753,2
BP,GO:0046470,phosphatidylcholine metabolic process,79/18493,0.012053893,0.026902459,0.009359198,5444/1071,"PON1,CETP",0.013583201,2
BP,GO:0048041,focal adhesion assembly,79/18493,0.012053893,0.026902459,0.009359198,7422/596,"VEGFA,BCL2",0.020178753,2
BP,GO:0051607,defense response to virus,228/18493,0.012194083,0.027192906,0.009460243,3569/3458/596,"IL6,IFNG,BCL2",0.036038725,3
BP,GO:0045913,positive regulation of carbohydrate metabolic process,80/18493,0.012346639,0.027487785,0.009562829,3630/207,"INS,AKT1",0.035223718,2
BP,GO:0048013,ephrin receptor signaling pathway,80/18493,0.012346639,0.027487785,0.009562829,4318/4313,"MMP9,MMP2",0.027038177,2
BP,GO:0044282,small molecule catabolic process,431/18493,0.012572204,0.027966951,0.009729528,207/4846/4843/5444,"AKT1,NOS3,NOS2,PON1",0.048534201,4
BP,GO:0007031,peroxisome organization,81/18493,0.012642495,0.028054102,0.009759847,847/4843,"CAT,NOS2",0.022943712,2
BP,GO:0016126,sterol biosynthetic process,81/18493,0.012642495,0.028054102,0.009759847,3156/1080,"HMGCR,CFTR",0.01065412,2
BP,GO:0032088,negative regulation of NF-kappaB transcription factor activity,81/18493,0.012642495,0.028054102,0.009759847,3586/847,"IL10,CAT",0.026496954,2
BP,GO:0014031,mesenchymal cell development,82/18493,0.012941448,0.028693948,0.009982446,5594/596,"MAPK1,BCL2",0.018496083,2
BP,GO:0014910,regulation of smooth muscle cell migration,83/18493,0.013243483,0.029267664,0.010182038,5054/596,"SERPINE1,BCL2",0.017186904,2
BP,GO:0034637,cellular carbohydrate biosynthetic process,83/18493,0.013243483,0.029267664,0.010182038,3630/207,"INS,AKT1",0.034608809,2
BP,GO:0042058,regulation of epidermal growth factor receptor signaling pathway,83/18493,0.013243483,0.029267664,0.010182038,207/4318,"AKT1,MMP9",0.031003547,2
BP,GO:0045921,positive regulation of exocytosis,83/18493,0.013243483,0.029267664,0.010182038,3458/1080,"IFNG,CFTR",0.017048074,2
BP,GO:0042446,hormone biosynthetic process,84/18493,0.013548587,0.029868727,0.010391144,3553/3458,"IL1B,IFNG",0.027272991,2
BP,GO:0046031,ADP metabolic process,84/18493,0.013548587,0.029868727,0.010391144,3630/6774,"INS,STAT3",0.033834879,2
BP,GO:0050886,endocrine process,84/18493,0.013548587,0.029868727,0.010391144,3553/4846,"IL1B,NOS3",0.027826457,2
BP,GO:0032412,regulation of ion transmembrane transporter activity,238/18493,0.013679125,0.030131948,0.010482717,4318/5243/1080,"MMP9,ABCB1,CFTR",0.024248232,3
BP,GO:0002028,regulation of sodium ion transport,85/18493,0.013856746,0.030498371,0.010610193,207/4846,"AKT1,NOS3",0.029370066,2
BP,GO:0006839,mitochondrial transport,241/18493,0.014143936,0.031079893,0.010812501,6774/7157/596,"STAT3,TP53,BCL2",0.034928335,3
BP,GO:0007050,cell cycle arrest,241/18493,0.014143936,0.031079893,0.010812501,7157/3576/3458,"TP53,CXCL8,IFNG",0.041779639,3
BP,GO:0045844,positive regulation of striated muscle tissue development,86/18493,0.014167947,0.031082155,0.010813288,3156/596,"HMGCR,BCL2",0.010479373,2
BP,GO:0048636,positive regulation of muscle organ development,86/18493,0.014167947,0.031082155,0.010813288,3156/596,"HMGCR,BCL2",0.010479373,2
BP,GO:0006112,energy reserve metabolic process,87/18493,0.014482177,0.031617666,0.010999589,3630/207,"INS,AKT1",0.033851877,2
BP,GO:0031058,positive regulation of histone modification,87/18493,0.014482177,0.031617666,0.010999589,7422/3553,"VEGFA,IL1B",0.029302965,2
BP,GO:0032612,interleukin-1 production,87/18493,0.014482177,0.031617666,0.010999589,3586/948,"IL10,CD36",0.017108561,2
BP,GO:0070098,chemokine-mediated signaling pathway,87/18493,0.014482177,0.031617666,0.010999589,6347/3576,"CCL2,CXCL8",0.029460918,2
BP,GO:1901863,positive regulation of muscle tissue development,87/18493,0.014482177,0.031617666,0.010999589,3156/596,"HMGCR,BCL2",0.010427802,2
BP,GO:2000106,regulation of leukocyte apoptotic process,87/18493,0.014482177,0.031617666,0.010999589,7157/3586,"TP53,IL10",0.028297451,2
BP,GO:0072659,protein localization to plasma membrane,244/18493,0.014617701,0.031887807,0.011093569,3630/207/3458,"INS,AKT1,IFNG",0.046079157,3
BP,GO:0006919,activation of cysteine-type endopeptidase activity involved in apoptotic process,88/18493,0.014799421,0.032232233,0.011213393,5468/836,"PPARG,CASP3",0.026689114,2
BP,GO:0034333,adherens junction assembly,88/18493,0.014799421,0.032232233,0.011213393,7422/596,"VEGFA,BCL2",0.019169969,2
BP,GO:0034248,regulation of cellular amide metabolic process,453/18493,0.014854939,0.03232712,0.011246404,3569/207/6774/5594,"IL6,AKT1,STAT3,MAPK1",0.062644413,4
BP,GO:0009791,post-embryonic development,89/18493,0.015119666,0.032876767,0.011437622,7422/596,"VEGFA,BCL2",0.019059467,2
BP,GO:0003012,muscle system process,456/18493,0.01518531,0.032992982,0.011478053,3553/5743/4846/3162,"IL1B,PTGS2,NOS3,HMOX1",0.052891761,4
BP,GO:0009308,amine metabolic process,90/18493,0.0154429,0.033418436,0.011626065,3630/7412,"INS,VCAM1",0.030322199,2
BP,GO:0014909,smooth muscle cell migration,90/18493,0.0154429,0.033418436,0.011626065,5054/596,"SERPINE1,BCL2",0.016541413,2
BP,GO:0045069,regulation of viral genome replication,90/18493,0.0154429,0.033418436,0.011626065,3576/596,"CXCL8,BCL2",0.018715869,2
BP,GO:0048145,regulation of fibroblast proliferation,90/18493,0.0154429,0.033418436,0.011626065,7157/5468,"TP53,PPARG",0.027945,2
BP,GO:1901184,regulation of ERBB signaling pathway,90/18493,0.0154429,0.033418436,0.011626065,207/4318,"AKT1,MMP9",0.029839143,2
BP,GO:0045639,positive regulation of myeloid cell differentiation,91/18493,0.015769108,0.034042648,0.011843225,6774/3458,"STAT3,IFNG",0.027358751,2
BP,GO:0048010,vascular endothelial growth factor receptor signaling pathway,91/18493,0.015769108,0.034042648,0.011843225,7422/3553,"VEGFA,IL1B",0.028676037,2
BP,GO:0048144,fibroblast proliferation,91/18493,0.015769108,0.034042648,0.011843225,7157/5468,"TP53,PPARG",0.027792833,2
BP,GO:0006165,nucleoside diphosphate phosphorylation,92/18493,0.016098278,0.034670256,0.012061566,3630/6774,"INS,STAT3",0.032398294,2
BP,GO:0042632,cholesterol homeostasis,92/18493,0.016098278,0.034670256,0.012061566,4023/1071,"LPL,CETP",0.013696901,2
BP,GO:0043255,regulation of carbohydrate biosynthetic process,92/18493,0.016098278,0.034670256,0.012061566,3630/207,"INS,AKT1",0.032948588,2
BP,GO:0055092,sterol homeostasis,93/18493,0.016430396,0.035276173,0.012272361,4023/1071,"LPL,CETP",0.013626313,2
BP,GO:0072080,nephron tubule development,93/18493,0.016430396,0.035276173,0.012272361,7422/596,"VEGFA,BCL2",0.018666325,2
BP,GO:0090277,positive regulation of peptide hormone secretion,93/18493,0.016430396,0.035276173,0.012272361,3630/1080,"INS,CFTR",0.021307287,2
BP,GO:0007281,germ cell development,255/18493,0.016431785,0.035276173,0.012272361,207/596/1080,"AKT1,BCL2,CFTR",0.024187858,3
BP,GO:0046939,nucleotide phosphorylation,94/18493,0.016765448,0.035878589,0.012481938,3630/6774,"INS,STAT3",0.032068145,2
BP,GO:0060993,kidney morphogenesis,94/18493,0.016765448,0.035878589,0.012481938,7422/596,"VEGFA,BCL2",0.01857182,2
BP,GO:0070301,cellular response to hydrogen peroxide,94/18493,0.016765448,0.035878589,0.012481938,3569/3586,"IL6,IL10",0.030200611,2
BP,GO:1905269,positive regulation of chromatin organization,94/18493,0.016765448,0.035878589,0.012481938,7422/3553,"VEGFA,IL1B",0.028230418,2
BP,GO:0007044,cell-substrate junction assembly,95/18493,0.017103422,0.036428943,0.012673402,7422/596,"VEGFA,BCL2",0.018486859,2
BP,GO:0032649,regulation of interferon-gamma production,95/18493,0.017103422,0.036428943,0.012673402,3553/3586,"IL1B,IL10",0.026958962,2
BP,GO:0061326,renal tubule development,95/18493,0.017103422,0.036428943,0.012673402,7422/596,"VEGFA,BCL2",0.018486859,2
BP,GO:0097327,response to antineoplastic agent,95/18493,0.017103422,0.036428943,0.012673402,3383/3162,"ICAM1,HMOX1",0.024571206,2
BP,GO:1990868,response to chemokine,95/18493,0.017103422,0.036428943,0.012673402,6347/3576,"CCL2,CXCL8",0.028252748,2
BP,GO:1990869,cellular response to chemokine,95/18493,0.017103422,0.036428943,0.012673402,6347/3576,"CCL2,CXCL8",0.028252748,2
BP,GO:0006644,phospholipid metabolic process,473/18493,0.017145837,0.036490549,0.012694834,4023/5444/7941/1071,"LPL,PON1,PLA2G7,CETP",0.026100941,4
BP,GO:0022604,regulation of cell morphogenesis,474/18493,0.01726589,0.036717165,0.012773673,6347/7422/3383/2147,"CCL2,VEGFA,ICAM1,F2",0.049622702,4
BP,GO:0009135,purine nucleoside diphosphate metabolic process,96/18493,0.017444305,0.036951328,0.012855136,3630/6774,"INS,STAT3",0.031784231,2
BP,GO:0009179,purine ribonucleoside diphosphate metabolic process,96/18493,0.017444305,0.036951328,0.012855136,3630/6774,"INS,STAT3",0.031784231,2
BP,GO:0032414,positive regulation of ion transmembrane transporter activity,96/18493,0.017444305,0.036951328,0.012855136,5243/1080,"ABCB1,CFTR",0.009329759,2
BP,GO:0048259,regulation of receptor-mediated endocytosis,96/18493,0.017444305,0.036951328,0.012855136,7422/5054,"VEGFA,SERPINE1",0.025933967,2
BP,GO:0120162,positive regulation of cold-induced thermogenesis,96/18493,0.017444305,0.036951328,0.012855136,7422/948,"VEGFA,CD36",0.017473829,2
BP,GO:0042752,regulation of circadian rhythm,97/18493,0.017788083,0.037650051,0.013098218,7157/5468,"TP53,PPARG",0.026964672,2
BP,GO:0000082,G1/S transition of mitotic cell cycle,263/18493,0.017827459,0.03770389,0.013116948,6347/7157/596,"CCL2,TP53,BCL2",0.032309073,3
BP,GO:0009185,ribonucleoside diphosphate metabolic process,98/18493,0.018134744,0.038293897,0.013322208,3630/6774,"INS,STAT3",0.031440297,2
BP,GO:0019395,fatty acid oxidation,98/18493,0.018134744,0.038293897,0.013322208,207/5468,"AKT1,PPARG",0.028247397,2
BP,GO:0008593,regulation of Notch signaling pathway,99/18493,0.018484274,0.038971131,0.013557813,207/6774,"AKT1,STAT3",0.029872053,2
BP,GO:0044264,cellular polysaccharide metabolic process,99/18493,0.018484274,0.038971131,0.013557813,3630/207,"INS,AKT1",0.031802508,2
BP,GO:0098656,anion transmembrane transport,268/18493,0.018732552,0.039463827,0.013729219,207/5243/1080,"AKT1,ABCB1,CFTR",0.024286421,3
BP,GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,100/18493,0.01883666,0.03959065,0.01377334,3569/3553,"IL6,IL1B",0.030118569,2
BP,GO:0010522,regulation of calcium ion transport into cytosol,100/18493,0.01883666,0.03959065,0.01377334,2147/596,"F2,BCL2",0.012375886,2
BP,GO:1901606,alpha-amino acid catabolic process,100/18493,0.01883666,0.03959065,0.01377334,4846/4843,"NOS3,NOS2",0.02157093,2
BP,GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,270/18493,0.019101671,0.040116474,0.013956271,3586/3383/7412,"IL10,ICAM1,VCAM1",0.037377922,3
BP,GO:0006476,protein deacetylation,101/18493,0.01919189,0.040212287,0.013989604,7422/3458,"VEGFA,IFNG",0.025263759,2
BP,GO:0007631,feeding behavior,101/18493,0.01919189,0.040212287,0.013989604,3630/6774,"INS,STAT3",0.030969222,2
BP,GO:0034766,negative regulation of ion transmembrane transport,101/18493,0.01919189,0.040212287,0.013989604,207/4318,"AKT1,MMP9",0.028214327,2
BP,GO:0001822,kidney development,271/18493,0.019287749,0.040381857,0.014048596,7422/847/596,"VEGFA,CAT,BCL2",0.029051121,3
BP,GO:0061564,axon development,493/18493,0.019648391,0.041105103,0.014300209,7422/5594/836/596,"VEGFA,MAPK1,CASP3,BCL2",0.042429022,4
BP,GO:0014812,muscle cell migration,103/18493,0.019910828,0.041557709,0.014457668,5054/596,"SERPINE1,BCL2",0.015480515,2
BP,GO:0015748,organophosphate ester transport,103/18493,0.019910828,0.041557709,0.014457668,5243/1071,"ABCB1,CETP",0.009943423,2
BP,GO:0032091,negative regulation of protein binding,103/18493,0.019910828,0.041557709,0.014457668,207/3586,"AKT1,IL10",0.027444364,2
BP,GO:0045185,maintenance of protein location,104/18493,0.020274511,0.042284158,0.014710395,207/3586,"AKT1,IL10",0.027294837,2
BP,GO:0044262,cellular carbohydrate metabolic process,278/18493,0.020618681,0.042306285,0.014718093,3630/207/6774,"INS,AKT1,STAT3",0.045296939,3
BP,GO:0002708,positive regulation of lymphocyte mediated immunity,105/18493,0.020640986,0.042306285,0.014718093,3569/3553,"IL6,IL1B",0.029499787,2
BP,GO:0002821,positive regulation of adaptive immune response,105/18493,0.020640986,0.042306285,0.014718093,3569/3553,"IL6,IL1B",0.029499787,2
BP,GO:0016236,macroautophagy,279/18493,0.020812873,0.042306285,0.014718093,207/836/3162,"AKT1,CASP3,HMOX1",0.038037312,3
BP,GO:0051188,cofactor biosynthetic process,279/18493,0.020812873,0.042306285,0.014718093,3630/6774/5743,"INS,STAT3,PTGS2",0.043237203,3
BP,GO:0002887,negative regulation of myeloid leukocyte mediated immunity,10/18493,0.020895082,0.042306285,0.014718093,3162,HMOX1,0.01121226,1
BP,GO:0010918,positive regulation of mitochondrial membrane potential,10/18493,0.020895082,0.042306285,0.014718093,207,AKT1,0.014816919,1
BP,GO:0014041,regulation of neuron maturation,10/18493,0.020895082,0.042306285,0.014718093,596,BCL2,0.004087947,1
BP,GO:0019062,virion attachment to host cell,10/18493,0.020895082,0.042306285,0.014718093,3383,ICAM1,0.012249426,1
BP,GO:0021548,pons development,10/18493,0.020895082,0.042306285,0.014718093,596,BCL2,0.004087947,1
BP,GO:0030388,"fructose 1,6-bisphosphate metabolic process",10/18493,0.020895082,0.042306285,0.014718093,3458,IFNG,0.01130055,1
BP,GO:0032025,response to cobalt ion,10/18493,0.020895082,0.042306285,0.014718093,836,CASP3,0.012008132,1
BP,GO:0032070,regulation of deoxyribonuclease activity,10/18493,0.020895082,0.042306285,0.014718093,207,AKT1,0.014816919,1
BP,GO:0032306,regulation of prostaglandin secretion,10/18493,0.020895082,0.042306285,0.014718093,3553,IL1B,0.013268218,1
BP,GO:0032308,positive regulation of prostaglandin secretion,10/18493,0.020895082,0.042306285,0.014718093,3553,IL1B,0.013268218,1
BP,GO:0032621,interleukin-18 production,10/18493,0.020895082,0.042306285,0.014718093,3586,IL10,0.012473404,1
BP,GO:0033860,regulation of NAD(P)H oxidase activity,10/18493,0.020895082,0.042306285,0.014718093,3630,INS,0.016180812,1
BP,GO:0044539,long-chain fatty acid import,10/18493,0.020895082,0.042306285,0.014718093,948,CD36,0.003192687,1
BP,GO:0045713,low-density lipoprotein particle receptor biosynthetic process,10/18493,0.020895082,0.042306285,0.014718093,5468,PPARG,0.01256772,1
BP,GO:0045792,negative regulation of cell size,10/18493,0.020895082,0.042306285,0.014718093,207,AKT1,0.014816919,1
BP,GO:0055091,phospholipid homeostasis,10/18493,0.020895082,0.042306285,0.014718093,1071,CETP,0.004909414,1
BP,GO:0060352,cell adhesion molecule production,10/18493,0.020895082,0.042306285,0.014718093,3553,IL1B,0.013268218,1
BP,GO:0070091,glucagon secretion,10/18493,0.020895082,0.042306285,0.014718093,3569,IL6,0.016231569,1
BP,GO:0070391,response to lipoteichoic acid,10/18493,0.020895082,0.042306285,0.014718093,948,CD36,0.003192687,1
BP,GO:0070942,neutrophil mediated cytotoxicity,10/18493,0.020895082,0.042306285,0.014718093,2147,F2,0.008033679,1
BP,GO:0071104,response to interleukin-9,10/18493,0.020895082,0.042306285,0.014718093,6774,STAT3,0.014299208,1
BP,GO:0071223,cellular response to lipoteichoic acid,10/18493,0.020895082,0.042306285,0.014718093,948,CD36,0.003192687,1
BP,GO:0071609,chemokine (C-C motif) ligand 5 production,10/18493,0.020895082,0.042306285,0.014718093,3586,IL10,0.012473404,1
BP,GO:0072584,caveolin-mediated endocytosis,10/18493,0.020895082,0.042306285,0.014718093,5594,MAPK1,0.012385902,1
BP,GO:0090557,establishment of endothelial intestinal barrier,10/18493,0.020895082,0.042306285,0.014718093,3383,ICAM1,0.012249426,1
BP,GO:0090594,inflammatory response to wounding,10/18493,0.020895082,0.042306285,0.014718093,3162,HMOX1,0.01121226,1
BP,GO:0097050,type B pancreatic cell apoptotic process,10/18493,0.020895082,0.042306285,0.014718093,3569,IL6,0.016231569,1
BP,GO:0150065,regulation of deacetylase activity,10/18493,0.020895082,0.042306285,0.014718093,7422,VEGFA,0.013564133,1
BP,GO:1900122,positive regulation of receptor binding,10/18493,0.020895082,0.042306285,0.014718093,4318,MMP9,0.012951723,1
BP,GO:1904321,response to forskolin,10/18493,0.020895082,0.042306285,0.014718093,1080,CFTR,0.003968731,1
BP,GO:1904322,cellular response to forskolin,10/18493,0.020895082,0.042306285,0.014718093,1080,CFTR,0.003968731,1
BP,GO:1904996,positive regulation of leukocyte adhesion to vascular endothelial cell,10/18493,0.020895082,0.042306285,0.014718093,3383,ICAM1,0.012249426,1
BP,GO:1990535,neuron projection maintenance,10/18493,0.020895082,0.042306285,0.014718093,3630,INS,0.016180812,1
BP,GO:2000551,regulation of T-helper 2 cell cytokine production,10/18493,0.020895082,0.042306285,0.014718093,3569,IL6,0.016231569,1
BP,GO:0032609,interferon-gamma production,106/18493,0.02101024,0.042475859,0.014777086,3553/3586,"IL1B,IL10",0.025709064,2
BP,GO:0050868,negative regulation of T cell activation,106/18493,0.02101024,0.042475859,0.014777086,3586/836,"IL10,CASP3",0.024450573,2
BP,GO:0006821,chloride transport,107/18493,0.021382261,0.04319568,0.015027508,5243/1080,"ABCB1,CFTR",0.008888076,2
BP,GO:0044843,cell cycle G1/S phase transition,282/18493,0.021401543,0.043202369,0.015029835,6347/7157/596,"CCL2,TP53,BCL2",0.030967306,3
BP,GO:0006690,icosanoid metabolic process,108/18493,0.021757035,0.043887234,0.015268095,5743/5444,"PTGS2,PON1",0.019501292,2
BP,GO:0005976,polysaccharide metabolic process,109/18493,0.022134551,0.044582249,0.015509886,3630/207,"INS,AKT1",0.030484175,2
BP,GO:0072009,nephron epithelium development,109/18493,0.022134551,0.044582249,0.015509886,7422/596,"VEGFA,BCL2",0.017359628,2
BP,GO:0072001,renal system development,286/18493,0.022200664,0.044648919,0.01553308,7422/847/596,"VEGFA,CAT,BCL2",0.028141857,3
BP,GO:0090068,positive regulation of cell cycle process,286/18493,0.022200664,0.044648919,0.01553308,3630/7157/3553,"INS,TP53,IL1B",0.042156442,3
BP,GO:0010508,positive regulation of autophagy,110/18493,0.022514796,0.044974375,0.015646305,3458/3162,"IFNG,HMOX1",0.022077495,2
BP,GO:1903510,mucopolysaccharide metabolic process,110/18493,0.022514796,0.044974375,0.015646305,207/3553,"AKT1,IL1B",0.027542075,2
BP,GO:0010906,regulation of glucose metabolic process,111/18493,0.022897756,0.044974375,0.015646305,3630/207,"INS,AKT1",0.03039835,2
BP,GO:0035601,protein deacylation,111/18493,0.022897756,0.044974375,0.015646305,7422/3458,"VEGFA,IFNG",0.024383891,2
BP,GO:0045446,endothelial cell differentiation,111/18493,0.022897756,0.044974375,0.015646305,3553/3383,"IL1B,ICAM1",0.025024227,2
BP,GO:0002862,negative regulation of inflammatory response to antigenic stimulus,11/18493,0.02296104,0.044974375,0.015646305,3586,IL10,0.012232214,1
BP,GO:0010623,programmed cell death involved in cell development,11/18493,0.02296104,0.044974375,0.015646305,596,BCL2,0.004008901,1
BP,GO:0019371,cyclooxygenase pathway,11/18493,0.02296104,0.044974375,0.015646305,5743,PTGS2,0.012510507,1
BP,GO:0032494,response to peptidoglycan,11/18493,0.02296104,0.044974375,0.015646305,3569,IL6,0.015917711,1
BP,GO:0033629,negative regulation of cell adhesion mediated by integrin,11/18493,0.02296104,0.044974375,0.015646305,5054,SERPINE1,0.011087069,1
BP,GO:0034115,negative regulation of heterotypic cell-cell adhesion,11/18493,0.02296104,0.044974375,0.015646305,3586,IL10,0.012232214,1
BP,GO:0035627,ceramide transport,11/18493,0.02296104,0.044974375,0.015646305,5243,ABCB1,0.004881938,1
BP,GO:0035747,natural killer cell chemotaxis,11/18493,0.02296104,0.044974375,0.015646305,6347,CCL2,0.013383839,1
BP,GO:0043129,surfactant homeostasis,11/18493,0.02296104,0.044974375,0.015646305,7422,VEGFA,0.013301852,1
BP,GO:0043301,negative regulation of leukocyte degranulation,11/18493,0.02296104,0.044974375,0.015646305,3162,HMOX1,0.010995456,1
BP,GO:0043619,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,11/18493,0.02296104,0.044974375,0.015646305,3162,HMOX1,0.010995456,1
BP,GO:0045346,regulation of MHC class II biosynthetic process,11/18493,0.02296104,0.044974375,0.015646305,3586,IL10,0.012232214,1
BP,GO:0045351,type I interferon biosynthetic process,11/18493,0.02296104,0.044974375,0.015646305,3586,IL10,0.012232214,1
BP,GO:0045899,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,11/18493,0.02296104,0.044974375,0.015646305,7157,TP53,0.013178365,1
BP,GO:0046007,negative regulation of activated T cell proliferation,11/18493,0.02296104,0.044974375,0.015646305,836,CASP3,0.01177594,1
BP,GO:0048712,negative regulation of astrocyte differentiation,11/18493,0.02296104,0.044974375,0.015646305,2147,F2,0.007878337,1
BP,GO:0048742,regulation of skeletal muscle fiber development,11/18493,0.02296104,0.044974375,0.015646305,596,BCL2,0.004008901,1
BP,GO:0051024,positive regulation of immunoglobulin secretion,11/18493,0.02296104,0.044974375,0.015646305,3569,IL6,0.015917711,1
BP,GO:0060439,trachea morphogenesis,11/18493,0.02296104,0.044974375,0.015646305,5594,MAPK1,0.012146404,1
BP,GO:0060947,cardiac vascular smooth muscle cell differentiation,11/18493,0.02296104,0.044974375,0.015646305,7422,VEGFA,0.013301852,1
BP,GO:0061307,cardiac neural crest cell differentiation involved in heart development,11/18493,0.02296104,0.044974375,0.015646305,5594,MAPK1,0.012146404,1
BP,GO:0061308,cardiac neural crest cell development involved in heart development,11/18493,0.02296104,0.044974375,0.015646305,5594,MAPK1,0.012146404,1
BP,GO:0070106,interleukin-27-mediated signaling pathway,11/18493,0.02296104,0.044974375,0.015646305,6774,STAT3,0.014022714,1
BP,GO:0070587,regulation of cell-cell adhesion involved in gastrulation,11/18493,0.02296104,0.044974375,0.015646305,3586,IL10,0.012232214,1
BP,GO:0070673,response to interleukin-18,11/18493,0.02296104,0.044974375,0.015646305,207,AKT1,0.014530415,1
BP,GO:0070757,interleukin-35-mediated signaling pathway,11/18493,0.02296104,0.044974375,0.015646305,6774,STAT3,0.014022714,1
BP,GO:0071281,cellular response to iron ion,11/18493,0.02296104,0.044974375,0.015646305,3162,HMOX1,0.010995456,1
BP,GO:0071639,positive regulation of monocyte chemotactic protein-1 production,11/18493,0.02296104,0.044974375,0.015646305,3553,IL1B,0.01301166,1
BP,GO:0099133,ATP hydrolysis coupled anion transmembrane transport,11/18493,0.02296104,0.044974375,0.015646305,1080,CFTR,0.003891991,1
BP,GO:1902950,regulation of dendritic spine maintenance,11/18493,0.02296104,0.044974375,0.015646305,3630,INS,0.015867935,1
BP,GO:1990440,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,11/18493,0.02296104,0.044974375,0.015646305,7157,TP53,0.013178365,1
BP,GO:0030258,lipid modification,291/18493,0.023222443,0.045453479,0.015812982,207/5468/7941,"AKT1,PPARG,PLA2G7",0.031724387,3
BP,GO:0006911,"phagocytosis, engulfment",112/18493,0.023283421,0.045474118,0.015820162,5468/948,"PPARG,CD36",0.015400595,2
BP,GO:0046717,acid secretion,112/18493,0.023283421,0.045474118,0.015820162,3553/4843,"IL1B,NOS2",0.022080949,2
BP,GO:0098732,macromolecule deacylation,112/18493,0.023283421,0.045474118,0.015820162,7422/3458,"VEGFA,IFNG",0.024297018,2
BP,GO:0006090,pyruvate metabolic process,113/18493,0.023671776,0.046132676,0.01604927,3630/6774,"INS,STAT3",0.029645594,2
BP,GO:0042303,molting cycle,113/18493,0.023671776,0.046132676,0.01604927,5743/596,"PTGS2,BCL2",0.016383975,2
BP,GO:0042633,hair cycle,113/18493,0.023671776,0.046132676,0.01604927,5743/596,"PTGS2,BCL2",0.016383975,2
BP,GO:1990778,protein localization to cell periphery,294/18493,0.023847717,0.046442099,0.016156916,3630/207/3458,"INS,AKT1,IFNG",0.041050916,3
BP,GO:0072089,stem cell proliferation,114/18493,0.02406281,0.046827267,0.016290914,7422/5243,"VEGFA,ABCB1",0.017947101,2
BP,GO:0006754,ATP biosynthetic process,116/18493,0.024852865,0.047633031,0.016571234,3630/6774,"INS,STAT3",0.029337163,2
BP,GO:0009132,nucleoside diphosphate metabolic process,116/18493,0.024852865,0.047633031,0.016571234,3630/6774,"INS,STAT3",0.029337163,2
BP,GO:0030968,endoplasmic reticulum unfolded protein response,116/18493,0.024852865,0.047633031,0.016571234,6347/3576,"CCL2,CXCL8",0.025965477,2
BP,GO:0051928,positive regulation of calcium ion transport,116/18493,0.024852865,0.047633031,0.016571234,6347/2147,"CCL2,F2",0.020868464,2
BP,GO:0002551,mast cell chemotaxis,12/18493,0.025022749,0.047633031,0.016571234,7422,VEGFA,0.013055542,1
BP,GO:0006983,ER overload response,12/18493,0.025022749,0.047633031,0.016571234,7157,TP53,0.012934341,1
BP,GO:0008228,opsonization,12/18493,0.025022749,0.047633031,0.016571234,1401,CRP,0.012871966,1
BP,GO:0010763,positive regulation of fibroblast migration,12/18493,0.025022749,0.047633031,0.016571234,207,AKT1,0.014261355,1
BP,GO:0010935,regulation of macrophage cytokine production,12/18493,0.025022749,0.047633031,0.016571234,948,CD36,0.003072977,1
BP,GO:0033004,negative regulation of mast cell activation,12/18493,0.025022749,0.047633031,0.016571234,3162,HMOX1,0.010791853,1
BP,GO:0042908,xenobiotic transport,12/18493,0.025022749,0.047633031,0.016571234,5243,ABCB1,0.004791539,1
BP,GO:0044650,adhesion of symbiont to host cell,12/18493,0.025022749,0.047633031,0.016571234,3383,ICAM1,0.01179013,1
BP,GO:0045091,regulation of single stranded viral RNA replication via double stranded DNA intermediate,12/18493,0.025022749,0.047633031,0.016571234,3576,CXCL8,0.012829467,1
BP,GO:0045342,MHC class II biosynthetic process,12/18493,0.025022749,0.047633031,0.016571234,3586,IL10,0.01200571,1
BP,GO:0045779,negative regulation of bone resorption,12/18493,0.025022749,0.047633031,0.016571234,3569,IL6,0.015622962,1
BP,GO:0045820,negative regulation of glycolytic process,12/18493,0.025022749,0.047633031,0.016571234,6774,STAT3,0.013763055,1
BP,GO:0051549,positive regulation of keratinocyte migration,12/18493,0.025022749,0.047633031,0.016571234,4318,MMP9,0.012466094,1
BP,GO:0051873,killing by host of symbiont cells,12/18493,0.025022749,0.047633031,0.016571234,2147,F2,0.007732454,1
BP,GO:0060019,radial glial cell differentiation,12/18493,0.025022749,0.047633031,0.016571234,6774,STAT3,0.013763055,1
BP,GO:0060081,membrane hyperpolarization,12/18493,0.025022749,0.047633031,0.016571234,1080,CFTR,0.003819922,1
BP,GO:0060670,branching involved in labyrinthine layer morphogenesis,12/18493,0.025022749,0.047633031,0.016571234,3586,IL10,0.01200571,1
BP,GO:0061430,bone trabecula morphogenesis,12/18493,0.025022749,0.047633031,0.016571234,4313,MMP2,0.01043599,1
BP,GO:0061478,response to platelet aggregation inhibitor,12/18493,0.025022749,0.047633031,0.016571234,1080,CFTR,0.003819922,1
BP,GO:0070486,leukocyte aggregation,12/18493,0.025022749,0.047633031,0.016571234,3553,IL1B,0.012770723,1
BP,GO:0070586,cell-cell adhesion involved in gastrulation,12/18493,0.025022749,0.047633031,0.016571234,3586,IL10,0.01200571,1
BP,GO:0071679,commissural neuron axon guidance,12/18493,0.025022749,0.047633031,0.016571234,7422,VEGFA,0.013055542,1
BP,GO:1901550,regulation of endothelial cell development,12/18493,0.025022749,0.047633031,0.016571234,3553,IL1B,0.012770723,1
BP,GO:1903140,regulation of establishment of endothelial barrier,12/18493,0.025022749,0.047633031,0.016571234,3553,IL1B,0.012770723,1
BP,GO:1905461,positive regulation of vascular associated smooth muscle cell apoptotic process,12/18493,0.025022749,0.047633031,0.016571234,5468,PPARG,0.01209649,1
BP,GO:2000121,regulation of removal of superoxide radicals,12/18493,0.025022749,0.047633031,0.016571234,948,CD36,0.003072977,1
BP,GO:2001223,negative regulation of neuron migration,12/18493,0.025022749,0.047633031,0.016571234,6774,STAT3,0.013763055,1
BP,GO:0001704,formation of primary germ layer,118/18493,0.025653486,0.048696618,0.01694125,4318/4313,"MMP9,MMP2",0.02273595,2
BP,GO:0009063,cellular amino acid catabolic process,118/18493,0.025653486,0.048696618,0.01694125,4846/4843,"NOS3,NOS2",0.020188051,2
BP,GO:0010811,positive regulation of cell-substrate adhesion,118/18493,0.025653486,0.048696618,0.01694125,7422/948,"VEGFA,CD36",0.016011521,2
BP,GO:0019730,antimicrobial humoral response,118/18493,0.025653486,0.048696618,0.01694125,3576/2147,"CXCL8,F2",0.020412763,2
BP,GO:0010948,negative regulation of cell cycle process,304/18493,0.025998091,0.049316155,0.017156783,6347/7157/596,"CCL2,TP53,BCL2",0.029662754,3
CC,GO:0034358,plasma lipoprotein particle,38/19659,9.30E-07,5.28E-05,3.50E-05,4023/5444/7941/1071,"LPL,PON1,PLA2G7,CETP",0.077647987,4
CC,GO:1990777,lipoprotein particle,38/19659,9.30E-07,5.28E-05,3.50E-05,4023/5444/7941/1071,"LPL,PON1,PLA2G7,CETP",0.077647987,4
CC,GO:0032994,protein-lipid complex,40/19659,1.15E-06,5.28E-05,3.50E-05,4023/5444/7941/1071,"LPL,PON1,PLA2G7,CETP",0.077647987,4
CC,GO:0045121,membrane raft,304/19659,1.99E-06,5.60E-05,3.72E-05,5743/5594/3383/836/4846/3162/948,"PTGS2,MAPK1,ICAM1,CASP3,NOS3,HMOX1,CD36",0.23402098,7
CC,GO:0098857,membrane microdomain,305/19659,2.03E-06,5.60E-05,3.72E-05,5743/5594/3383/836/4846/3162/948,"PTGS2,MAPK1,ICAM1,CASP3,NOS3,HMOX1,CD36",0.23402098,7
CC,GO:0098589,membrane region,316/19659,2.57E-06,5.90E-05,3.92E-05,5743/5594/3383/836/4846/3162/948,"PTGS2,MAPK1,ICAM1,CASP3,NOS3,HMOX1,CD36",0.232769921,7
CC,GO:0005901,caveola,77/19659,1.61E-05,0.000317862,0.000210938,5743/5594/4846/3162,"PTGS2,MAPK1,NOS3,HMOX1",0.122621919,4
CC,GO:0034774,secretory granule lumen,321/19659,3.75E-05,0.000583919,0.000387498,3630/7422/5594/4353/5054/847,"INS,VEGFA,MAPK1,MPO,SERPINE1,CAT",0.178872021,6
CC,GO:0031012,extracellular matrix,490/19659,4.41E-05,0.000583919,0.000387498,7422/4318/3383/5054/4313/4312/4314,"VEGFA,MMP9,ICAM1,SERPINE1,MMP2,MMP1,MMP3",0.187738728,7
CC,GO:0044853,plasma membrane raft,102/19659,4.89E-05,0.000583919,0.000387498,5743/5594/4846/3162,"PTGS2,MAPK1,NOS3,HMOX1",0.113362826,4
CC,GO:0060205,cytoplasmic vesicle lumen,338/19659,4.99E-05,0.000583919,0.000387498,3630/7422/5594/4353/5054/847,"INS,VEGFA,MAPK1,MPO,SERPINE1,CAT",0.178872021,6
CC,GO:0031983,vesicle lumen,339/19659,5.08E-05,0.000583919,0.000387498,3630/7422/5594/4353/5054/847,"INS,VEGFA,MAPK1,MPO,SERPINE1,CAT",0.178872021,6
CC,GO:0009897,external side of plasma membrane,359/19659,0.000682616,0.007246228,0.004808709,3383/7412/959/2147/948,"ICAM1,VCAM1,CD40LG,F2,CD36",0.067925941,5
CC,GO:0031091,platelet alpha granule,91/19659,0.000777214,0.007661114,0.005084035,7422/5054/948,"VEGFA,SERPINE1,CD36",0.04322384,3
CC,GO:0044438,microbody part,101/19659,0.001051679,0.00907073,0.006019478,847/4843/3156,"CAT,NOS2,HMGCR",0.038312047,3
CC,GO:0044439,peroxisomal part,101/19659,0.001051679,0.00907073,0.006019478,847/4843/3156,"CAT,NOS2,HMGCR",0.038312047,3
CC,GO:0034364,high-density lipoprotein particle,26/19659,0.001209375,0.009817283,0.006514902,5444/1071,"PON1,CETP",0.017370428,2
CC,GO:1904813,ficolin-1-rich granule lumen,124/19659,0.001896544,0.01454017,0.009649083,4318/5594/847,"MMP9,MAPK1,CAT",0.048578181,3
CC,GO:0005777,peroxisome,134/19659,0.002365251,0.016320232,0.01083036,847/4843/3156,"CAT,NOS2,HMGCR",0.033526993,3
CC,GO:0042579,microbody,134/19659,0.002365251,0.016320232,0.01083036,847/4843/3156,"CAT,NOS2,HMGCR",0.033526993,3
CC,GO:0005788,endoplasmic reticulum lumen,301/19659,0.002905784,0.019095155,0.012671842,3569/3630/5743/2147,"IL6,INS,PTGS2,F2",0.066584733,4
CC,GO:0090575,RNA polymerase II transcription factor complex,161/19659,0.00396915,0.02474295,0.016419807,6774/7157/5468,"STAT3,TP53,PPARG",0.047140646,3
CC,GO:0062023,collagen-containing extracellular matrix,332/19659,0.004123825,0.02474295,0.016419807,4318/3383/5054/4313,"MMP9,ICAM1,SERPINE1,MMP2",0.055379525,4
CC,GO:0005782,peroxisomal matrix,52/19659,0.00477645,0.026366004,0.017496891,847/4843,"CAT,NOS2",0.023342152,2
CC,GO:0031907,microbody lumen,52/19659,0.00477645,0.026366004,0.017496891,847/4843,"CAT,NOS2",0.023342152,2
CC,GO:0101002,ficolin-1-rich granule,185/19659,0.00584253,0.030038739,0.019934175,4318/5594/847,"MMP9,MAPK1,CAT",0.040247211,3
CC,GO:0045177,apical part of cell,373/19659,0.006212447,0.030038739,0.019934175,7412/5243/1080/948,"VCAM1,ABCB1,CFTR,CD36",0.026794697,4
CC,GO:0005778,peroxisomal membrane,60/19659,0.006312489,0.030038739,0.019934175,847/3156,"CAT,HMGCR",0.018218108,2
CC,GO:0031903,microbody membrane,60/19659,0.006312489,0.030038739,0.019934175,847/3156,"CAT,HMGCR",0.018218108,2
CC,GO:0044798,nuclear transcription factor complex,198/19659,0.007044784,0.032406006,0.02150513,6774/7157/5468,"STAT3,TP53,PPARG",0.043702431,3
CC,GO:0031093,platelet alpha granule lumen,67/19659,0.007816764,0.034797209,0.023091969,7422/5054,"VEGFA,SERPINE1",0.026406264,2
MF,GO:0005126,cytokine receptor binding,281/17632,3.81E-10,9.56E-08,5.33E-08,3569/6774/6347/7422/3576/3553/3586/836/3458/959,"IL6,STAT3,CCL2,VEGFA,CXCL8,IL1B,IL10,CASP3,IFNG,CD40LG",0.655185839,10
MF,GO:0005125,cytokine activity,219/17632,2.20E-08,2.76E-06,1.54E-06,3569/6347/7422/3576/3553/3586/3458/959,"IL6,CCL2,VEGFA,CXCL8,IL1B,IL10,IFNG,CD40LG",0.412371238,8
MF,GO:0048018,receptor ligand activity,478/17632,6.13E-08,5.13E-06,2.86E-06,3569/3630/6347/7422/3576/3553/3586/3458/959/2147,"IL6,INS,CCL2,VEGFA,CXCL8,IL1B,IL10,IFNG,CD40LG,F2",0.485711069,10
MF,GO:0019902,phosphatase binding,178/17632,1.11E-07,6.98E-06,3.89E-06,207/6774/7157/5468/5594/3156/596,"AKT1,STAT3,TP53,PPARG,MAPK1,HMGCR,BCL2",0.289257733,7
MF,GO:0020037,heme binding,131/17632,4.00E-07,1.67E-05,9.33E-06,5743/4846/4353/3162/847/4843,"PTGS2,NOS3,MPO,HMOX1,CAT,NOS2",0.235227362,6
MF,GO:0019903,protein phosphatase binding,133/17632,4.37E-07,1.67E-05,9.33E-06,207/6774/7157/5468/3156/596,"AKT1,STAT3,TP53,PPARG,HMGCR,BCL2",0.224893496,6
MF,GO:0051721,protein phosphatase 2A binding,29/17632,4.66E-07,1.67E-05,9.33E-06,207/7157/3156/596,"AKT1,TP53,HMGCR,BCL2",0.131463227,4
MF,GO:0046906,tetrapyrrole binding,141/17632,6.17E-07,1.94E-05,1.08E-05,5743/4846/4353/3162/847/4843,"PTGS2,NOS3,MPO,HMOX1,CAT,NOS2",0.232092736,6
MF,GO:0050661,NADP binding,50/17632,4.37E-06,0.000121976,6.80E-05,4846/847/4843/3156,"NOS3,CAT,NOS2,HMGCR",0.107035278,4
MF,GO:0002020,protease binding,125/17632,7.84E-06,0.000196874,0.00010981,3630/7157/836/5054/596,"INS,TP53,CASP3,SERPINE1,BCL2",0.153835937,5
MF,GO:0048037,cofactor binding,495/17632,9.29E-05,0.002120801,0.001182917,5743/4846/4353/3162/847/4843/3156,"PTGS2,NOS3,MPO,HMOX1,CAT,NOS2,HMGCR",0.142284085,7
MF,GO:0004222,metalloendopeptidase activity,113/17632,0.000110644,0.002314296,0.001290842,4318/4313/4312/4314,"MMP9,MMP2,MMP1,MMP3",0.081793843,4
MF,GO:0070851,growth factor receptor binding,132/17632,0.000201469,0.003577669,0.001995513,3569/7422/3553/3586,"IL6,VEGFA,IL1B,IL10",0.098913063,4
MF,GO:0004601,peroxidase activity,52/17632,0.000205135,0.003577669,0.001995513,5743/4353/847,"PTGS2,MPO,CAT",0.062874027,3
MF,GO:0004252,serine-type endopeptidase activity,250/17632,0.000213805,0.003577669,0.001995513,4318/4313/4312/4314/2147,"MMP9,MMP2,MMP1,MMP3,F2",0.090230845,5
MF,GO:0016684,"oxidoreductase activity, acting on peroxide as acceptor",56/17632,0.000255732,0.004011798,0.002237656,5743/4353/847,"PTGS2,MPO,CAT",0.061595705,3
MF,GO:0008236,serine-type peptidase activity,273/17632,0.000321029,0.004739896,0.002643767,4318/4313/4312/4314/2147,"MMP9,MMP2,MMP1,MMP3,F2",0.085724884,5
MF,GO:0017171,serine hydrolase activity,277/17632,0.000343216,0.004785958,0.002669459,4318/4313/4312/4314/2147,"MMP9,MMP2,MMP1,MMP3,F2",0.085569972,5
MF,GO:0016653,"oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor",13/17632,0.000366168,0.004837268,0.002698078,4846/4843,"NOS3,NOS2",0.035613993,2
MF,GO:0042379,chemokine receptor binding,66/17632,0.000415761,0.00493508,0.002752634,6774/6347/3576,"STAT3,CCL2,CXCL8",0.06931594,3
MF,GO:0016705,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen",161/17632,0.000429408,0.00493508,0.002752634,5743/4846/3162/4843,"PTGS2,NOS3,HMOX1,NOS2",0.075732634,4
MF,GO:0008201,heparin binding,163/17632,0.000449928,0.00493508,0.002752634,7422/4353/2147/4023,"VEGFA,MPO,F2,LPL",0.069090199,4
MF,GO:0008083,growth factor activity,166/17632,0.000482007,0.00493508,0.002752634,3569/7422/3586/2147,"IL6,VEGFA,IL10,F2",0.084474474,4
MF,GO:0010181,FMN binding,15/17632,0.000491542,0.00493508,0.002752634,4846/4843,"NOS3,NOS2",0.035480267,2
MF,GO:0030169,low-density lipoprotein particle binding,15/17632,0.000491542,0.00493508,0.002752634,1401/948,"CRP,CD36",0.027819772,2
MF,GO:0008237,metallopeptidase activity,189/17632,0.000784488,0.00757333,0.004224168,4318/4313/4312/4314,"MMP9,MMP2,MMP1,MMP3",0.065815192,4
MF,GO:0016209,antioxidant activity,86/17632,0.000901876,0.008384109,0.004676395,5743/4353/847,"PTGS2,MPO,CAT",0.053368474,3
MF,GO:0004620,phospholipase activity,99/17632,0.001355113,0.012147617,0.006775563,3162/4023/7941,"HMOX1,LPL,PLA2G7",0.033837996,3
MF,GO:0005539,glycosaminoglycan binding,222/17632,0.001424116,0.012325972,0.006875044,7422/4353/2147/4023,"VEGFA,MPO,F2,LPL",0.057183516,4
MF,GO:0071813,lipoprotein particle binding,28/17632,0.001737714,0.014069877,0.00784774,1401/948,"CRP,CD36",0.022332342,2
MF,GO:0071814,protein-lipid complex binding,28/17632,0.001737714,0.014069877,0.00784774,1401/948,"CRP,CD36",0.022332342,2
MF,GO:1901681,sulfur compound binding,242/17632,0.00195272,0.015316645,0.008543149,7422/4353/2147/4023,"VEGFA,MPO,F2,LPL",0.054357779,4
MF,GO:0005178,integrin binding,126/17632,0.002698915,0.020375358,0.011364741,3553/3383/7412,"IL1B,ICAM1,VCAM1",0.046230197,3
MF,GO:0016298,lipase activity,127/17632,0.002760009,0.020375358,0.011364741,3162/4023/7941,"HMOX1,LPL,PLA2G7",0.029870124,3
MF,GO:0001103,RNA polymerase II repressing transcription factor binding,38/17632,0.003187029,0.022220675,0.012394002,6774/5468,"STAT3,PPARG",0.032336716,2
MF,GO:0016248,channel inhibitor activity,38/17632,0.003187029,0.022220675,0.012394002,596/1080,"BCL2,CFTR",0.009696922,2
MF,GO:0016709,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen",39/17632,0.003354624,0.022757041,0.01269317,4846/4843,"NOS3,NOS2",0.02526979,2
MF,GO:0050662,coenzyme binding,285/17632,0.00352284,0.022796924,0.012715416,4846/847/4843/3156,"NOS3,CAT,NOS2,HMGCR",0.044909954,4
MF,GO:0052689,carboxylic ester hydrolase activity,139/17632,0.003560535,0.022796924,0.012715416,4023/5444/7941,"LPL,PON1,PLA2G7",0.023940531,3
MF,GO:0001085,RNA polymerase II transcription factor binding,140/17632,0.003632976,0.022796924,0.012715416,6774/7157/5468,"STAT3,TP53,PPARG",0.048184524,3
MF,GO:0004712,protein serine/threonine/tyrosine kinase activity,43/17632,0.00406531,0.024295067,0.013551033,207/5594,"AKT1,MAPK1",0.031973368,2
MF,GO:0048020,CCR chemokine receptor binding,43/17632,0.00406531,0.024295067,0.013551033,6774/6347,"STAT3,CCL2",0.032847987,2
MF,GO:0032813,tumor necrosis factor receptor superfamily binding,46/17632,0.004640154,0.027085549,0.015107478,836/959,"CASP3,CD40LG",0.022930154,2
MF,GO:0008009,chemokine activity,49/17632,0.005250325,0.029800713,0.016621912,6347/3576,"CCL2,CXCL8",0.02996572,2
MF,GO:0004879,nuclear receptor activity,50/17632,0.005461485,0.029800713,0.016621912,6774/5468,"STAT3,PPARG",0.029843469,2
MF,GO:0098531,"transcription factor activity, direct ligand regulated sequence-specific DNA binding",50/17632,0.005461485,0.029800713,0.016621912,6774/5468,"STAT3,PPARG",0.029843469,2
MF,GO:0043621,protein self-association,55/17632,0.006574781,0.03511213,0.019584455,7157/5468,"TP53,PPARG",0.027538494,2
MF,GO:0016597,amino acid binding,59/17632,0.007533391,0.039393357,0.02197239,4846/4843,"NOS3,NOS2",0.021604302,2
MF,GO:0031406,carboxylic acid binding,192/17632,0.008710836,0.04462081,0.024888101,5468/4846/4843,"PPARG,NOS3,NOS2",0.033128017,3
MF,GO:0005548,phospholipid transporter activity,65/17632,0.009082069,0.045591986,0.025429793,5243/1071,"ABCB1,CETP",0.009653783,2
